
<html lang="en"     class="pb-page"  data-request-id="767d77e7-db02-41da-877e-5a79f90ed182"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2008.51.issue-7;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm7011563;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and Related Heteroaromatic Bicyclic Systems" /></meta><meta name="dc.Creator" content="Andrea  Cappelli" /></meta><meta name="dc.Creator" content="Chiara  Nannicini" /></meta><meta name="dc.Creator" content="Andrea  Gallelli" /></meta><meta name="dc.Creator" content="Germano  Giuliani" /></meta><meta name="dc.Creator" content="Salvatore  Valenti" /></meta><meta name="dc.Creator" content="Gal.la Pericot  Mohr" /></meta><meta name="dc.Creator" content="Maurizio  Anzini" /></meta><meta name="dc.Creator" content="Laura  Mennuni" /></meta><meta name="dc.Creator" content="Flora  Ferrari" /></meta><meta name="dc.Creator" content="Gianfranco  Caselli" /></meta><meta name="dc.Creator" content="Antonio  Giordani" /></meta><meta name="dc.Creator" content="Walter  Peris" /></meta><meta name="dc.Creator" content="Francesco  Makovec" /></meta><meta name="dc.Creator" content="Gianluca  Giorgi" /></meta><meta name="dc.Creator" content="Salvatore  Vomero" /></meta><meta name="dc.Description" content="Novel AT1 receptor antagonists bearing the pyrazolo[3,4-b]pyridine bicyclic heteroaromatic system (or structurally related moieties) were designed and synthesized as the final step of a large progr..." /></meta><meta name="Description" content="Novel AT1 receptor antagonists bearing the pyrazolo[3,4-b]pyridine bicyclic heteroaromatic system (or structurally related moieties) were designed and synthesized as the final step of a large progr..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 5, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm7011563" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm7011563" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm7011563" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm7011563" /></link>
        
    
    

<title>Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and Related Heteroaromatic Bicyclic Systems | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm7011563" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and Related Heteroaromatic Bicyclic Systems" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0019.jpeg" /></meta><meta property="og:description" content=" Novel AT1 receptor antagonists bearing the pyrazolo[3,4-b]pyridine bicyclic heteroaromatic system (or structurally related moieties) were designed and synthesized as the final step of a large program devoted to the development of new antihypertensive agents and to the understanding of the molecular basis of their pharmacodynamic and pharmacokinetic properties. The preliminary pharmacological characterization revealed nanomolar AT1 receptor affinity for several compounds of the series and a potent antagonistic activity in isolated rabbit aortic strip functional assay for 7c and 8a. These results stimulated the study of the biopharmaceutical properties of some selected compounds, which were found to be characterized by a permeability from medium to high. Remarkably, the least permeable 7c showed both permeability and oral bioavailability (80%) higher than losartan, but its terminal half-life was shorter. These results suggest that the permeability is not a limiting factor in the pharmacokinetics of these AT1 receptor antagonists." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm7011563"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm7011563">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm7011563&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm7011563&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm7011563&amp;href=/doi/10.1021/jm7011563" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2137-2146</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm700961r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm701437d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Evaluation of AT<sub>1</sub> Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-<i>b</i>]pyridine and Related Heteroaromatic Bicyclic Systems</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Cappelli">Andrea Cappelli</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Nannicini">Chiara Nannicini</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Gallelli">Andrea Gallelli</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Germano++Giuliani">Germano Giuliani</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Salvatore++Valenti">Salvatore Valenti</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gal.la+Pericot++Mohr">Gal.la Pericot Mohr</a></span><span class="author-xref-symbol "><sup>Â§</sup></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maurizio++Anzini">Maurizio Anzini</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Mennuni">Laura Mennuni</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Flora++Ferrari">Flora Ferrari</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gianfranco++Caselli">Gianfranco Caselli</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Giordani">Antonio Giordani</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walter++Peris">Walter Peris</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Makovec">Francesco Makovec</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gianluca++Giorgi">Gianluca Giorgi</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Salvatore++Vomero">Salvatore Vomero</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Tel: +39 0577 234320 . Fax: +39 0577 234333. E-mail: <a href="/cdn-cgi/l/email-protection#05666475756069696c45706b6c766c2b6c71"><span class="__cf_email__" data-cfemail="fc9f9d8c8c99909095bc8992958f95d29588">[emailÂ protected]</span></a></div><div class="corresp-fn" id="afn1">â Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena.</div><div class="corresp-fn" id="afn2">â¡Present address: Dipartimento di Scienze Farmacobiologiche, UniversitÃ  degli Studi Magna GrÃ¦cia di Catanzaro, Complesso NinÃ¬ Barbieri, 88021, Roccelletta di Borgia (CZ), Italy.</div><div class="corresp-fn" id="fn2">Â§Present address: Medicinal Chemistry, Siena Biotech, Via Torre Fiorentina 1, 53100 Siena, Italy.</div><div class="corresp-fn" id="afn3">â¥Rottapharm S.p.A.</div><div class="corresp-fn" id="afn4">â¥Dipartimento di Chimica, UniversitÃ  di Siena.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm7011563&amp;href=/doi/10.1021%2Fjm7011563" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2137â2146</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 5, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 September 2007</li><li><span class="item_label"><b>Published</b> online</span>5 March 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 April 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm7011563" title="DOI URL">https://doi.org/10.1021/jm7011563</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2137%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAndrea%2BCappelli%252C%2BChiara%2BNannicini%252C%2BAndrea%2BGallelli%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D7%26contentID%3Djm7011563%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BAT1%2BAngiotensin%2BII%2BReceptor%2BAntagonists%2BBased%2Bon%2Bthe%2BPyrazolo%255B3%252C4-b%255Dpyridine%2Band%2BRelated%2BHeteroaromatic%2BBicyclic%2BSystems%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2146%26publicationDate%3DApril%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm7011563"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2463</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">49</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm7011563" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and Related Heteroaromatic Bicyclic Systems&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Cappelli&quot;},{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Nannicini&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Gallelli&quot;},{&quot;first_name&quot;:&quot;Germano&quot;,&quot;last_name&quot;:&quot;Giuliani&quot;},{&quot;first_name&quot;:&quot;Salvatore&quot;,&quot;last_name&quot;:&quot;Valenti&quot;},{&quot;first_name&quot;:&quot;Gal.la&quot;,&quot;last_name&quot;:&quot;Pericot Mohr&quot;},{&quot;first_name&quot;:&quot;Maurizio&quot;,&quot;last_name&quot;:&quot;Anzini&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Mennuni&quot;},{&quot;first_name&quot;:&quot;Flora&quot;,&quot;last_name&quot;:&quot;Ferrari&quot;},{&quot;first_name&quot;:&quot;Gianfranco&quot;,&quot;last_name&quot;:&quot;Caselli&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Giordani&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;Peris&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Makovec&quot;},{&quot;first_name&quot;:&quot;Gianluca&quot;,&quot;last_name&quot;:&quot;Giorgi&quot;},{&quot;first_name&quot;:&quot;Salvatore&quot;,&quot;last_name&quot;:&quot;Vomero&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;2137-2146&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm7011563&quot;},&quot;abstract&quot;:&quot;Novel AT1 receptor antagonists bearing the pyrazolo[3,4-b]pyridine bicyclic heteroaromatic system (or structurally related moieties) were designed and synthesized as the final step of a large program devoted to the development of new antihypertensive agents and to the understanding of the molecular basis of their pharmacodynamic and pharmacokinetic properties. The preliminary pharmacological characterization revealed nanomolar AT1 receptor affinity for several compounds of the series and a potent antagonistic activity in isolated rabbit aortic strip functional assay for 7c and 8a. These results stimulated the study of the biopharmaceutical properties of some selected compounds, which were found to be characterized by a permeability from medium to high. Remarkably, the least permeable 7c showed both permeability and oral bioavailability (80%) higher than losartan, but its terminal half-life was shorter. These results suggest that the permeability is not a limiting factor in the pharmacokinetics of these AT1 re&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7011563&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7011563" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7011563&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7011563" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7011563&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7011563" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm7011563&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7011563&amp;href=/doi/10.1021/jm7011563" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm7011563" /></input><a href="/doi/pdf/10.1021/jm7011563" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (786 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm7011563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm7011563%26sid%3Dliteratum%253Aachs%26pmid%3D18318468%26genre%3Darticle%26aulast%3DCappelli%26date%3D2008%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BAT1%2BAngiotensin%2BII%2BReceptor%2BAntagonists%2BBased%2Bon%2Bthe%2BPyrazolo%255B3%252C4-b%255Dpyridine%2Band%2BRelated%2BHeteroaromatic%2BBicyclic%2BSystems%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D7%26spage%3D2137%26epage%3D2146%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Novel AT<sub>1</sub> receptor antagonists bearing the pyrazolo[3,4-<i>b</i>]pyridine bicyclic heteroaromatic system (or structurally related moieties) were designed and synthesized as the final step of a large program devoted to the development of new antihypertensive agents and to the understanding of the molecular basis of their pharmacodynamic and pharmacokinetic properties. The preliminary pharmacological characterization revealed nanomolar AT<sub>1</sub> receptor affinity for several compounds of the series and a potent antagonistic activity in isolated rabbit aortic strip functional assay for <b>7c</b> and <b>8a</b>. These results stimulated the study of the biopharmaceutical properties of some selected compounds, which were found to be characterized by a permeability from medium to high. Remarkably, the least permeable <b>7c</b> showed both permeability and oral bioavailability (80%) higher than losartan, but its terminal half-life was shorter. These results suggest that the permeability is not a limiting factor in the pharmacokinetics of these AT<sub>1</sub> receptor antagonists.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Angiotensin II (Ang II)<a class="ref internalNav" href="#fn1" aria-label="a">a</a> type 1 (AT<sub>1</sub>) receptor belongs to the G protein-coupled receptor superfamily and mediates virtually all the known physiological actions of Ang II through interaction with heterotrimeric G-protein and subsequent activation of several effector systems (phospholipases C, D, A2, adenyl cyclase, etc.). AT<sub>1</sub> receptor shows the seven hydrophobic transmembrane domains forming Î±-helices in the lipid bilayer of the cell membrane and plays a key role in the renin-angiotensin system involved in the regulation of cardiovascular functions and pathophysiology of hypertension.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a><div class="NLM_fn" id="fn1"><i>a</i><p class="last">Abbreviations: Ang II, angiotensin II; DEM, diethoxymethane; DBU, 1,8-diazabicyclo[5.4.0]undec-7-ene; DMEM, Dulbeccoâs modified eagle medium.</p></div></div><div class="NLM_p">The discovery of potent and orally active nonpeptide Ang II antagonists such as losartan and eprosartan has encouraged the development of a large number of similar compounds.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Among them, irbesartan, candesartan, valsartan, telmisartan, tasosartan, and olmesartan are on the market. Most of the developed AT<sub>1</sub> receptor antagonists are characterized by the presence in their structure of the biphenyl fragment bearing an acidic moiety and differ in the nature of the pendent heterocyclic system (valsartan lacks the heterocyclic moiety) connected to the para position of the proximal phenyl.</div><div class="NLM_p">The ortho-fused bicyclic imidazo[4,5-<i>b</i>]pyridine moiety of compound <b>2a</b> (L-158,809) appears to be, from the point of view of the interaction with AT<sub>1</sub> receptor, a particularly effective heterocyclic system.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Indeed, this congener of losartan has been reported to show a subnanomolar AT<sub>1</sub> receptor affinity about 1 order of magnitude higher than that of losartan and represents one of the most potent nonpeptide Ang II antagonists so far developed.</div><div class="NLM_p">On the other hand, irbesartan<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> shows a spirofused bicyclic system, the main axis of which is oriented in a slightly different manner with respect to the corresponding one of compounds <b>2</b>. The bicyclic systems of these two compounds are profoundly different from the steric point of view, but each of them shows two potential hydrogen bond acceptors. These results can be considered representative of the widespread information contained in the literature concerning AT<sub>1</sub> receptor antagonists in suggesting that a large variety of heterocyclic moieties is tolerated by the receptor.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">At the beginning of an investigation devoted to both the development of new antihypertensive agents and the understanding of the molecular basis of their pharmacodynamic and pharmacokinetic properties, we explored the effects of the molecular manipulation of the distal phenyl group of compounds <b>2</b> leading to the development of compounds <b>4</b>â<b>6</b>. Some representative compounds of the series showed in vitro properties comparable to those shown by losartan,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> but pharmacokinetic studies performed with the selected candidates for further preclinical studies revealed low oral bioavailability and a rapid excretion as a possible result of a rapid conjugation with glucuronic acid.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">As a further step of the investigation, the structural modification of imidazo[4,5-<i>b</i>]pyridine moiety of compounds <b>2</b> led to the design of compounds <b>7</b> and <b>8</b>. In the ârecentlyâ described potent AT<sub>1</sub> receptor antagonist <b>9</b> the hydrogen bond acceptor imidazole nitrogen of irbesartan is transformed into a pyrazolidinedione carbonyl and the lipophilic spiro-fused cyclopentane moiety is placed between the two carbonyl groups.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> On the other hand, in compounds <b>7</b> and <b>8</b> the second potential hydrogen bonding acceptor is incorporated into the lipophilic moiety. In the design of these compounds the attention was focused on the effects of the orientation of the bicyclic system in order to obtain information useful to refine the previously published AT<sub>1</sub> receptor model.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p last">In this paper the synthesis, the preliminary pharmacological and biopharmaceutical characterization and the deduction of structureâaffinity relationships of the novel Ang II antagonists <b>7</b> and <b>8</b> are described.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The preparation of tetrazole derivatives <b>7a</b>â<b>p</b> was performed by means of a multistep procedure described in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>â<a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0003.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) SOCl<sub>2</sub>, DMF (cat.); (b) R<sub>1</sub>-NHNH<sub>2</sub>Â·C<sub>2</sub>O<sub>4</sub>H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, NaOH, H<sub>2</sub>O; (c) 1-pentanol, Na<sub>2</sub>CO<sub>3</sub>; (d) NaH, DMF; (e) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, DMF; (f) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0004.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) H<sub>2</sub>, Pd/C, Na<sub>2</sub>CO<sub>3</sub>, C<sub>2</sub>H<sub>5</sub>OH; (b) morpholine, C<sub>2</sub>H<sub>5</sub>OH.</p></p></figure><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0007.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R = H (<b>7j</b>), C(C<sub>6</sub>H<sub>5</sub>)<sub>3</sub> (<b>17j</b>). Reagents: (a) CH<sub>3</sub>ONa, CH<sub>3</sub>OH; (b) CH<sub>3</sub>NH<sub>2</sub>, C<sub>2</sub>H<sub>5</sub>OH.</p></p></figure><div class="NLM_p">The synthesis of pyrazolo[3,4-<i>b</i>]pyridine intermediates <b>16a</b>â<b>k</b>,<b>m</b> was accomplished starting from the suitable commercially available nicotinic acids <b>10</b>â<b>14</b>, which were activated by reaction with thionyl chloride and then made to react with the appropriate hydrazine derivatives to obtain intermediates <b>15a</b>â<b>k</b>,<b>m</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Hydrazide derivatives <b>15a</b>â<b>k</b>,<b>m</b> were then cyclized in refluxing 1-pentanol in the presence of Na<sub>2</sub>CO<sub>3</sub> as the base, to give compounds <b>16a</b>â<b>k</b>,<b>m</b>. Moreover, pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>16j</b>,<b>k</b> were used as starting material for the preparation of <b>16l</b>,<b>p</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><div class="NLM_p">Pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>16</b> are intriguing compounds, which show prototropic tautomerism. For instance, crystallographic analysis of the two homologues <b>16a</b>,<b>c</b> show that they crystallize in different prototropic forms characterized by different crystal colors: red prisms in the case of <b>16a</b> and colorless needles for <b>16c</b> (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structure of pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>16aÂ·H<sub>2</sub>O</b> (left) and <b>16c</b> (right). Ellipsoids enclose 50% probability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Alkylation of <b>16a</b>â<b>m</b>,<b>p</b> with 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> in the presence of NaH as the base gave the expected biphenyl derivatives <b>17a</b>â<b>m</b>,<b>p</b> in acceptable yields, which were deprotected with formic acid to obtain target tetrazole derivatives <b>17a</b>â<b>m</b>,<b>p</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The structure of tetrazole derivative <b>7a</b> was confirmed by single crystal X-ray diffraction studies (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of target compound <b>7a</b>. Ellipsoids enclose 50% probability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The remaining target pyrazolo[3,4-<i>b</i>]pyridine <b>7n</b>,<b>o</b> were prepared by nucleophilic displacement of chlorine atom of <b>17j</b> (in the case of <b>7n</b>) or <b>7j</b> (in the case of <b>7o</b>) with sodium methoxide or methylamine, respectively.</div><div class="NLM_p">Indazolone derivative <b>18</b> was prepared by means of the same chemistry described for pyrazolo[3,4-<i>b</i>]pyridines <b>7a</b>â<b>m</b>,<b>p</b> with the peculiarity that the cyclization of hydrazide derivative <b>20</b> was carried out in the presence of a palladium catalyst (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0008.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>-NHNH<sub>2</sub>Â·C<sub>2</sub>O<sub>4</sub>H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, NaOH, H<sub>2</sub>O; (c) NaOH, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, C<sub>2</sub>H<sub>5</sub>OH; (d) NaH, DMF; (e) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, DMF; (f) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">The target pyrrolo[3,4-<i>b</i>]pyridine derivative <b>7q</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) was synthesized from ethyl 2-methylnicotinate (<b>23</b>), which was brominated and cyclized with propylamine to obtain compound <b>24</b>, the active methylene of which was acylated with dimethyl carbonate in the presence of sodium hydride as the base to give ester <b>25</b>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Compound <b>25</b> was deprotonated with sodium hydride in THF and alkylated with 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole to give biphenyl derivative <b>26</b>, which was promptly deprotected with sodium hydroxide to obtain target tetrazole derivative <b>7q</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0009.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) NBS, benzoyl peroxide, CCl<sub>4</sub>; (b) CH<sub>3</sub>(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub>, C<sub>2</sub>H<sub>5</sub>OH; (c) CH<sub>3</sub>OCOOCH<sub>3</sub>, NaH, DMF; (d) NaH, THF; (e) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, THF; (f) NaOH, H<sub>2</sub>O, C<sub>2</sub>H<sub>5</sub>OH.</p></p></figure><div class="NLM_p">Target compounds <b>8a</b>â<b>c</b> were prepared following the multistep procedure described in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. The introduction of the required lipophilic side chain in position 1 of the pyrazolo[3,4-<i>b</i>]pyridine nucleus was carried out in an indirect manner by reaction of the appropriate ethyl nicotinate derivatives <b>27</b>â<b>29</b> with the suitable alkylhydrazine to obtain bicyclic compounds <b>30</b>â<b>33</b>. Crystallographic studies of compounds <b>30</b> and <b>32</b> showed that these compounds exist in the solid state in the OH-tautomers (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Accordingly, alkylation of <b>30</b> and <b>31</b> with 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole in the presence of sodium hydride as the base led to the O-alkylated derivatives <b>34a</b>,<b>b</b>, which were deprotected to afford the final tetrazole compounds <b>35a</b>,<b>b</b>. Thus, the preparation of compounds <b>8a</b>â<b>c</b> required the development of a convergent procedure similar to that described for the synthesis of losartan (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0010.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R<sub>1</sub> = <i>n</i>-C<sub>3</sub>H<sub>7</sub> (<b>35a</b>), <i>n</i>-C<sub>4</sub>H<sub>9</sub> (<b>35b</b>); R<sub>2</sub> = H (<b>8a</b>), CH<sub>3</sub> (<b>8b</b>), Cl (<b>8c</b>). Reagents: (a) R<sub>1</sub>-NH-NH<sub>2</sub>Â·C<sub>2</sub>O<sub>4</sub>H<sub>2</sub>, TEA, C<sub>2</sub>H<sub>5</sub>OH; (b) NaH, DMF; (c) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, DMF; (d) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>; (e) <i>tert</i>-butyldimethylsilyl trifluoromethanesulfonate, <i>N,N</i>-diisopropylethylamine, THF; (f) Br-C<sub>6</sub>H<sub>4</sub>-CH<sub>2</sub>Br, (<i>n</i>-Bu)<sub>4</sub>NF, THF; (g) 5-(2â²-boronophenyl)-2-(triphenylmethyl)-2<i>H</i>-tetrazole, PPh<sub>3</sub>, Pd(OAc)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, diethoxymethane (DEM), H<sub>2</sub>O.</p></p></figure><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>30</b> (left) and <b>32</b> (right). Ellipsoids enclose 50% probability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>31</b>â<b>33</b> were benzylated with 4-bromobenzyl bromide via the corresponding silyl ether derivatives <b>36a</b>â<b>c</b> to obtain the mixtures of N- and O-alkylated products <b>37</b> and <b>38</b>, respectively. The expected N-alkylated derivatives <b>37a</b>â<b>c</b> were isolated from their respective mixtures by flash chromatography (the structure of <b>37b</b> was confirmed by crystallography, see the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>) and subjected to Suzuki coupling reaction with 5-(2â²-boronophenyl)-2-(triphenylmethyl)-2<i>H</i>-tetrazole<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> to obtain the biphenyl derivatives <b>39a</b>â<b>c</b>; deprotection with formic acid gave final tetrazole derivatives <b>8a</b>â<b>c</b>.</div><div class="NLM_p">Deaza derivatives <b>8d</b>â<b>g</b> were synthesized starting from ethyl 2-methylnicotinate (<b>23</b>) by means of a procedure developed by combining the chemistry<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> used for the preparation of pyrrolo[3,4-<i>b</i>]pyridine derivative <b>7q</b> with the assembly of the biphenyl moiety based on the Suzuki coupling (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The structure of intermediate compounds <b>41</b> and <b>44d</b> was confirmed by crystallographic studies (see the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0012.jpeg" id="gs7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R<sub>1</sub> = H (<b>8d</b>), C<sub>2</sub>H<sub>5</sub> (<b>8e</b>), <i>n</i>-C<sub>3</sub>H<sub>7</sub> (<b>8f</b>), <i>n</i>-C<sub>4</sub>H<sub>9</sub> (<b>8g</b>). Reagents: (a) NBS, benzoyl peroxide, CCl<sub>4</sub>; (b) 4-bromobenzylamine hydrochloride, TEA, C<sub>2</sub>H<sub>5</sub>OH; (c) 5-(2â²-boronophenyl)-2-(triphenylmethyl)-2<i>H</i>-tetrazole, PPh<sub>3</sub>, Pd(OAc)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, DEM, H<sub>2</sub>O; (d) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>; (e) CH<sub>3</sub>OCOOCH<sub>3</sub>, NaH, DMF; (f) DBU, DMF, R<sub>1</sub>I; (g) NaOH, H<sub>2</sub>O, C<sub>2</sub>H<sub>5</sub>OH.</p></p></figure><div class="NLM_p">Finally, the procedure for the synthesis of pyrido[2,3-<i>d</i>]pyridazin-8-one derivative <b>45</b> is reported in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>. Condensation of anhydride <b>46</b> and butylhydrazine in ethanol afforded compound <b>47</b>, which exists in the solid state as the OH-tautomer (see the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>). Reaction with sodium hydride and subsequently with 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> gave the product of O-alkylation <b>48</b>, which was deprotected with formic acid to obtain target compound <b>45</b>.</div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0013.jpeg" id="gs8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) NH<sub>2</sub>NHC<sub>4</sub>H<sub>9</sub><sup>â¢</sup>C<sub>2</sub>O<sub>4</sub>H<sub>2</sub>, TEA, C<sub>2</sub>H<sub>5</sub>OH; (b) NaH, DMF; (c) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, DMF; (d) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> StructureâAffinity Relationship Studies</h3><div class="NLM_p">The newly synthesized bicyclic derivatives <b>7a</b>â<b>q</b>, <b>8a</b>â<b>g</b>, <b>18</b>, <b>35a</b>,<b>b</b>, <b>45</b> (showing a suitable degree of purity as confirmed by <sup>1</sup>H NMR and combustion analyses) were tested for their potential ability to displace [<sup>125</sup>I]Sar1,Ile8-Ang II specifically bound to AT<sub>1</sub> receptor in rat hepatic membranes, in comparison with reference compounds <b>2a</b>,<b>b</b>, losartan, and valsartan, following well-established protocols.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The results of the binding studies summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> show that most of the tested compounds displayed submicromolar affinity for AT<sub>1</sub> receptor with the most potent compound <b>7c</b> and its positional isomer <b>8a</b> showing IC<sub>50</sub> values in the nanomolar range.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. AT<sub>1</sub> Receptor Binding Affinities of Compounds <b>2</b>, <b>7a</b>â<b>q</b>, <b>8a</b>â<b>g</b>, <b>18</b>, <b>35a</b>,<b>b</b>, and <b>45</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0014.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom">X</th><th align="center" valign="bottom">R<sub>1</sub></th><th align="center" valign="bottom">R<sub>2</sub></th><th align="center" valign="bottom">R<sub>3</sub></th><th align="center" valign="bottom">binding IC<sub>50</sub> (nM) Â± SEM<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th align="center" valign="bottom" char=".">rabbit aortic strips p<i>A</i><sub>2</sub><a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>2a</b></td><td align="left">Â </td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">Â </td><td align="left">Â </td><td align="left">0.4âÂ±â0.1</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>2b</b></td><td align="left">Â </td><td align="left"><i>n</i>-C<sub>3</sub>H<sub>7</sub></td><td align="left">Â </td><td align="left">Â </td><td align="left">0.8âÂ±â0.01</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7a</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>3</sub>H<sub>7</sub></td><td align="left">H</td><td align="left">H</td><td align="left">108âÂ±â18</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7b</b></td><td align="left">N</td><td align="left"><i>i</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">H</td><td align="left">H</td><td align="left">2300âÂ±â290</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7c</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">H</td><td align="left">H</td><td align="left">18âÂ±â1</td><td align="char" char=".">7.98</td></tr><tr valign="top"><td align="left"><b>7d</b></td><td align="left">N</td><td align="left"><i>i</i>-C<sub>5</sub>H<sub>11</sub></td><td align="left">H</td><td align="left">H</td><td align="left">124âÂ±â8</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7e</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>5</sub>H<sub>11</sub></td><td align="left">H</td><td align="left">H</td><td align="left">53âÂ±â4</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7f</b></td><td align="left">N</td><td align="left">CH<sub>2</sub>C<sub>6</sub>H<sub>5</sub></td><td align="left">H</td><td align="left">H</td><td align="left">>3000</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7g</b></td><td align="left">N</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">1870âÂ±â555</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7 h</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>3</sub>H<sub>7</sub></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">291âÂ±â29</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7i</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">81âÂ±â18</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7j</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">Cl</td><td align="left">H</td><td align="left">168âÂ±â15</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7k</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">Cl</td><td align="left">F</td><td align="left">427âÂ±â134</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7l</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">H</td><td align="left">F</td><td align="left">70âÂ±â32</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7m</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">H</td><td align="left">Cl</td><td align="left">76âÂ±â29</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7n</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">OCH<sub>3</sub></td><td align="left">H</td><td align="left">258âÂ±â27</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7o</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">NHCH<sub>3</sub></td><td align="left">H</td><td align="left">124âÂ±â16</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7p</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">morpholino</td><td align="left">H</td><td align="left">600âÂ±â97</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>7q</b></td><td align="left">CH</td><td align="left"><i>n</i>-C<sub>3</sub>H<sub>7</sub></td><td align="left">H</td><td align="left">H</td><td align="left">>3000</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>8a</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">H</td><td align="left">Â </td><td align="left">39âÂ±â5</td><td align="char" char=".">7.83</td></tr><tr valign="top"><td align="left"><b>8b</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">CH<sub>3</sub></td><td align="left">Â </td><td align="left">90âÂ±â9</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>8c</b></td><td align="left">N</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">Cl</td><td align="left">Â </td><td align="left">461âÂ±â66</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>8d</b></td><td align="left">CH</td><td align="left">H</td><td align="left">H</td><td align="left">Â </td><td align="left">>10000</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>8e</b></td><td align="left">CH</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">H</td><td align="left">Â </td><td align="left">>10000</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>8f</b></td><td align="left">CH</td><td align="left"><i>n</i>-C<sub>3</sub>H<sub>7</sub></td><td align="left">H</td><td align="left">Â </td><td align="left">154âÂ±â21</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>8g</b></td><td align="left">CH</td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">H</td><td align="left">Â </td><td align="left">95âÂ±â32</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">598âÂ±â72</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>35a</b></td><td align="left">Â </td><td align="left"><i>n</i>-C<sub>3</sub>H<sub>7</sub></td><td align="left">Â </td><td align="left">Â </td><td align="left">146âÂ±â33</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>35b</b></td><td align="left">Â </td><td align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub></td><td align="left">Â </td><td align="left">Â </td><td align="left">254âÂ±â91</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>45</b></td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">114âÂ±â6</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">Ang II</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">0.4âÂ±â0.1</td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">losartan</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">6.7âÂ±â0.5</td><td align="char" char=".">8.48</td></tr><tr valign="top"><td align="left">valsartan</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">3.4âÂ±â0.3</td><td align="char" char=".">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Each value is the mean Â± SEM of 3 determinations and represents the concentration giving half-the maximum inhibition of [<sup>125</sup>I]Sar<sup>1</sup>,Ile<sup>8</sup>-Ang II specific binding to rat hepatic membranes.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">The antagonism of Ang II-contracted rabbit aorta strips was assayed by using 60 min as time of contact of the tested compound. Only one curve was obtained from each strip.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (a) Effects of the Modification of the Heterocyclic System</h3><div class="NLM_p">Among the heterocyclic moieties and their relative orientations with respect to the biphenyltetrazole component investigated in the present work, the pyrazolo[3,4-<i>b</i>]pyridine showing a <b>2a</b>-like orientation typical of compound <b>7c</b> is the most effective configuration from the point of view of the interaction with the AT<sub>1</sub> receptor. However, the difference in affinity between <b>7c</b> and <b>2a</b> suggests that the carbonyl group of <b>7c</b> does not show an optimal geometry for the interaction with the receptor hydrogen-bonding donors (e.g., N111, N294, or S252).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> A similar conclusion has been drawn in the case of pyrazolidinedione derivative <b>9</b>.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">The variation in orientation of the pyrazolo[3,4-<i>b</i>]pyridine heterocyclic system leading to <b>8a</b> has limited effects on the receptor affinity. This result suggests a partial equivalence of the orientations of the pyrazolo[3,4-<i>b</i>]pyridine system shown by compounds <b>7c</b> and <b>8a</b>.</div><div class="NLM_p">A significant affinity decrease is observed when the heterocyclic system of <b>8a</b> is bound to the methylbiphenyltetrazole component by its oxygen atom as it occurs in compounds <b>35a</b>,<b>b</b>. The introduction of a carbonyl group into the pyrazolo[3,4-<i>b</i>]pyridine system of <b>35b</b> leading to pyrido[2,3-<i>d</i>]pyridazino-8-one derivative <b>45</b> has limited effects on the receptor affinity.</div><div class="NLM_p">The replacement of the pyridine nitrogen atom of <b>7c</b> with an aromatic CH group leading to indazolone derivative <b>18</b> produces a considerable (33-fold) decrease in the affinity. The result demonstrates the key role played by the pyridine nitrogen in the interaction with the AT<sub>1</sub> receptor.</div><div class="NLM_p">The transformation of the pyrazolo[3,4-<i>b</i>]pyridine heterocyclic system of <b>7a</b>,<b>c</b> into the pyrrolo[3,4-<i>b</i>]pyridine system of <b>7q</b> has dramatic effects on the AT<sub>1</sub> receptor affinity. This transformation involves an important center of the molecule, which plays the role of linker between the methylbiphenyltetrazole component and the heterocyclic moiety and affects their relative orientation (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superposition of <b>7a</b> crystallographic structure (white) with a low energy conformer of <b>7q</b> (cyan). This result suggests that <b>7q</b>can populate the solid state conformation of <b>7a</b>. Thus, the difference in the AT<sub>1</sub> receptor affinity between <b>7a</b> and <b>7q</b> is probably connected to the relative orientation of the pendent bicyclic system determined by the linker geometry (a sp<sup>3</sup> carbon in the case of <b>7q</b> and a partially pyramidal nitrogen atom for <b>7a</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the other hand, the effect is more limited when the same transformation is carried out in compound <b>8a</b> to obtain <b>8g</b>. In this case, the transformation involves a linking atom bound to a lipophilic substituent, for which the binding prerequisites are likely to be less stringent.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (b) Effects of the Modification of the Lipophilic Substituent on the Five-Membered Ring</h3><div class="NLM_p">The work performed on losartan congeners has demonstrated the importance of a suitable lipophilic substituent at 2-position of imidazole, fused imidazole, or equivalent moieties in the interaction with the AT<sub>1</sub> receptor. While in the case of losartan derivatives the <i>n</i>-propyl and <i>n</i>-butyl chains are optimal,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> in imidazo[4,5-<i>b</i>]pyridine derivatives <b>2</b>, ethyl and <i>n</i>-propyl groups were reported to be equivalent and better than the <i>n</i>-butyl one.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Interestingly, the <i>n</i>-butyl group appears to be the optimal lipophilic substituent in the two short series of pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>7a</b>â<b>f</b> and <b>7g</b>â<b>i</b> and in pyrrolo[3,4-<i>b</i>]pyridine derivatives <b>8d</b>â<b>g</b>. This result seems to suggest different binding modalities between compounds <b>2</b> and our derivatives <b>7</b> and <b>8</b> probably due to the change of the geometry of the hydrogen bonding acceptor (see Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>).</div><figure id="cht1" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0001.jpeg" id="gc1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Compounds <b>1</b>â<b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="cht2" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0002.jpeg" id="gc2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Structures of Compounds <b>2a</b>, <b>7</b>â<b>9</b>, and Irbesartan<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>The potential hydrogen bonding acceptors are indicated in red.</p></p></figure><div class="NLM_p last">Moreover, the structureâaffinity relationship analysis in the series <b>7a</b>â<b>f</b> shows that the linear alkyl chains interact with the binding site more tightly than the branched ones (in agreement with the results described for losartan derivatives;<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> compare <b>7a</b> with <b>7b</b> and <b>7c</b> with <b>7d</b>) and the benzyl substituent of <b>7f</b> is not tolerated at all.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (c) Effects of the Introduction of Substituents on the Pyridine Ring</h3><div class="NLM_p">The introduction of substituents on the pyridine moiety of compound <b>7c</b> has negative effects on the affinity for the receptor, and the extent of the affinity decrease depends on the features of the substituent and on the position involved. In fact, a methyl group (<b>7i</b>) is better tolerated than a chlorine atom (<b>7j</b>), or methoxy (<b>7n</b>) and methylamino (<b>7o</b>) groups, or again a morpholine substituent (<b>7p</b>). Furthermore, the chlorine atom is better tolerated when inserted in position 3 (<b>7m</b>) than position 2 (<b>7j</b>) of the pyridine ring. Finally, the best accepted substitution pattern appears to be a fluorine atom in position 3 (compound <b>7l</b>), while the contemporary presence of the two halogen atoms in positions 2 and 3 of the pyridine ring (<b>7k</b>) produces an important affinity decrease.</div><div class="NLM_p last">It is noteworthy that the insertion of either a methyl group (<b>8b</b>) or a chlorine atom (<b>8c</b>) in the position 2 of the pyridine ring of compound <b>8a</b> has negative effects very similar to those observed in compounds <b>7c</b>,<b>i</b>,<b>j</b>. This result suggests a common role for the pyridine ring of compounds <b>7c</b> and <b>8a</b> in spite of their different orientation with respect to the methylbiphenyltetrazole component.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Functional Studies</h3><div class="NLM_p">The most potent AT<sub>1</sub> receptorâligands <b>7c</b> and <b>8a</b> were selected among the newly synthesized compounds and their potential antagonistic activity was investigated in vitro, using the contractile response of isolated rabbit aortic strips as a functional assay. Tissue preincubation with increasing amounts of compounds <b>7c</b> and <b>8a</b> produced progressive parallel rightward shifts of the endogenous agonist concentrationâresponse curve. Shildâs plot analysis gave derived p<i>A</i><sub>2</sub> values of 7.83 and 7.98 for compound <b>8a</b> and <b>7c</b>, respectively. Nevertheless, differently from losartan and <b>7c</b>, compound <b>8a</b> lowered the upper plateau of the concentrationâresponse curve of Ang II in a concentration-dependent way, providing unambiguous evidence for an insurmountable antagonism (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). This result attains a particular importance in consideration of the fact that <b>7c</b> and <b>8a</b> are position isomers showing the same pendent heterocyclic system in two different orientations (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>) and suggests that the (in)surmountable antagonist properties can be modulated by very small structural changes in these AT<sub>1</sub> receptor antagonists.</div><figure id="fig5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0016.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Concentrationâcontractile response curves for Ang II in isolated rabbit aortic strips, in the presence of different concentrations [10 nM (â¼), 30 nM (â²), or 100 nM (Ã)] of compound <b>8a</b> or of its vehicle (â).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vitro Intestinal Permeability Experiments</h3><div class="NLM_p">The permeability studies performed with Caco-2 monolayers<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> show that pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>7c</b>,<b>m</b>, <b>8a</b>,<b>b</b> and pyrrolo[3,4-<i>b</i>]pyridine derivative <b>8g</b> are characterized by a medium to high permeability in apical to basolateral (AâB) experiments showing <i>P</i><sub>app</sub> values ranging from 1.78 to 10.8 Ã 10<sup>â6</sup> cm/s (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). For comparison, propanolol shows a <i>P</i><sub>app</sub> value of 8.0 Ã 10<sup>â6</sup> cm/s in the same test, cimetidine a <i>P</i><sub>app</sub> value of 1.1 Ã 10<sup>â6</sup> cm/s, and vinblastine (a well-known P-glycoproteinâsubstrate) a <i>P</i><sub>app</sub> value of 0.1 Ã 10<sup>â6</sup> cm/s. All the newly synthesized compounds show a <i>P</i><sub>app</sub> (BâA) value similar to the <i>P</i><sub>app</sub> (AâB) value (BâA/AâB ratio < 2, data not shown) suggesting that <b>7c</b>,<b>m</b>, and <b>8a</b>,<b>b</b>,<b>g</b> are not substrates for efflux. In the short series of the compounds evaluated in such an assay, the least permeable was pyrazolo[3,4-<i>b</i>]pyridine derivative <b>7c</b>, which shows a <i>P</i><sub>app</sub> value slightly higher than those shown by cimetidine and losartan and is about 1 order of magnitude more permeable than the previously described 3-tetrazolylquinolinone derivative <b>4b</b> (CR3210, <i>P</i><sub>app</sub> = 0.1 Ã 10<sup>â6</sup> cm/s).<a onclick="showRef(event, 'cit8c'); return false;" href="javascript:void(0);" class="ref cit8c">(8c)</a> The variation in orientation of the pyrazolo[3,4-<i>b</i>]pyridine heterocyclic system leading to <b>8a</b> has a 2-fold enhancing effect on the permeability, while the introduction of a chlorine atom in position 5 of the pyrazolo[3,4-<i>b</i>]pyridine nucleus of <b>7c</b> produces a more pronounced enhancing effect, so that <b>7m</b> is the most permeable among the compounds tested. On the other hand, the introduction of a methyl group in position 6 of pyrazolo[3,4-<i>b</i>]pyridine nucleus of <b>8a</b>, as well as the transformation of the pyrazolo[3,4-<i>b</i>]pyridine heterocyclic system of <b>7c</b> into pyrrolo[3,4-<i>b</i>]pyridine one of <b>7q</b> slightly improves the permeability. It is noteworthy that the compound showing the highest ClogP (compound <b>8g</b>) is not the most permeable, and more in general, the permeability shown by these compounds is apparently poorly related to their lipophilicity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Parameters of Compounds <b>1</b>, <b>4b</b>, <b>7c</b>,<b>m</b>, and <b>8a</b>,<b>b</b>,<b>g</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0017.gif" alt="" id="gr18" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom" char=".">MW</th><th align="center" valign="bottom" char=".">binding IC<sub>50</sub> (nM)</th><th align="center" valign="bottom" char="."><i>C</i> log <i>P</i><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></th><th align="center" valign="bottom" char=".">Caco-2 permeability <i>P</i><sub>app</sub> (a-b)<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a> (Ã10<sup>â6</sup> cm/s)</th><th align="center" valign="bottom" char=".">dose (mg/kg) (route)</th><th align="center" valign="bottom" char=".">AUC (ÂµgÂ·h/mL)</th><th align="center" valign="bottom" char="."><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a> (h)</th><th align="center" valign="bottom" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a> (Âµg/mL)</th><th align="center" valign="bottom" char="."><i>t</i><sub>max</sub><a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a> (h)</th><th align="center" valign="bottom" char=".">oral bioavail (%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b> (losartan)</td><td align="char" char=".">422.91</td><td align="char" char=".">6.7</td><td align="char" char=".">4.11<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="char" char=".">1.15<a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="char" char=".">3â(iv)</td><td align="char" char=".">12.4</td><td align="char" char=".">4.7</td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">30â(os)</td><td align="char" char=".">74.8</td><td align="char" char=".">3.0</td><td align="char" char=".">27.5</td><td align="char" char=".">0.5</td><td align="char" char=".">60</td></tr><tr valign="top"><td align="left"><b>4b</b></td><td align="char" char=".">460.53</td><td align="char" char=".">6.9</td><td align="char" char=".">4.7</td><td align="char" char=".">0.10</td><td align="char" char=".">3â(iv)</td><td align="char" char=".">0.89</td><td align="char" char=".">0.68</td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">30â(os)</td><td align="char" char=".">4.40</td><td align="char" char=".">1.0</td><td align="char" char=".">4.2</td><td align="char" char=".">0.5</td><td align="char" char=".">49</td></tr><tr valign="top"><td align="left"><b>7c</b></td><td align="char" char=".">425.49</td><td align="char" char=".">18</td><td align="char" char=".">2.95</td><td align="char" char=".">1.78</td><td align="char" char=".">5â(iv)</td><td align="char" char=".">1.41</td><td align="char" char=".">1.0</td><td align="char" char=".">6.32</td><td align="char" char=".">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">15â(os)</td><td align="char" char=".">3.38</td><td align="char" char=".">0.9</td><td align="char" char=".">4.10</td><td align="char" char=".">0.5</td><td align="char" char=".">80</td></tr><tr valign="top"><td align="left"><b>7m</b></td><td align="char" char=".">459.93</td><td align="char" char=".">76</td><td align="char" char=".">3.70</td><td align="char" char=".">10.8</td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>8a</b></td><td align="char" char=".">425.49</td><td align="char" char=".">39</td><td align="char" char=".">2.57</td><td align="char" char=".">3.6</td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>8b</b></td><td align="char" char=".">439.51</td><td align="char" char=".">90</td><td align="char" char=".">3.07</td><td align="char" char=".">8.7</td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left"><b>8g</b></td><td align="char" char=".">424.50</td><td align="char" char=".">95</td><td align="char" char=".">4.49</td><td align="char" char=".">5.6</td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td><td align="char" char=".">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last"><i>C</i> log <i>P</i> calculated by means of CS ChemDraw Ultra 8.0 (Cambridge Soft Corporation, Cambridge, MA 02140 USA).</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Apical to basolateral Caco-2 permeability.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last"><i>t</i><sub>1/2</sub>: terminal half-life.</p></div><div class="footnote" id="tbl2-fn4"><sup>d</sup><p class="last">C<sub>max</sub>: observed maximum concentration after administration.</p></div><div class="footnote" id="tbl2-fn5"><sup>e</sup><p class="last"><i>t</i><sub>max</sub>: time to reach maximum concentration.</p></div><div class="footnote" id="tbl2-fn6"><sup>f</sup><p class="last">For comparison, the log <i>P</i><sub>HPLC</sub> value described in the literature was 4.2; see ref <a class="ref internalNav" href="#ref15" aria-label="15">15</a>.</p></div><div class="footnote" id="tbl2-fn7"><sup>g</sup><p class="last">See ref <a class="ref internalNav" href="#ref15" aria-label="15">15</a>.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Pharmacokinetic Studies</h3><div class="NLM_p last">The pharmacokinetic properties of compound <b>7c</b> were evaluated in rats by standard procedures<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> in comparison with reference AT<sub>1</sub> antagonist <b>1</b> (losartan). The results shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> suggest that this compound is a chemical entity characterized by very good intestinal absorption and rapid excretion in rats. In fact, pyrazolo[3,4-<i>b</i>]pyridine derivative <b>7c</b> showed a bioavailability of 80%, but its terminal half-life ranges from 0.9 to 1.0 h.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>7</b> and <b>8</b> were designed as part of a large program devoted to the development of new antihypertensive agents and to the understanding of the molecular basis of their pharmacodynamic and pharmacokinetic properties.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> The designed compounds were synthesized by combining the classical losartan chemistry (linear and convergent approaches) with the chemistry of pyrazolo[3,4-<i>b</i>]pyridines and pyrrolo[3,4-<i>b</i>]pyridines. Among the newly synthesized bicyclic derivatives, several compounds displayed high affinity for AT<sub>1</sub> receptor. The most potent compounds <b>7c</b> and <b>8a</b> show IC<sub>50</sub> values in the nanomolar range and represent interesting candidates for further preclinical studies. It is noteworthy that compound <b>7c</b> and its positional isomer <b>8a</b> show quite similar IC<sub>50</sub> values: 18 and 39 nM, respectively. This small difference finds a support in the literature when <b>7c</b> and <b>8a</b> are compared with AT<sub>1</sub> receptor antagonists <b>9</b>, <b>49</b>, and <b>50</b> (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>).<sup>9</sup> The attempts to optimize the interaction with the AT<sub>1</sub> receptor failed to give ligands more potent than <b>7c</b> and <b>8a</b>, but they afforded several congeners showing interesting affinities and providing valuable information about the interaction with the receptor.</div><figure id="cht3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0018.jpeg" id="gc3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Structures of Compounds <b>7c</b>, <b>8a</b>, <b>9</b>, <b>49</b>, and <b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>The potential hydrogen bonding acceptors are indicated in red.</p></p></figure><div class="NLM_p">The potential antagonist activity of compounds <b>7c</b> and <b>8a</b> was investigated in vitro, using the contractile response of isolated rabbit aortic strips as a functional assay. In this test, <b>7c</b> was found to behave as a surmountable antagonist, while compound <b>8a</b> lowered the upper plateau of the concentrationâresponse curve of Ang II in a concentration-dependent way, providing unambiguous evidence for an insurmountable antagonism. In view of the fact that <b>7c</b> and <b>8a</b> are position isomers bearing the same pendent bicyclic system in two different orientations, the difference in antagonist behavior suggests that the surmountable/insurmountable antagonist properties can be modulated by very small structural changes.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">The results prompted the characterization of the biopharmaceutical properties of some selected compounds. The investigations showed that pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>7c</b>,<b>m</b>, <b>8a</b>,<b>b</b>, and pyrrolo[3,4-<i>b</i>]pyridine derivative <b>8g</b> are characterized by a permeability from medium to high and are not substrates for efflux. The least permeable <b>7c</b> shows a <i>P</i><sub>app</sub> value (1.78 Ã 10<sup>â6</sup> cm/s) slightly higher that shown by losartan and is about 1 order of magnitude more permeable than the previously described 3-tetrazolylquinolinone derivative <b>4b</b> (<i>P</i><sub>app</sub> = 0.1 Ã 10<sup>â6</sup> cm/s).<a onclick="showRef(event, 'cit8c'); return false;" href="javascript:void(0);" class="ref cit8c">(8c)</a> Moreover, pharmacokinetic studies showed the high oral bioavailability (80%) of <b>7c</b>, which is significantly higher than that shown by losartan and <b>4b</b>.<a onclick="showRef(event, 'ref17 cit8c'); return false;" href="javascript:void(0);" class="ref ref17 cit8c">(17, 8c)</a> The observed differences in bioavailability can be explained on the basis of the different permeability of <b>7c</b> and <b>4b</b> and by the substantial first-pass hepatic metabolism in the case of losartan.<a onclick="showRef(event, 'ref18 cit3b'); return false;" href="javascript:void(0);" class="ref ref18 cit3b">(18, 3b)</a></div><div class="NLM_p last">However, <b>7c</b> shows a terminal half-life (about 1.0 h) similar to the one shown by <b>4b</b>, but shorter than that of losartan. These results suggest that the permeability is not a limiting factor in the pharmacokinetics of these pyrazolo[3,4-<i>b</i>]pyridine derivatives, and further studies are required in order to evaluate the role of UDP-glucuronosyltransferases (EC 2.4.1.17) in the metabolism-excretion of these tetrazole derivatives.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In particular, compound <b>8a</b> showing nanomolar AT<sub>1</sub> receptor affinity, high permeability, and insurmountable antagonism (which may contribute to the duration of action<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>) can be considered an interesting candidate for further preclinical characterization.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p last">All chemicals used were of reagent grade. Yields refer to purified products and are not optimized. Melting points were determined in open capillaries on a Gallenkamp apparatus and are uncorrected. Microanalyses were carried out by means of a Perkin-Elmer 240C or a Perkin-Elmer Series II CHNS/O Analyzer 2400. Merck silica gel 60 (230â400 mesh) was used for column chromatography. Merck TLC plates, silica gel 60 F<sub>254</sub> were used for TLC. <sup>1</sup>H NMR spectra were recorded with a Bruker AC 200 spectrometer in the indicated solvents (TMS as internal standard): the values of the chemical shifts are expressed in ppm and the coupling constants (<i>J</i>) in Hz. Mass spectra were recorded on either a Varian Saturn 3 spectrometer or a ThermoFinnigan LCQ-Deca.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> X-Ray Crystallography</h3><div class="NLM_p">Single crystals of <b>7a</b>, <b>16a</b>,<b>c</b>, <b>30</b>, <b>32</b>, <b>37b</b>, <b>41</b>, <b>44d</b>, and <b>47</b> were submitted to X-ray data collection. Data for compound <b>41</b> were obtained by a Bruker-Nonius FR591 rotating anode diffractometer with a 95 mm CCD camera at 120 K. All the other data were obtained by a Siemens P4 four-circle diffractometer at 293 K. Both the instruments were equipped with a graphite monochromated Mo KÎ± radiation (Î» = 0.71069 Ã).</div><div class="NLM_p last">The structures were solved by direct methods implemented in the SHELXS-97 program.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The refinements were carried out by full-matrix anisotropic least-squares on F2 for all reflections for non-H atoms by means of the SHELXL-97 program.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Biological Methods</h3><div id="sec5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Angiotensin II Receptor Binding Assay</h4><div class="NLM_p last"><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Male Wistar rats (Charles River, Calco, Italy) were killed by decapitation and their livers were rapidly removed. Ang II receptors from rat liver were prepared by differential centrifugation. The liver was dissected free of fatty tissue and minced accurately with small scissors, and about 3 g of tissue was homogenized by Polytron Ultra-Turrax (maximal speed for 2 Ã 30 s) in ice-cold 20 vol of Tris-HCl 5 mM, sucrose 0.25 M (pH 7.4). The homogenate was centrifuged at 750<i>g</i> for 10 min, and the supernatant was filtered through cheesecloth and saved. The pellets were homogenized and centrifuged as before. The combined supernatants were centrifuged at 50000<i>g</i> for 15 min. The resulting pellet was resuspended in TrisâHCl 5 mM, sucrose 0.25 M (pH 7.4) and centrifuged as above. The final pellets were used immediately or stored frozen at â70 Â°C before use. The membrane pellets were resuspended in the assay buffer (TrisâHCl 50 mM, NaCl 100 mM, MgCl<sub>2</sub> 10 mM, EDTA 1 mM, bacitracin 100 ÂµM, PMSF 100 ÂµM, BSA 0.1%, pH 7.4) to obtain a final protein concentration of 0.25 mg/mL. Binding of [<sup>125</sup>I]Sar<sup>1</sup>,Ile<sup>8</sup>-Angiotensin II (Perkin-Elmer Life and Analytical Sciences, S.A. 2000 Ci/mmol) to liver membranes was performed at 25 Â°C for 180 min in 96-well filtration plates (Millipore GFB-Multiscreen). Each 250 ÂµL incubate contained the following: [<sup>125</sup>I]Sar<sup>1</sup>,Ile<sup>8</sup>-Angiotensin II (25 pM), liver membrane proteins (25 Âµg) and standard or test compounds. Nonspecific binding was measured in the presence of 1 ÂµM Ang II and represented 5â10% of total binding. Binding was terminated by rapid vacuum filtration using a Millipore Multiscreen device. Receptorâligand complex trapped on filters was washed twice with 200 ÂµL of ice-cold NaCl 100 mM, MgCl<sub>2</sub> 100 mM. Dried filters discs were punched out and counted in a Î³-counter with 92% efficiency. The IC<sub>50</sub> value (concentration for 50% displacement of the specifically bound [<sup>125</sup>I]Sar<sup>1</sup>,Ile<sup>8</sup>-Angiotensin II) was estimated for the linear portion of the competition curves.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Angiotensin II Functional Antagonism in Rabbit Aorta Strips</h4><div class="NLM_p last"><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> New Zealand White rabbits (3â4 kg body weight, Harlan Italy) were killed by cervical dislocation, after a slight ether anesthesia. The descending thoracic aorta, with the endothelium removed, was cut into helical strips 3â4 mm wide and 15â20 mm long. These strips were mounted in 20-mL tissue baths containing KrebsâHenseleit solution of the following composition (mM): NaCl 118; KCl 4.69; KH<sub>2</sub>PO<sub>4</sub> 1.17; MgSO<sub>4</sub>Â·7H<sub>2</sub>O 1.17; CaCl<sub>2</sub>Â·2 H<sub>2</sub>O 2.51; NaHCO<sub>3</sub> 25; glucose 11.1. The tissue baths were kept at 37 Â°C and aerated with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. Each strip was connected to an isometric transducer (Basile, Italy), and a resting tension of 2 g was applied to the tissues. Changes in isometric tension were displayed on a four-channel pen recorder (Basile, Italy). The tissues were allowed to equilibrate for 1 h and were washed every 10 min. At the beginning of the experiment, a 67 mM KCl solution was administered to check the sensitivity of the preparations as well as to determine their maximal contractile response. After 30 min washout, test substances or their respective vehicles were added. Sixty minutes later, cumulative concentrationâresponse curves of angiotensin II were obtained. Only one curve was obtained from each strip, and the contractile response was expressed as percentage (%) of the maximal contraction achieved with KCl. Curve analysis was performed by using the Allfit<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> program, which calculates lower and upper plateau, slope and agonist EC<sub>50</sub>, and allows the comparison of two or more curves. Antagonist potency was evaluated by the estimation of p<i>A</i><sub>2</sub> values.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> In Vitro Intestinal Permeability Experiments</h4><div class="NLM_p">The permeability studies were performed with Caco-2 monolayers as described in the literature.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Caco-2 cells were cultured in supplemented Dulbeccoâs modified eagle medium (DMEM) with 10% fetal bovine serum, 1% nonessential amino acids, 10 mM Hepes buffer, and a Pen/Strept mixture (50U penicillin and 50 mg/mL streptomycin) and split at confluence by trypsinization.</div><div class="NLM_p">For transport studies, 200000 cells/well were seeded onto Millicell 24-well cell culture plates, and after 24 h incubation at 37 Â°C with 5% CO<sub>2</sub>/95% O<sub>2</sub>, the culture medium was changed with Enterocyte Differentiation Medium with additives (Becton Dickinson Bioscience), which allows Caco-2 cells to establish within 3 days a differentiated enterocyte monolayer. Transepithelial electric resistance was measured with a Millipore Millicell-ERS instrument and was >1000 ohms.</div><div class="NLM_p last">The transport across the Caco-2 monolayer was determined in two ways: from apical to basolateral side (AâB) by adding a 10 ÂµM solution of the compound in DMEM (1% final concentration of DMSO) to the apical side and from basolateral to apical side (BâA) by adding a 10 ÂµM solution of the compound in DMEM (1% final concentration of DMSO) to the basolateral side; after 2 h incubation period at 37 Â°C, the basolateral side solution, together with the apical and the starting solutions, was analyzed and quantified by LCâMS/MS (column: Waters X-terra C18, 2.5 ÂµM, 2.5 Ã 50 mm, room temperature; mobile phase: acetonitrileâwater, flow 250 ÂµL/min; interface: ESI positive mode). The experiments were performed with buffers at different pH (6.5 apical vs 7.4 basolateral) to better mimic the physiological conditions and propranolol, cimetidine, and vinblastine were evaluated as controls. Caco-2 apparent permeability values (<i>P</i><sub>app</sub>) were calculated by means of the following equation: <span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/jm-2007-011563_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span> where Î<i>Q</i>/Î<i>t</i> was the rate of appearance of the drug in the receiver chamber, <i>C</i><sub>0</sub> was the initial concentration of the drug in the donor chamber, and <i>A</i> was the surface area of the monolayer. All <i>P</i><sub>app</sub> values were standardized and reported as 10<sup>â6</sup> cm/s.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Pharmacokinetics in Rats</h4><div class="NLM_p last">Compounds where either orally administered or injected through the tail vein to fasted SpragueâDawley rats weighing 250â300 g. After the administration, blood samples were taken at selected times and the plasma content was analyzed by HPLC, followed by <i>t</i><sub>Â½</sub> and area under curve calculation (AUC).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/jm7011563">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Full experimental details for the synthesis and the characterization of <b>7</b> and <b>8</b> and related compounds (chemistry, NMR, MS, crystallography). This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7011563/suppl_file/jm7011563-file002.pdf">jm7011563-file002.pdf (1.09 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm7011563" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Cappelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#15767465657079797c55607b7c667c3b7c61"><span class="__cf_email__" data-cfemail="c1a2a0b1b1a4adada881b4afa8b2a8efa8b5">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Nannicini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Gallelli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Germano Giuliani</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salvatore Valenti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gal.la Pericot Mohr</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maurizio Anzini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Mennuni</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Flora Ferrari</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianfranco Caselli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Giordani</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter Peris</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Makovec</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianluca Giorgi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salvatore Vomero</span> - <span class="hlFld-Affiliation affiliation">Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy, Rottapharm S.p.A., Via Valosa di Sopra 7, 20052 Monza, Italy, and Dipartimento di Chimica, UniversitÃ  di Siena, Via A. Moro, 53100 Siena, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Prof. Stefania DâAgata DâOttavi for the careful reading of the manuscript, Dr. Roberto Beretta (Rottapharm, Monza, Italy) for the combustion analyses, and INSTM (Consorzio Interuniversitario Nazionale per la Scienza e la Tecnologia dei Materiali) for the access to Accelrys software. This work was partially supported by MUR (Ministero dellâUniversitÃ  e della Ricerca) - PRIN (Programmi di ricerca di Rilevante Interesse Nazionale).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">De Gasparo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catt, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, T.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXIII. The Angiotensin II Receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">â</span> <span class="NLM_lpage">472</span><div class="note"><p class="first last">and references cited therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=10977869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCmsbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2000&pages=415-472&author=M.+De+Gasparoauthor=K.+J.+Cattauthor=T.+Inagamiauthor=J.+W.+Wrightauthor=T.+Unger&title=International+Union+of+Pharmacology.+XXIII.+The+Angiotensin+II+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">International union of pharmacology. XXIII. The angiotensin II receptors</span></div><div class="casAuthors">De Gasparo, M.; Catt, K. J.; Inagami, T.; Wright, J. W.; Unger, Th.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">415-472</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with 741 refs.  The cardiovascular and other actions of angiotensin II (Ang II) are mediated by AT1 and AT2 receptors, which are seven transmembrane glycoproteins with 30% sequence similarity.  Most species express a single autosomal AT1 gene, but two related AT1A and AT1B receptor genes are expressed in rodents.  AT1 receptors are predominantly coupled to Gq/11, and signal through phospholipases A, C, D, inositol phosphates, calcium channels, and a variety of serine/threonine and tyrosine kinases.  Many AT1-induced growth responses are mediated by transactivation of growth factor receptors.  The receptor binding sites for agonist and nonpeptide antagonist ligands have been defined.  The latter compds. are as effective as angiotensin converting enzyme inhibitors in cardiovascular diseases but are better tolerated.  The AT2 receptor is expressed at high d. during fetal development.  It is much less abundant in adult tissues and is up-regulated in pathol. conditions.  Its signaling pathways include serine and tyrosine phosphatases, phospholipase A2, nitric oxide, and cyclic guanosine monophosphate.  The AT2 receptor counteracts several of the growth responses initiated by the AT1 and growth factor receptors.  The AT4 receptor specifically binds Ang IV (Ang 3-8), and is located in brain and kidney.  Its signaling mechanisms are unknown, but it influences local blood flow and is assocd. with cognitive processes and sensory and motor functions.  Although AT1 receptors mediate most of the known actions of Ang II, the AT2 receptor contributes to the regulation of blood pressure and renal function.  The development of specific nonpeptide receptor antagonists has led to major advances in the physiol., pharmacol., and therapy of the renin-angiotensin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSSYESfE8nPrVg90H21EOLACvtfcHk0lhT3lTpA8t1dA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCmsbk%253D&md5=6abc5466d51de53202ecf1fd9ba3c186</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGasparo%26aufirst%3DM.%26aulast%3DCatt%26aufirst%3DK.%2BJ.%26aulast%3DInagami%26aufirst%3DT.%26aulast%3DWright%26aufirst%3DJ.%2BW.%26aulast%3DUnger%26aufirst%3DT.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXIII.%2520The%2520Angiotensin%2520II%2520Receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2000%26volume%3D52%26spage%3D415%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Inoue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagami, T.</span><span> </span><span class="NLM_article-title">A Review of Mutagenesis Studies of Angiotensin II Type 1 Receptor, the Three-Dimensional Receptor Model in Search of the Agonist Binding Site and the Hypothesis of a Receptor Activation Mechanism</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">â</span> <span class="NLM_lpage">714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1097%2F00004872-199715070-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=9222937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK2sXkslaktL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=703-714&author=Y.+Inoueauthor=N.+Nakamuraauthor=T.+Inagami&title=A+Review+of+Mutagenesis+Studies+of+Angiotensin+II+Type+1+Receptor%2C+the+Three-Dimensional+Receptor+Model+in+Search+of+the+Agonist+Binding+Site+and+the+Hypothesis+of+a+Receptor+Activation+Mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism</span></div><div class="casAuthors">Inoue, Yoshihisa; Nakamura, Norifumi; Inagami, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">703-714</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">A review with 91 refs.  To seek the mechanism whereby agonists, competitive antagonists and insurmountable antagonists affect the receptor function differently, by reviewing recent mutagenesis studies of angiotensin II type 1 receptor (AT1) in which the binding of the agonist and antagonists and receptor signaling were affected.  The authors built a model of seven transmembrane spanning domains of the AT1 receptors using bacteriorhodopsin as a template.  The C-terminal of angiotensin II binds to Lys199 in transmembrane domain 5, whereas the guanidinium group of Arg2 binds to Asp281 in transmembrane domain 7.  Of studies using mutagenesis supporting proposed ligand-docking models are discussed.  The authors submit a set of hypotheses for a mechanism whereby the ligand binding induces changes in the receptor conformation by the rotation of transmembrane helixes as the initial event for the subsequent activation of a G protein.  In this mechanism antagonists are not capable of rotating the helixes but agonists are able to do so, which results in the formation of a hydrogen bond between Asp74 in transmembrane domain 2 and Tyr292 in transmembrane domain 7.  This mechanism also provides plausible explanation for the activation of monoamine receptors.  Competitive antagonists share the same binding sites with agonists, but insurmountable antagonists do not, and binding of the latter does not preclude agonist binding, for example, to Asp281.  This hypothesis of the intrareceptor signaling mechanism and the receptor model indicate that some amino acid residues essential for the signaling play their roles in the intrareceptor activation mechanism, whereas others participate directly in ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxQyRUXveVbVg90H21EOLACvtfcHk0ljxnsCL2rsBpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslaktL8%253D&md5=48cbe83dca10ab04adf9b6cfa47a7e55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2F00004872-199715070-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-199715070-00001%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DInagami%26aufirst%3DT.%26atitle%3DA%2520Review%2520of%2520Mutagenesis%2520Studies%2520of%2520Angiotensin%2520II%2520Type%25201%2520Receptor%252C%2520the%2520Three-Dimensional%2520Receptor%2520Model%2520in%2520Search%2520of%2520the%2520Agonist%2520Binding%2520Site%2520and%2520the%2520Hypothesis%2520of%2520a%2520Receptor%2520Activation%2520Mechanism%26jtitle%3DJ.%2520Hypertens.%26date%3D1997%26volume%3D15%26spage%3D703%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, P. B. M. W. M.</span><span> </span><span class="NLM_article-title">Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive Therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">â</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9504722" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK28Xjt1Oltw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=625-656&author=R.+R.+Wexlerauthor=W.+J.+Greenleeauthor=J.+D.+Irvinauthor=M.+R.+Goldbergauthor=K.+Prendergastauthor=R.+D.+Smithauthor=P.+B.+M.+W.+M.+Timmermans&title=Nonpeptide+Angiotensin+II+Receptor+Antagonists%3A+The+Next+Generation+in+Antihypertensive+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive Therapy</span></div><div class="casAuthors">Wexler, Ruth R.; Greenlee, William J.; Irvin, John D.; Goldberg, Michael R.; Prendergast, Kristine; Smith, Ronald D.; Timmermans, Pieter B. M. W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-56</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 326 refs. which includes AT1-selective antagonists, AT2-selective antagonists, mol. modeling, and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox8R0LMBNKD7Vg90H21EOLACvtfcHk0ljxnsCL2rsBpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjt1Oltw%253D%253D&md5=218425943d7b9f3bcf37c205eca08c6f</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fjm9504722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9504722%26sid%3Dliteratum%253Aachs%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DIrvin%26aufirst%3DJ.%2BD.%26aulast%3DGoldberg%26aufirst%3DM.%2BR.%26aulast%3DPrendergast%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26aulast%3DTimmermans%26aufirst%3DP.%2BB.%2BM.%2BW.%2BM.%26atitle%3DNonpeptide%2520Angiotensin%2520II%2520Receptor%2520Antagonists%253A%2520The%2520Next%2520Generation%2520in%2520Antihypertensive%2520Therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D625%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieffer, B.</span><span> </span><span class="NLM_article-title">Angiotensin II AT<sub>1</sub> Receptor Antagonist. Clinical Implications of Active Metabolites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">â</span> <span class="NLM_lpage">2270</span><div class="note"><p class="first last">and references cited therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm0204237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2261-2270&author=B.+Schmidtauthor=B.+Schieffer&title=Angiotensin+II+AT1+Receptor+Antagonist.+Clinical+Implications+of+Active+Metabolites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1021%2Fjm0204237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204237%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DSchieffer%26aufirst%3DB.%26atitle%3DAngiotensin%2520II%2520AT1%2520Receptor%2520Antagonist.%2520Clinical%2520Implications%2520of%2520Active%2520Metabolites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2261%26epage%3D2270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mantlo, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondeyka, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegl, P. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotti, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schorn, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmert, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patchett, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Potent, Orally Active Imidazo[4,5-b]pyridine-Based Angiotensin II Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2919</span><span class="NLM_x">â</span> <span class="NLM_lpage">2922</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00113a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2919-2922&author=N.+B.+Mantloauthor=P.+K.+Chakravartyauthor=D.+L.+Ondeykaauthor=P.+K.+S.+Sieglauthor=R.+S.+Changauthor=V.+J.+Lottiauthor=K.+A.+Faustauthor=T.-B.+Chenauthor=T.+W.+Schornauthor=C.+S.+Sweetauthor=S.+E.+Emmertauthor=A.+A.+Patchettauthor=W.+J.+Greenlee&title=Potent%2C+Orally+Active+Imidazo%5B4%2C5-b%5Dpyridine-Based+Angiotensin+II+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm00113a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00113a035%26sid%3Dliteratum%253Aachs%26aulast%3DMantlo%26aufirst%3DN.%2BB.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DOndeyka%26aufirst%3DD.%2BL.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DChang%26aufirst%3DR.%2BS.%26aulast%3DLotti%26aufirst%3DV.%2BJ.%26aulast%3DFaust%26aufirst%3DK.%2BA.%26aulast%3DChen%26aufirst%3DT.-B.%26aulast%3DSchorn%26aufirst%3DT.%2BW.%26aulast%3DSweet%26aufirst%3DC.%2BS.%26aulast%3DEmmert%26aufirst%3DS.%2BE.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DPotent%252C%2520Orally%2520Active%2520Imidazo%255B4%252C5-b%255Dpyridine-Based%2520Angiotensin%2520II%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2919%26epage%3D2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantlo, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivlighn, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Evaluation of Heterocyclic Acid Equivalents as Tetrazole Replacements in Imidazopyridine-Based Nonpeptide Angiotensin II Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">â</span> <span class="NLM_lpage">44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=41-44&author=D.+Kimauthor=N.+B.+Mantloauthor=R.+S.+Changauthor=S.+D.+Kivlighnauthor=W.+J.+Greenlee&title=Evaluation+of+Heterocyclic+Acid+Equivalents+as+Tetrazole+Replacements+in+Imidazopyridine-Based+Nonpeptide+Angiotensin+II+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DMantlo%26aufirst%3DN.%2BB.%26aulast%3DChang%26aufirst%3DR.%2BS.%26aulast%3DKivlighn%26aufirst%3DS.%2BD.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DEvaluation%2520of%2520Heterocyclic%2520Acid%2520Equivalents%2520as%2520Tetrazole%2520Replacements%2520in%2520Imidazopyridine-Based%2520Nonpeptide%2520Angiotensin%2520II%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D41%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Adams, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudeau, L.</span><span> </span><span class="NLM_article-title">Irbesartan: Review of Pharmacology and Comparative Properties</span> <span class="citation_source-journal">Can. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">â</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=10822210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A280%3ADC%252BD3c3osVWjsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=22-31&author=M.+A.+Adamsauthor=L.+Trudeau&title=Irbesartan%3A+Review+of+Pharmacology+and+Comparative+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Irbesartan: review of pharmacology and comparative properties</span></div><div class="casAuthors">Adams M A; Trudeau L</div><div class="citationInfo"><span class="NLM_cas:title">The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-31</span>
        ISSN:<span class="NLM_cas:issn">1198-581X</span>.
    </div><div class="casAbstract">The recently developed and marketed angiotensin II type 1 (AT1) receptor blockers (ARBs) have demonstrated efficacy equivalent to that of other leading classes of antihypertensive agents, with superior tolerability profiles.  The specific targeting of the AT1 receptor afforded by these agents has demonstrated more complete blockade of the renin-angiotensin system than that offered by angiotensin-converting enzyme inhibitors.  These data notwithstanding, differentiation within the class of ARBs has been limited.  With the accumulation of additional data with ARBs, it has recently become possible to make within-class distinctions, based in large part on the individual pharmacological profiles of the ARBs.  To this end, absorption, distribution, half-life, dose response and level of angiotensin II antagonism are of special note.  When these properties are viewed as a group, the ARB irbesartan appears to offer advantages beyond those attained with other ARBs.  Irbesartan is well absorbed, does not require biotransformation to an active metabolite to exert its antihypertensive activity, offers a large volume of distribution, has a half-life that is sufficient to allow once-daily dosing, is associated with a strong and consistent dose-response and has been demonstrated to provide a level of angiotensin II antagonism that is statistically superior to that offered by some other ARBs.  These pharmacological differences may explain the clinical superiority of irbesartan compared with losartan, the first member of the ARB class.  As even more data on the ARBs become available, the ability to determine the advantages of specific members of this class will be enhanced, distinctions that already have begun to come to light.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjRUmdpq1iC3y-c-E1v-fmfW6udTcc2eaOMuk-zY4GB7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3osVWjsg%253D%253D&md5=9b02dbb76e7f666999255a94fdcdb11f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DM.%2BA.%26aulast%3DTrudeau%26aufirst%3DL.%26atitle%3DIrbesartan%253A%2520Review%2520of%2520Pharmacology%2520and%2520Comparative%2520Properties%26jtitle%3DCan.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D7%26spage%3D22%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chakravarty, P. K.</span><span> </span><span class="NLM_article-title">Antihypertensive Agents</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">â</span> <span class="NLM_lpage">458</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1517%2F13543776.5.5.431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK2MXotVWhtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=431-458&author=P.+K.+Chakravarty&title=Antihypertensive+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antihypertensive agents</span></div><div class="casAuthors">Chakravarty, Prasun K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">431-58</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications</span>)
        </div><div class="casAbstract">A review with 383 refs.  The primary agent and patent literature (July 1993 to Feb. 1995) describing angiotensin II antagonists, renin inhibitors, angiotensin converting enzyme(ACE) inhibitors, endothelin antagonists, potassium channel agonist/openers, calcium channel blockers, Î±-adrenergic receptor antagonists and nitro vasodilators are assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYlfxpMESlMLVg90H21EOLACvtfcHk0libCRwRFbxMgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotVWhtbc%253D&md5=06a90374c3b2c7b5ab2fb3484884af31</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543776.5.5.431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.5.5.431%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26atitle%3DAntihypertensive%2520Agents%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D1995%26volume%3D5%26spage%3D431%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pericot Mohr, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennuni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menziani, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Benedetti, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, G.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Structural Studies, Biological Evaluation, and Computational Simulations of Novel Potent AT<sub>1</sub> Angiotensin II Receptor Antagonists Based on the 4-Phenylquinoline Structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2574</span><span class="NLM_x">â</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031100t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2574-2586&author=A.+Cappelliauthor=G.+Pericot+Mohrauthor=A.+Gallelliauthor=M.+Rizzoauthor=M.+Anziniauthor=S.+Vomeroauthor=L.+Mennuniauthor=F.+Ferrariauthor=F.+Makovecauthor=M.+C.+Menzianiauthor=P.+G.+De+Benedettiauthor=G.+Giorgi&title=Design%2C+Synthesis%2C+Structural+Studies%2C+Biological+Evaluation%2C+and+Computational+Simulations+of+Novel+Potent+AT1+Angiotensin+II+Receptor+Antagonists+Based+on+the+4-Phenylquinoline+Structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm031100t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031100t%26sid%3Dliteratum%253Aachs%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DPericot%2BMohr%26aufirst%3DG.%26aulast%3DGallelli%26aufirst%3DA.%26aulast%3DRizzo%26aufirst%3DM.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DVomero%26aufirst%3DS.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DMenziani%26aufirst%3DM.%2BC.%26aulast%3DDe%2BBenedetti%26aufirst%3DP.%2BG.%26aulast%3DGiorgi%26aufirst%3DG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Structural%2520Studies%252C%2520Biological%2520Evaluation%252C%2520and%2520Computational%2520Simulations%2520of%2520Novel%2520Potent%2520AT1%2520Angiotensin%2520II%2520Receptor%2520Antagonists%2520Based%2520on%2520the%25204-Phenylquinoline%2520Structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2574%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rizzo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventrice, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Sarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procopio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span> </span><span class="NLM_article-title">Determination of a Novel Angiotensin-AT<sub>1</sub> Antagonist CR3210 in Biological Samples by HPLC</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">â</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1016%2FS0014-827X%2803%2900141-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=13679177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Gqsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=837-844&author=M.+Rizzoauthor=M.+Anziniauthor=A.+Cappelliauthor=S.+Vomeroauthor=D.+Ventriceauthor=G.+De+Sarroauthor=S.+Procopioauthor=N.+Costaauthor=F.+Makovec&title=Determination+of+a+Novel+Angiotensin-AT1+Antagonist+CR3210+in+Biological+Samples+by+HPLC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of a novel angiotensin-AT1 antagonist CR 3210 in biological samples by HPLC</span></div><div class="casAuthors">Rizzo, M.; Anzini, M.; Cappelli, A.; Vomero, S.; Ventrice, D.; De Sarro, G.; Procopio, S.; Costa, N.; Makovec, F.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">837-844</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A simple and sensitive method for the detn. of a new angiotensin-AT1 antagonist i.e. CR 3210, 4-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-3-(2H-tetrazol-5-yl)quinoline, is described.  The assay was used to describe the pharmacokinetic profile of the title compd. after i.v. and i.p. administration to Sprague Dawley rats.  CR 3210 and the internal std. CR 1505 (loxiglumide, 4-[(3,4-dichlorobenzoyl)amino]-5-[(3-methoxypropyl)pentylamino]-5-oxopentanoic acid) were isolated from rat plasma by solid-phase extn.  The sorbent extn. material along with the pH in the conditioning soln. and the washing vol. were considered pivotal parameters for the optimization of the procedure.  The sepns. were performed by reversed-phase HPLC with UV detection.  The samples were injected onto the anal. column (Tracer Extrasil ODS1) and detected at 238 nm, giving a retention time of 6.19 min for CR 3210 and 4.39 min for the internal std., resp.  The selectivity of the method showed to be satisfactory.  The mean recovery of CR 3210 from spiked rat plasma was 80.3 at 1 Î¼g/mL and 79.9 at 2 Î¼g/mL.  The lower limit of detection (LOD) was taken as 0.014 Î¼g/mL in plasma samples.  The lower limit of quantification (LOQ) was taken as 0.02 Î¼g/mL, the lowest calibration std. using 500 Î¼g rat plasma.  The procedures were validated according to international stds. with a good reproducibility and linear response from 0.02 to 2 Î¼g/mL.  The sensitivity of the method allowed for its application to pharmacokinetic studies.  The maximal concn. was detected 5' after the IV administration, whereas no significant absorption was evident after IP administration of CR 3210 to Sprague-Dawley rats.  The authors' study suggests the absence of extensive bio-transformation of the drug in vivo, supported by the evidence that no metabolites were detected in plasma samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtXU4w4Rh4_rVg90H21EOLACvtfcHk0libCRwRFbxMgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Gqsbw%253D&md5=f7cdf0fe5e47495513b5001419610852</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2803%2900141-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252803%252900141-1%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DM.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DVomero%26aufirst%3DS.%26aulast%3DVentrice%26aufirst%3DD.%26aulast%3DDe%2BSarro%26aufirst%3DG.%26aulast%3DProcopio%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DN.%26aulast%3DMakovec%26aufirst%3DF.%26atitle%3DDetermination%2520of%2520a%2520Novel%2520Angiotensin-AT1%2520Antagonist%2520CR3210%2520in%2520Biological%2520Samples%2520by%2520HPLC%26jtitle%3DFarmaco%26date%3D2003%26volume%3D58%26spage%3D837%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rizzo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventrice, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procopio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Sarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span> </span><span class="NLM_article-title">Sensitive SPE-HPLC Method to Determine a Novel Angiotensin-AT<sub>1</sub> Antagonist in Biological Samples</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">â</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1016%2Fj.jpba.2003.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=15063465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVWrt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2004&pages=321-329&author=M.+Rizzoauthor=D.+Ventriceauthor=F.+Monforteauthor=S.+Procopioauthor=G.+De+Sarroauthor=M.+Anziniauthor=A.+Cappelliauthor=F.+Makovec&title=Sensitive+SPE-HPLC+Method+to+Determine+a+Novel+Angiotensin-AT1+Antagonist+in+Biological+Samples"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitive SPE-HPLC method to determine a novel angiotensin-AT1 antagonist in biological samples</span></div><div class="casAuthors">Rizzo, M.; Ventrice, D.; Monforte, F.; Procopio, S.; De Sarro, G.; Anzini, M.; Cappelli, A.; Makovec, F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-329</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A high-performance liq. chromatog. (HPLC)-method after solid-phase extn. (SPE) was developed to det. a new angiotensin-AT1 antagonist, i.e.  CR 3210 (C27H24N8; MW=460.54), 4-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-3-(2H-tetrazol-5-yl)quinoline in rat plasma and urine after oral administration to Sprague-Dawley rats.  CR 3210 and the internal std. (IS) CR 1505 (loxiglumide), i.e. 4-[(3,4-dichlorobenzoyl)amino]-5-[(3-methoxypropyl)pentylamino]-5-oxopentanoic acid, were isolated from rat urine and plasma by solid-phase extn.  The procedure was optimized regarding the sorbent extn. material, the pH in the conditioning soln., the washing step, the dry time and the type of elution solvent.  The sepn. was performed by reversed-phase high-performance liq. chromatog. with UV detection.  The samples were injected onto the anal. column (Tracer Extrasil ODS1) and detected at 238 nm, giving a capacity factor of 1.87 for CR 3210 and 1.10 for the internal std.  The selectivity of the method was satisfactory.  The mean recovery of CR 3210 from spiked rat plasma was 68.5 at 75 ng/mL and 80.9 at 3000 ng/mL; the mean recovery of CR 3210 from spiked rat urine was 69.9 at 75 ng/mL and 78.6 at 3000 ng/mL.  The lower limit of detection (LOD) was 14 ng/mL in plasma and 22 ng/mL in urine samples.  The lower limit of quantification (LOQ) was taken as 30 ng/mL, the lowest calibration std. using 500 Î¼l rat plasma and urine.  The procedures were validated according to international stds. with a good reproducibility and linear response from 30 to 3000 ng/mL, for either plasma or urine.  The sensitivity of the method allowed for its application to pharmacokinetic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXIDoCq_-GrVg90H21EOLACvtfcHk0lhBqgcEqYxhSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVWrt7k%253D&md5=1b393f2832d4f68c2b7ecb93e0fc6e52</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2003.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2003.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DM.%26aulast%3DVentrice%26aufirst%3DD.%26aulast%3DMonforte%26aufirst%3DF.%26aulast%3DProcopio%26aufirst%3DS.%26aulast%3DDe%2BSarro%26aufirst%3DG.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DMakovec%26aufirst%3DF.%26atitle%3DSensitive%2520SPE-HPLC%2520Method%2520to%2520Determine%2520a%2520Novel%2520Angiotensin-AT1%2520Antagonist%2520in%2520Biological%2520Samples%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2004%26volume%3D35%26spage%3D321%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pericot Mohr, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeazzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennuni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinrath, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valoti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span> </span><span class="NLM_article-title">Further Studies on Imidazo[4,5-<i>b</i>]pyridine AT<sub>1</sub> Angiotensin II Receptor Antagonists. Effects of the Transformation of the 4-Phenylquinoline Backbone into 4-Phenylisoquinolinone or 1-Phenylindene Scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6451</span><span class="NLM_x">â</span> <span class="NLM_lpage">6464</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmurvJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6451-6464&author=A.+Cappelliauthor=G.+Pericot+Mohrauthor=G.+Giulianiauthor=S.+Galeazziauthor=M.+Anziniauthor=L.+Mennuniauthor=F.+Ferrariauthor=F.+Makovecauthor=E.+M.+Kleinrathauthor=T.+Langerauthor=M.+Valotiauthor=G.+Giorgiauthor=S.+Vomero&title=Further+Studies+on+Imidazo%5B4%2C5-b%5Dpyridine+AT1+Angiotensin+II+Receptor+Antagonists.+Effects+of+the+Transformation+of+the+4-Phenylquinoline+Backbone+into+4-Phenylisoquinolinone+or+1-Phenylindene+Scaffolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Further Studies on Imidazo[4,5-b]pyridine AT1 Angiotensin II Receptor Antagonists. Effects of the Transformation of the 4-Phenylquinoline Backbone into 4-Phenylisoquinolinone or 1-Phenylindene Scaffolds</span></div><div class="casAuthors">Cappelli, Andrea; Mohr, Galla Pericot; Giuliani, Germano; Galeazzi, Simone; Anzini, Maurizio; Mennuni, Laura; Ferrari, Flora; Makovec, Francesco; Kleinrath, Eva M.; Langer, Thierry; Valoti, Massimo; Giorgi, Gianluca; Vomero, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6451-6464</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 4-phenylquinoline fragment of novel AT1 receptor antagonists 4 based on imidazo[4,5-b]pyridine moiety was replaced by 4-phenylisoquinolinone (compds. 5) or 1-phenylindene (compds. 6) scaffolds to investigate the structure-activity relationships.  Binding studies showed that most of the synthesized compds. display high affinity for the AT1 receptor.  Because of the in vitro high potency of carboxylic acids 5b,f, they were evaluated in permeability (in Caco-2 cells) and in pharmacokinetic studies in comparison with quinoline derivs. 4b,i,j,k.  The studies showed that these compds. are characterized by rapid excretion, low membrane permeability, and low oral bioavailability.  The structure optimization of the indene derivs. led to compds. 6e,f possessing interesting AT1 receptor affinities.  Optimization produced polymg. AT1 receptor ligand 6c, which forms a thermoreversible polymer (poly-6c) and is released from the latter by a temp.-dependent kinetics.  The results suggest the possibility of developing novel polymeric prodrugs based on a new release mechanism.  Finally, a set of 34 AT1 receptor antagonists was used as a new test for the evaluation of the predictive capability of the previously published qual. and quant. pharmacophore models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRYwdCWa7Tw7Vg90H21EOLACvtfcHk0lhBqgcEqYxhSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmurvJ&md5=9a5ed2a095d5b881e3f39f47cc33613a</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1021%2Fjm0603163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603163%26sid%3Dliteratum%253Aachs%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DPericot%2BMohr%26aufirst%3DG.%26aulast%3DGiuliani%26aufirst%3DG.%26aulast%3DGaleazzi%26aufirst%3DS.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DKleinrath%26aufirst%3DE.%2BM.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DValoti%26aufirst%3DM.%26aulast%3DGiorgi%26aufirst%3DG.%26aulast%3DVomero%26aufirst%3DS.%26atitle%3DFurther%2520Studies%2520on%2520Imidazo%255B4%252C5-b%255Dpyridine%2520AT1%2520Angiotensin%2520II%2520Receptor%2520Antagonists.%2520Effects%2520of%2520the%2520Transformation%2520of%2520the%25204-Phenylquinoline%2520Backbone%2520into%25204-Phenylisoquinolinone%2520or%25201-Phenylindene%2520Scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6451%26epage%3D6464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">While this work was in progress, a series of potent AT<sub>1</sub> receptor antagonists based on the pyrazolidine-3,5-dione structure was reported.</p></div><span class="NLM_contrib-group">Le Bourdonnec, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houssin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ©nichart, J.-P.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacological Evaluation of New Pyrazolidine-3,5-diones as AT<sub>1</sub> Angiotensin II Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2685</span><span class="NLM_x">â</span> <span class="NLM_lpage">2697</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9904147" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2685-2697&author=B.+Le+Bourdonnecauthor=E.+Meulonauthor=S.+Yousauthor=J.-F.+Goossensauthor=R.+Houssinauthor=J.-P.+H%C3%A9nichart&title=Synthesis+and+Pharmacological+Evaluation+of+New+Pyrazolidine-3%2C5-diones+as+AT1+Angiotensin+II+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm9904147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904147%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBourdonnec%26aufirst%3DB.%26aulast%3DMeulon%26aufirst%3DE.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DJ.-F.%26aulast%3DHoussin%26aufirst%3DR.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.-P.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520New%2520Pyrazolidine-3%252C5-diones%2520as%2520AT1%2520Angiotensin%2520II%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2685%26epage%3D2697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Le Bourdonnec, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauvin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durant, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houssin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ©nichart, J.-P.</span><span> </span><span class="NLM_article-title">Comparison of 3D Structures and AT<sub>1</sub> Binding Properties of Pyrazolidine-3,5-diones and Tetrahydropyridazine-3,6-diones with Parent Antihypertensive Drug Irbesartan</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">â</span> <span class="NLM_lpage">4798</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010457z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4794-4798&author=B.+Le+Bourdonnecauthor=C.+Cauvinauthor=E.+Meulonauthor=S.+Yousauthor=J.-F.+Goossensauthor=F.+Durantauthor=R.+Houssinauthor=J.-P.+H%C3%A9nichart&title=Comparison+of+3D+Structures+and+AT1+Binding+Properties+of+Pyrazolidine-3%2C5-diones+and+Tetrahydropyridazine-3%2C6-diones+with+Parent+Antihypertensive+Drug+Irbesartan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm010457z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010457z%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBourdonnec%26aufirst%3DB.%26aulast%3DCauvin%26aufirst%3DC.%26aulast%3DMeulon%26aufirst%3DE.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DJ.-F.%26aulast%3DDurant%26aufirst%3DF.%26aulast%3DHoussin%26aufirst%3DR.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.-P.%26atitle%3DComparison%2520of%25203D%2520Structures%2520and%2520AT1%2520Binding%2520Properties%2520of%2520Pyrazolidine-3%252C5-diones%2520and%2520Tetrahydropyridazine-3%252C6-diones%2520with%2520Parent%2520Antihypertensive%2520Drug%2520Irbesartan%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4794%26epage%3D4798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Carini, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncia, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldrich, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santella, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, P. B. M. W. M.</span><span> </span><span class="NLM_article-title">Nonpeptide Angiotensin II Receptor Antagonists: The Discovery of a Series of <i>N</i>-(Biphenylmethyl)imidazoles as Potent, Orally Active Antihypertensives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2525</span><span class="NLM_x">â</span> <span class="NLM_lpage">2547</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00112a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2525-2547&author=D.+J.+Cariniauthor=J.+V.+Dunciaauthor=P.+E.+Aldrichauthor=A.+T.+Chiuauthor=A.+L.+Johnsonauthor=M.+E.+Pierceauthor=W.+A.+Priceauthor=J.+B.+Santellaauthor=G.+J.+Wellsauthor=R.+R.+Wexlerauthor=P.+C.+Wongauthor=S.-E.+Yooauthor=P.+B.+M.+W.+M.+Timmermans&title=Nonpeptide+Angiotensin+II+Receptor+Antagonists%3A+The+Discovery+of+a+Series+of+N-%28Biphenylmethyl%29imidazoles+as+Potent%2C+Orally+Active+Antihypertensives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm00112a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00112a031%26sid%3Dliteratum%253Aachs%26aulast%3DCarini%26aufirst%3DD.%2BJ.%26aulast%3DDuncia%26aufirst%3DJ.%2BV.%26aulast%3DAldrich%26aufirst%3DP.%2BE.%26aulast%3DChiu%26aufirst%3DA.%2BT.%26aulast%3DJohnson%26aufirst%3DA.%2BL.%26aulast%3DPierce%26aufirst%3DM.%2BE.%26aulast%3DPrice%26aufirst%3DW.%2BA.%26aulast%3DSantella%26aufirst%3DJ.%2BB.%26aulast%3DWells%26aufirst%3DG.%2BJ.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DYoo%26aufirst%3DS.-E.%26aulast%3DTimmermans%26aufirst%3DP.%2BB.%2BM.%2BW.%2BM.%26atitle%3DNonpeptide%2520Angiotensin%2520II%2520Receptor%2520Antagonists%253A%2520The%2520Discovery%2520of%2520a%2520Series%2520of%2520N-%2528Biphenylmethyl%2529imidazoles%2520as%2520Potent%252C%2520Orally%2520Active%2520Antihypertensives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2525%26epage%3D2547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basile, A. S.</span><span> </span><span class="NLM_article-title">Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">4275</span><span class="NLM_x">â</span> <span class="NLM_lpage">4284</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960325j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK28XlslWrtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=4275-4284&author=M.+Anziniauthor=A.+Cappelliauthor=S.+Vomeroauthor=G.+Giorgiauthor=T.+Langerauthor=G.+Bruniauthor=M.+R.+Romeoauthor=A.+S.+Basile&title=Molecular+Basis+of+Peripheral+vs+Central+Benzodiazepine+Receptor+Selectivity+in+a+New+Class+of+Peripheral+Benzodiazepine+Receptor+Ligands+Related+to+Alpidem"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of Peripheral vs. Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem</span></div><div class="casAuthors">Anzini, Maurizio; Cappelli, Andrea; Vomero, Salvatore; Giorgi, Gianluca; Langer, Thierry; Bruni, Giancarlo; Romeo, Raffaella; Basile, Anthony S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4275-4284</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alpidem (1), the anxiolytic imidazopyridine, has nanomolar binding affinity for both the central benzodiazepine receptor (CBR) and the peripheral benzodiazepine receptor (PBR).  A novel class of PBR ligands related to alpidem has been designed by comparing the interaction models of alpidem with PBR and CBR.  Several compds. in this class have shown high selectivity for PBR vs. CBR, and the selectivity has been discussed in terms of interaction models.  The binding behavior of the three selected compds. was extensively studied by competition and satn. assays, and the results suggest that they are capable of recognizing two sites labeled by [3H]PK11195.  The mol. structure of one of the most active compds. has been detd. by x-ray diffraction and compared with that of alpidem.  Mol. modeling studies suggest that the bioactive conformation of the most active compd. is likely to be very similar to the conformation found in the crystal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwjLUHIM9CbrVg90H21EOLACvtfcHk0lggJExUgmdaww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlslWrtLg%253D&md5=6ca98ac59c013d9a70925ca33ebfaf70</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm960325j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960325j%26sid%3Dliteratum%253Aachs%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DVomero%26aufirst%3DS.%26aulast%3DGiorgi%26aufirst%3DG.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DBruni%26aufirst%3DG.%26aulast%3DRomeo%26aufirst%3DM.%2BR.%26aulast%3DBasile%26aufirst%3DA.%2BS.%26atitle%3DMolecular%2520Basis%2520of%2520Peripheral%2520vs%2520Central%2520Benzodiazepine%2520Receptor%2520Selectivity%2520in%2520a%2520New%2520Class%2520of%2520Peripheral%2520Benzodiazepine%2520Receptor%2520Ligands%2520Related%2520to%2520Alpidem%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D4275%26epage%3D4284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Larsen, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corley, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reamer, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschaen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossano, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bookes, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnett, J. F.</span><span> </span><span class="NLM_article-title">Efficient Synthesis of Losartan, A Nonpeptide Angiotensin II Receptor Antagonist</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6391</span><span class="NLM_x">â</span> <span class="NLM_lpage">6394</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00100a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK2cXmsFGksbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=6391-6394&author=R.+D.+Larsenauthor=A.+O.+Kingauthor=C.+Y.+Chenauthor=E.+G.+Corleyauthor=B.+S.+Fosterauthor=F.+E.+Robertsauthor=C.+Yangauthor=D.+R.+Liebermanauthor=R.+A.+Reamerauthor=D.+M.+Tschaenauthor=T.+R.+Verhoevenauthor=P.+J.+Reiderauthor=Y.+S.+Loauthor=L.+T.+Rossanoauthor=A.+S.+Bookesauthor=D.+Meloniauthor=J.+R.+Mooreauthor=J.+F.+Arnett&title=Efficient+Synthesis+of+Losartan%2C+A+Nonpeptide+Angiotensin+II+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Synthesis of Losartan, A Nonpeptide Angiotensin II Receptor Antagonist</span></div><div class="casAuthors">Larsen, Robert D.; King, Anthony O.; Chen, Cheng Y.; Corley, Edward G.; Foster, Bruce S.; Roberts, F. Edward; Yang, Chunhua; Lieberman, David R.; Reamer, Robert A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6391-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A highly efficient, convergent approach to the synthesis of the angiotensin II receptor antagonist losartan is described.  Directed ortho-metalation of 2-trityl-5-phenyltetrazole provides the key boronic acid intermediate.  This methodol. overcomes many of the drawbacks assocd. with previously reported syntheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwOeIqOlm7mrVg90H21EOLACvtfcHk0lggJExUgmdaww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsFGksbw%253D&md5=79224d9dee9b79b2f5494cc2f4215f59</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjo00100a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00100a048%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DR.%2BD.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DCorley%26aufirst%3DE.%2BG.%26aulast%3DFoster%26aufirst%3DB.%2BS.%26aulast%3DRoberts%26aufirst%3DF.%2BE.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLieberman%26aufirst%3DD.%2BR.%26aulast%3DReamer%26aufirst%3DR.%2BA.%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26aulast%3DLo%26aufirst%3DY.%2BS.%26aulast%3DRossano%26aufirst%3DL.%2BT.%26aulast%3DBookes%26aufirst%3DA.%2BS.%26aulast%3DMeloni%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%2BR.%26aulast%3DArnett%26aufirst%3DJ.%2BF.%26atitle%3DEfficient%2520Synthesis%2520of%2520Losartan%252C%2520A%2520Nonpeptide%2520Angiotensin%2520II%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D6391%26epage%3D6394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezeny, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, T. R.</span><span> </span><span class="NLM_article-title">Mechanistic Studies of the Suzuki Cross-Coupling Reaction</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8151</span><span class="NLM_x">â</span> <span class="NLM_lpage">8156</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00105a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK2MXit12lt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=8151-8156&author=G.+B.+Smithauthor=G.+C.+Dezenyauthor=D.+L.+Hughesauthor=A.+O.+Kingauthor=T.+R.+Verhoeven&title=Mechanistic+Studies+of+the+Suzuki+Cross-Coupling+Reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Studies of the Suzuki Cross-Coupling Reaction</span></div><div class="casAuthors">Smith, George B.; Dezeny, George C.; Hughes, David L.; King, Anthony O.; Verhoeven, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">8151-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The key step in the synthesis of the drug losartan is a palladium-catalyzed cross-coupling reaction of an aryl bromide and a boronic acid.  The reaction scheme was defined in kinetic studies using HPLC, and computer simulation served to depict the time dependence of the concns. of palladium species, which were not obsd. exptl.  Two catalyst poisons were identified and characterized.  One was an isomeric impurity of the aryl bromide; the other was formed in the reaction mixt. upon hydrolysis of the boronic acid and two of its impurities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJiOg6dctaybVg90H21EOLACvtfcHk0lggJExUgmdaww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXit12lt7c%253D&md5=db8e7f75415a8032063380eb78e43c90</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fjo00105a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00105a036%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BB.%26aulast%3DDezeny%26aufirst%3DG.%2BC.%26aulast%3DHughes%26aufirst%3DD.%2BL.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26atitle%3DMechanistic%2520Studies%2520of%2520the%2520Suzuki%2520Cross-Coupling%2520Reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D8151%26epage%3D8156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegl, P. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantlo, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patchett, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotti, V. J.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> Pharmacology of L-158,809, a New Highly Potent and Selective Angiotensin II Receptor Antagonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=1625192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK38XlsVejtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1992&pages=133-138&author=R.+S.+L.+Changauthor=P.+K.+S.+Sieglauthor=B.+W.+Clineschmidtauthor=N.+B.+Mantloauthor=P.+K.+Chakravartyauthor=W.+J.+Greenleeauthor=A.+A.+Patchettauthor=V.+J.+Lotti&title=In+vitro+Pharmacology+of+L-158%2C809%2C+a+New+Highly+Potent+and+Selective+Angiotensin+II+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist</span></div><div class="casAuthors">Chang, R. S. L.; Siegl, P. K. S.; Clineschmidt, B. V.; Mantlo, N. B.; Chakravarty, P. K.; Greenlee, W. J.; Patchett, A. A.; Lotti, V. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-8</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">L-158,809 (I), interacted in a competitive manner with rabbit aortic angiotensin II (AII) receptors as detd. by Scatchard anal. of the specific binding of [125I]Sar1Ile8-AII.  The affinity of I (IC50 = 0.3 nM) for AII receptors in this tissue was appreciably greater than that of other reported nonpeptide AII antagonists such as DuP-753 (IC50 = 54 nM) and EXP3174 (IC50 = 6 nM) and similar to the natural ligand, AII.  I also exhibited a high potency at AII receptors in several other tissues from different animal species (IC50 = 0.2-0.8 nM).  In vitro functional assays utilizing AII-induced aldosterone release in rat adrenal cortical cells demonstrated further that I acts as a competitive, high affinity antagonist of AII (pA2 = 10.5) and lacks agonist activity.  I also potently inhibited AII-induced inositol phosphate accumulation in vascular smooth muscle cells and contractile responses to AII in isolated blood vessels.  The specificity of I for AII receptors was demonstrated by its lack of activity (IC50 > 1 Î¼M) in several other receptor binding assays and its inability to affect in vitro functional responses produced by other agonists.  I demonstrated a very high selectivity for the AT1 compared to the AT2 receptor subtype (AT2 IC50 â¥ 10 Î¼M).  The high affinity and selectivity makes I a valuable new tool for investigating the physiol. and pharmacol. actions of AII.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvYXfKq9_TcLVg90H21EOLACvtfcHk0liXAIrS0NvyLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlsVejtb8%253D&md5=c841de436207fc3fa4aa882bfb72170d</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DClineschmidt%26aufirst%3DB.%2BW.%26aulast%3DMantlo%26aufirst%3DN.%2BB.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DLotti%26aufirst%3DV.%2BJ.%26atitle%3DIn%2520vitro%2520Pharmacology%2520of%2520L-158%252C809%252C%2520a%2520New%2520Highly%2520Potent%2520and%2520Selective%2520Angiotensin%2520II%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1992%26volume%3D262%26spage%3D133%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Robertoson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunoosamy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. L.</span><span> </span><span class="NLM_article-title">Effects of Peptidase Inhibition on Angiotensin Receptor Agonist and Antagonist Potency in Rabbit Isolated Thoracic Aorta</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">â</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=1354540" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1992&pages=166-172&author=M.+J.+Robertosonauthor=M.+P.+Cunoosamyauthor=K.+L.+Clark&title=Effects+of+Peptidase+Inhibition+on+Angiotensin+Receptor+Agonist+and+Antagonist+Potency+in+Rabbit+Isolated+Thoracic+Aorta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobertoson%26aufirst%3DM.%2BJ.%26aulast%3DCunoosamy%26aufirst%3DM.%2BP.%26aulast%3DClark%26aufirst%3DK.%2BL.%26atitle%3DEffects%2520of%2520Peptidase%2520Inhibition%2520on%2520Angiotensin%2520Receptor%2520Agonist%2520and%2520Antagonist%2520Potency%2520in%2520Rabbit%2520Isolated%2520Thoracic%2520Aorta%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D106%26spage%3D166%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Epithelial Transport of Drugs in Cell Culture. I: A Model for Studying the Passive Diffusion of Drugs over Intestinal Absorbtive (Caco-2) Cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">476</span><span class="NLM_x">â</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1002%2Fjps.2600790604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=1975619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFSru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1990&pages=476-482&author=P.+Artursson&title=Epithelial+Transport+of+Drugs+in+Cell+Culture.+I%3A+A+Model+for+Studying+the+Passive+Diffusion+of+Drugs+over+Intestinal+Absorbtive+%28Caco-2%29+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial transport of drugs in cell culture.  I:  a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells</span></div><div class="casAuthors">Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">476-82</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A human intestinal cell line, Caco-2, was used as a model to study the passive diffusion of drugs across intestinal epithelium.  The cells formed continuous monolayers when grown on permeable filters of polycarbonate.  After 10 days in culture, the monolayers had a transmembrane resistance of â¼260 Î©.cm2 and a cell d. of 0.9 Ã 106 cells/cm2.  At this time the cells were impermeable to [14C]polyethyleneglycol (MW 4000).  These characteristics remained const. for 20 days (i.e., from day 10 to day 30).  Six Î²-blocking agents with a 2000-fold range of lipophilicity were studied for their transepithelial transport properties.  The transport parameters were independent of drug concn. and transport direction.  The apparent permeability coeffs. ranged from 41.91 Ã 10-6 cm/s for the most lipophilic drug, propranolol, to 0.203 Ã 10-6 cm/s for the most hydrophilic drug, atenolol.  The transport parameters were compared with those published for rat ileum.  The transport rates were similar for four out of five drugs.  Atenolol was transported at a slower rate in the Caco-2 model, which may be explained by the fact that the Caco-2 cells form a tighter epithelium than the rat ileal enterocytes.  Thus, Caco-2 cells may be used to model the intestinal absorption of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9RIMzEBiAqrVg90H21EOLACvtfcHk0liXAIrS0NvyLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFSru74%253D&md5=68642fc4f08aaaa5a343822bea9ee95f</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600790604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600790604%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DEpithelial%2520Transport%2520of%2520Drugs%2520in%2520Cell%2520Culture.%2520I%253A%2520A%2520Model%2520for%2520Studying%2520the%2520Passive%2520Diffusion%2520of%2520Drugs%2520over%2520Intestinal%2520Absorbtive%2520%2528Caco-2%2529%2520Cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1990%26volume%3D79%26spage%3D476%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Artursson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J.</span><span> </span><span class="NLM_article-title">Correlation between Oral Drug Absorption in Humans and Apparent Drug Permeability Coefficients in Human Intestinal Epithelial (Caco-2) Cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun..</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">â</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1016%2F0006-291X%2891%2991647-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=1673839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1991&pages=880-885&author=P.+Arturssonauthor=J.+Karlsson&title=Correlation+between+Oral+Drug+Absorption+in+Humans+and+Apparent+Drug+Permeability+Coefficients+in+Human+Intestinal+Epithelial+%28Caco-2%29+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells</span></div><div class="casAuthors">Artursson, P.; Karlsson, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">880-5</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Monolayers of a well differentiated human intestinal epithelial cell line, Caco-2, were used as a model to study passive drug absorption across the intestinal epithelium.  Absorption rate consts. (expressed as apparent permeability coeffs.) were detd. for 20 drugs and peptides with different structural properties.  The permeability coeffs. ranged from approx. 5 Ã 10-8 to 5 Ã 10-5 cm/s.  A good correlation was obtained between data on oral absorption in humans and the results in the Caco-2 model.  Drugs that are completely absorbed in humans had permeability coeffs. >1 Ã 10-6 cm/s.  Drugs that are absorbed to >1% but <100% had permeability coeffs. of 0.1-1.0 Ã 10-6 cm/s while drugs and peptides that are absorbed to <1% had permeability coeffs. of â¤1 Ã 10-7 cm/s.  The results indicate that Caco-2 monolayers can be used as a model for studies on intestinal drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdvsEluSXCILVg90H21EOLACvtfcHk0liXAIrS0NvyLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D&md5=3b1e14cae3beb0345014284e3aa6a7c0</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991647-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991647-U%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DKarlsson%26aufirst%3DJ.%26atitle%3DCorrelation%2520between%2520Oral%2520Drug%2520Absorption%2520in%2520Humans%2520and%2520Apparent%2520Drug%2520Permeability%2520Coefficients%2520in%2520Human%2520Intestinal%2520Epithelial%2520%2528Caco-2%2529%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun..%26date%3D1991%26volume%3D175%26spage%3D880%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ribadeneira, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aungst, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyermann, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-M.</span><span> </span><span class="NLM_article-title">Effects of Structural Modifications on the Intestinal Permeability of Angiotensin II Receptor Antagonists and the Correlation of In Vitro, In Situ, and In Vivo Absorption</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">â</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=227-233&author=M.+D.+Ribadeneiraauthor=B.+J.+Aungstauthor=C.+J.+Eyermannauthor=S.-M.+Huang&title=Effects+of+Structural+Modifications+on+the+Intestinal+Permeability+of+Angiotensin+II+Receptor+Antagonists+and+the+Correlation+of+In+Vitro%2C+In+Situ%2C+and+In+Vivo+Absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRibadeneira%26aufirst%3DM.%2BD.%26aulast%3DAungst%26aufirst%3DB.%2BJ.%26aulast%3DEyermann%26aufirst%3DC.%2BJ.%26aulast%3DHuang%26aufirst%3DS.-M.%26atitle%3DEffects%2520of%2520Structural%2520Modifications%2520on%2520the%2520Intestinal%2520Permeability%2520of%2520Angiotensin%2520II%2520Receptor%2520Antagonists%2520and%2520the%2520Correlation%2520of%2520In%2520Vitro%252C%2520In%2520Situ%252C%2520and%2520In%2520Vivo%2520Absorption%26jtitle%3DPharm.%2520Res.%26date%3D1996%26volume%3D13%26spage%3D227%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Takezako, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogonea, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnik, S. S.</span><span> </span><span class="NLM_article-title">âNetwork Leaningâ as a Mechanism of Insurmountable Antagonism of the Angiotensin II Type 1 Receptor by Non-peptide Antagonists</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15248</span><span class="NLM_x">â</span> <span class="NLM_lpage">15257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15248-15257&author=T.+Takezakoauthor=C.+Gogoneaauthor=Y.+Saadauthor=K.+Nodaauthor=S.+S.+Karnik&title=%E2%80%9CNetwork+Leaning%E2%80%9D+as+a+Mechanism+of+Insurmountable+Antagonism+of+the+Angiotensin+II+Type+1+Receptor+by+Non-peptide+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakezako%26aufirst%3DT.%26aulast%3DGogonea%26aufirst%3DC.%26aulast%3DSaad%26aufirst%3DY.%26aulast%3DNoda%26aufirst%3DK.%26aulast%3DKarnik%26aufirst%3DS.%2BS.%26atitle%3D%25E2%2580%259CNetwork%2520Leaning%25E2%2580%259D%2520as%2520a%2520Mechanism%2520of%2520Insurmountable%2520Antagonism%2520of%2520the%2520Angiotensin%2520II%2520Type%25201%2520Receptor%2520by%2520Non-peptide%2520Antagonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15248%26epage%3D15257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">The marketed AT<sub>1</sub> receptor antagonists show limited oral bioavailability (e. g. eprosartan 13%, valsartan 25%, losartan 33%, candesartan 42%, telmisartan 50%, irbesartan 60â80%.</p></div><span class="NLM_contrib-group">Israili, Z. H.</span><span> </span><span class="NLM_article-title">Clinical Pharmacokinetics of Angiotensin II (AT1) Receptor Blockers in Hypertension</span> <span class="citation_source-journal">J. Hum. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S73</span><span class="NLM_x">â</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=S73-86&issue=1&author=Z.+H.+Israili&title=Clinical+Pharmacokinetics+of+Angiotensin+II+%28AT1%29+Receptor+Blockers+in+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsraili%26aufirst%3DZ.%2BH.%26atitle%3DClinical%2520Pharmacokinetics%2520of%2520Angiotensin%2520II%2520%2528AT1%2529%2520Receptor%2520Blockers%2520in%2520Hypertension%26jtitle%3DJ.%2520Hum.%2520Hypertens.%26date%3D2000%26volume%3D14%26issue%3D1%26spage%3DS73%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brunner, H. R.</span><span> </span><span class="NLM_article-title">The New Angiotensin II Receptor Antagonist, Irbesartan</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">311S</span><span class="NLM_x">â</span> <span class="NLM_lpage">317S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1997&pages=311S-317S&author=H.+R.+Brunner&title=The+New+Angiotensin+II+Receptor+Antagonist%2C+Irbesartan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunner%26aufirst%3DH.%2BR.%26atitle%3DThe%2520New%2520Angiotensin%2520II%2520Receptor%2520Antagonist%252C%2520Irbesartan%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D1997%26volume%3D10%26spage%3D311S%26epage%3D317S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">Moreover, losartan exhibiting highly variable oral bioavailability is transported by P-glycoprotein, while its carboxylic acid metabolite is not a P-glycoprotein substrate; see:</p></div><span class="NLM_contrib-group">Soldner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutschler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christians, U.</span><span> </span><span class="NLM_article-title">Active Transport of the Angiotensin-II Antagonist Losartan and its Main Metabolite EXP 3174 Across MDCK-MDR1 and Caco-2 Cell Monolayers</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">â</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1038%2Fsj.bjp.0703150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=10725273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1egsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=1235-1243&author=A.+Soldnerauthor=L.+Z.+Benetauthor=E.+Mutschlerauthor=U.+Christians&title=Active+Transport+of+the+Angiotensin-II+Antagonist+Losartan+and+its+Main+Metabolite+EXP+3174+Across+MDCK-MDR1+and+Caco-2+Cell+Monolayers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers</span></div><div class="casAuthors">Soldner, Andrea; Benet, Leslie Z.; Mutschler, Ernst; Christians, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1235-1243</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors studied the functional interaction between transport and metab. by comparing the transport of losartan and its active metabolite EXP 3174 (EXP) across cell monolayers.  Epithelial layers of Caco-2 cells as well as MDR1, MRP-1 and MRP-2 overexpressing cells, in comparison to the resp. wild-types, were used to characterize the transcellular transport of losartan and EXP.  Losartan transport in MDCK-MDR1 and Caco-2 cells was saturable and energy-dependent with a significantly greater basolateral-to-apical (B/A) than apical-to-basolateral (A/B) flux (ratio = 31Â±1 in MDCK-MDR1 and ratio 4Â±1 in Caco-2 cells).  The B/A flux of losartan was inhibited by cyclosporine and vinblastine, inhibitors of P-glycoprotein and MRP.  In contrast, no active losartan transport was obsd. in MRP-1 or MRP-2 overexpressing cells.  The metabolite was only transported in Caco-2 cells with a B/A-to-A/B ratio of 5Â±1, while lacking active transport in the MDR1, MRP-1 or MRP-2 overexpressing cells.  The B/A flux of EXP was significantly inhibited by cyclosporine and vinblastine.  In conclusion, losartan is transported by P-glycoprotein and other intestinal transporters, that do not include MRP-1 and MRP-2.  In contrast, the carboxylic acid metabolite is not a P-glycoprotein substrate, but displays considerably higher affinity for other transporters than losartan, that again most probably do not include MRP-1 and MRP-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1aTLfRPhJ9rVg90H21EOLACvtfcHk0ljWdE42VxXuOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1egsL4%253D&md5=fdc0bf483ec38ec5ba573b295b6a4b7f</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703150%26sid%3Dliteratum%253Aachs%26aulast%3DSoldner%26aufirst%3DA.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DMutschler%26aufirst%3DE.%26aulast%3DChristians%26aufirst%3DU.%26atitle%3DActive%2520Transport%2520of%2520the%2520Angiotensin-II%2520Antagonist%2520Losartan%2520and%2520its%2520Main%2520Metabolite%2520EXP%25203174%2520Across%2520MDCK-MDR1%2520and%2520Caco-2%2520Cell%2520Monolayers%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D129%26spage%3D1235%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><a href="http://www.fda.gov/cder/foi/label/2002/20386s28lbl.pdf" class="extLink">http://www.fda.gov/cder/foi/label/2002/20386s28lbl.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.fda.gov%2Fcder%2Ffoi%2Flabel%2F2002%2F20386s28lbl.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Comparative studies on the UDP-glucuronosyltransferase-dependent metabolism showed that intrinsic clearance (CL<sub>intrinsic</sub> = <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub>) of compound <b>4b</b> is 7-fold higher than that shown by <b>2a</b> (Valoti, M. Personal communication). Interestingly, other authors reported that the absence of <b>2a</b> glucuronide in the hepatocyte and its presence in the bile suggest that its rate of formation is much slower than that of transport out of the cell [see:</p></div><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieter, P. A.</span><span> </span><span class="NLM_article-title">Disposition of Angiotensin II Receptor Antagonist L-158,809 in Rats and Rhesus Monkeys</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">â</span> <span class="NLM_lpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=183-188&author=A.+E.+Collettiauthor=P.+A.+Krieter&title=Disposition+of+Angiotensin+II+Receptor+Antagonist+L-158%2C809+in+Rats+and+Rhesus+Monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DKrieter%26aufirst%3DP.%2BA.%26atitle%3DDisposition%2520of%2520Angiotensin%2520II%2520Receptor%2520Antagonist%2520L-158%252C809%2520in%2520Rats%2520and%2520Rhesus%2520Monkeys%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1994%26volume%3D22%26spage%3D183%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huskey, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.-H. L.</span><span> </span><span class="NLM_article-title">N-Glucuronidation Reactions. I. Tetrazole N-Glucuronidation of Selected Angiotensin II Receptor Antagonists in Hepatic Microsome from Rats, Dogs, Monkeys, and Humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">â</span> <span class="NLM_lpage">799</span><div class="note"><p class="first last">and references cited therein]</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1993&pages=792-799&author=S.+W.+Huskeyauthor=R.+R.+Millerauthor=S.-H.+L.+Chiu&title=N-Glucuronidation+Reactions.+I.+Tetrazole+N-Glucuronidation+of+Selected+Angiotensin+II+Receptor+Antagonists+in+Hepatic+Microsome+from+Rats%2C+Dogs%2C+Monkeys%2C+and+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuskey%26aufirst%3DS.%2BW.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26atitle%3DN-Glucuronidation%2520Reactions.%2520I.%2520Tetrazole%2520N-Glucuronidation%2520of%2520Selected%2520Angiotensin%2520II%2520Receptor%2520Antagonists%2520in%2520Hepatic%2520Microsome%2520from%2520Rats%252C%2520Dogs%252C%2520Monkeys%252C%2520and%2520Humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1993%26volume%3D21%26spage%3D792%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Vauquelin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Liefde, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birzbier, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderheyden, P. M. L.</span><span> </span><span class="NLM_article-title">New Insights in Insurmountable Antagonism</span> <span class="citation_source-journal">Fund. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">â</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1046%2Fj.1472-8206.2002.00095.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=12570014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFGqsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=263-272&author=G.+Vauquelinauthor=I.+Van+Liefdeauthor=B.+B.+Birzbierauthor=P.+M.+L.+Vanderheyden&title=New+Insights+in+Insurmountable+Antagonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">New insights in insurmountable antagonism</span></div><div class="casAuthors">Vauquelin, G.; Van Liefde, I.; Birzbier, B. B.; Vanderheyden, P. M. L.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Antagonists that produce parallel rightward shifts of agonist dose-response curves with no alteration of the maximal response are traditionally classified as surmountable, while insurmountable antagonists also depress the maximal response.  Although the longevity of the antagonist-receptor complex is quoted in many studies to explain insurmountable antagonism, slowly interconverting receptor conformations, allosteric binding sites, and receptor internalization have been evoked as alternative explanations.  To complicate matters even further, insurmountable antagonism is not only drug-related; it may also depend on the tissue, species, and exptl. design.  For the sake of drug development, it is important to elucidate the mol. mechanisms of insurmountable antagonism.  New exptl. approaches, such as intact cell studies and the use of computer-assisted simulations based on dynamic receptor models, herald the advent of better insight in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdd2pIzF7eurVg90H21EOLACvtfcHk0ljWdE42VxXuOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFGqsbw%253D&md5=3a0a020f6fba65ac16bce0d8b87f4b70</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1046%2Fj.1472-8206.2002.00095.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1472-8206.2002.00095.x%26sid%3Dliteratum%253Aachs%26aulast%3DVauquelin%26aufirst%3DG.%26aulast%3DVan%2BLiefde%26aufirst%3DI.%26aulast%3DBirzbier%26aufirst%3DB.%2BB.%26aulast%3DVanderheyden%26aufirst%3DP.%2BM.%2BL.%26atitle%3DNew%2520Insights%2520in%2520Insurmountable%2520Antagonism%26jtitle%3DFund.%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D16%26spage%3D263%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span>SHELXS-97, Rel. 97-2, A Program for Automatic Solution of Crystal Structures, <span class="NLM_publisher-name">Gottingen University</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=G.+M.+Sheldrick&title=SHELXS-97%2C+Rel.+97-2%2C+A+Program+for+Automatic+Solution+of+Crystal+Structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26jtitle%3DSHELXS-97%252C%2520Rel.%252097-2%252C%2520A%2520Program%2520for%2520Automatic%2520Solution%2520of%2520Crystal%2520Structures%26pub%3DGottingen%2520University%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span>SHELXL-97, Rel. 97-2, A Program for Crystal Structure Refinement, <span class="NLM_publisher-name">Gottingen University</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=G.+M.+Sheldrick&title=SHELXL-97%2C+Rel.+97-2%2C+A+Program+for+Crystal+Structure+Refinement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26jtitle%3DSHELXL-97%252C%2520Rel.%252097-2%252C%2520A%2520Program%2520for%2520Crystal%2520Structure%2520Refinement%26pub%3DGottingen%2520University%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">De Lean, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodbard, D.</span><span> </span><span class="NLM_article-title">Simultaneous Analysis of Families of Sigmoidal Curves: Application to Bioassay, Radioligand Assay and Physiological Dose-Response Curves</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">E97</span><span class="NLM_x">â</span> <span class="NLM_lpage">E102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1978&pages=E97-E102&author=K.+W.+De+Leanauthor=P.+J.+Munsonauthor=D.+Rodbard&title=Simultaneous+Analysis+of+Families+of+Sigmoidal+Curves%3A+Application+to+Bioassay%2C+Radioligand+Assay+and+Physiological+Dose-Response+Curves"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLean%26aufirst%3DK.%2BW.%26aulast%3DMunson%26aufirst%3DP.%2BJ.%26aulast%3DRodbard%26aufirst%3DD.%26atitle%3DSimultaneous%2520Analysis%2520of%2520Families%2520of%2520Sigmoidal%2520Curves%253A%2520Application%2520to%2520Bioassay%252C%2520Radioligand%2520Assay%2520and%2520Physiological%2520Dose-Response%2520Curves%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1978%26volume%3D235%26spage%3DE97%26epage%3DE102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 49 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yapeng Bao, Zongfa Deng, Jing Feng, Weiwei Zhu, Jin Li, Jinqiao Wan, <span class="NLM_string-name hlFld-ContribAuthor">Guansai Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A B2(OH)4-Mediated Synthesis of 2-Substituted Indazolone and Its Application in a DNA-Encoded Library. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (16)
                                     , 6277-6282. <a href="https://doi.org/10.1021/acs.orglett.0c02032" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02032%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BB2%252528OH%2525294-Mediated%252BSynthesis%252Bof%252B2-Substituted%252BIndazolone%252Band%252BIts%252BApplication%252Bin%252Ba%252BDNA-Encoded%252BLibrary%26aulast%3DBao%26aufirst%3DYapeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19062020%26date%3D01082020%26volume%3D22%26issue%3D16%26spage%3D6277%26epage%3D6282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie S. Zhu, Makhluf J. Haddadin, <span class="NLM_string-name hlFld-ContribAuthor">Mark J. Kurth</span>. </span><span class="cited-content_cbyCitation_article-title">DavisâBeirut Reaction: Diverse Chemistries of Highly Reactive Nitroso Intermediates in Heterocycle Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2019,</strong> <em>52 </em>
                                    (8)
                                     , 2256-2265. <a href="https://doi.org/10.1021/acs.accounts.9b00220" title="DOI URL">https://doi.org/10.1021/acs.accounts.9b00220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.9b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.9b00220%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DDavis%2525E2%252580%252593Beirut%252BReaction%25253A%252BDiverse%252BChemistries%252Bof%252BHighly%252BReactive%252BNitroso%252BIntermediates%252Bin%252BHeterocycle%252BSynthesis%26aulast%3DZhu%26aufirst%3DJie%2BS.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29042019%26date%3D22072019%26volume%3D52%26issue%3D8%26spage%3D2256%26epage%3D2265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie S. Zhu, Niklas Kraemer, Clarabella J. Li, Makhluf J. Haddadin, <span class="NLM_string-name hlFld-ContribAuthor">Mark J. Kurth</span>. </span><span class="cited-content_cbyCitation_article-title">Photochemical Preparation of 1,2-Dihydro-3H-indazol-3-ones in Aqueous Solvent at Room Temperature. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (24)
                                     , 15493-15498. <a href="https://doi.org/10.1021/acs.joc.8b02356" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02356%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPhotochemical%252BPreparation%252Bof%252B1%25252C2-Dihydro-3H-indazol-3-ones%252Bin%252BAqueous%252BSolvent%252Bat%252BRoom%252BTemperature%26aulast%3DZhu%26aufirst%3DJie%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11092018%26date%3D06122018%26date%3D23112018%26volume%3D83%26issue%3D24%26spage%3D15493%26epage%3D15498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie S. Zhu, Niklas Kraemer, Marina E. Shatskikh, Clarabella J. Li, Jung-Ho Son, Makhluf J. Haddadin, Dean J. Tantillo, <span class="NLM_string-name hlFld-ContribAuthor">Mark J. Kurth</span>. </span><span class="cited-content_cbyCitation_article-title">NâN Bond Formation between Primary Amines and Nitrosos: Direct Synthesis of 2-Substituted Indazolones with Mechanistic Insights. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (16)
                                     , 4736-4739. <a href="https://doi.org/10.1021/acs.orglett.8b01655" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01655%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DN%2525E2%252580%252593N%252BBond%252BFormation%252Bbetween%252BPrimary%252BAmines%252Band%252BNitrosos%25253A%252BDirect%252BSynthesis%252Bof%252B2-Substituted%252BIndazolones%252Bwith%252BMechanistic%252BInsights%26aulast%3DZhu%26aufirst%3DJie%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25052018%26date%3D01082018%26volume%3D20%26issue%3D16%26spage%3D4736%26epage%3D4739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie S.  Zhu</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Duong</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Teuthorn</span>, <span class="hlFld-ContribAuthor ">Julia Y.  Lu</span>, <span class="hlFld-ContribAuthor ">Jung-Ho  Son</span>, <span class="hlFld-ContribAuthor ">Makhluf J.  Haddadin</span>, and <span class="hlFld-ContribAuthor ">Mark J.  Kurth</span>  . </span><span class="cited-content_cbyCitation_article-title">DavisâBeirut Reaction: Alkoxide versus Hydroxide Addition to the Key o-Nitrosoimine Intermediate. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (5)
                                     , 1308-1311. <a href="https://doi.org/10.1021/acs.orglett.8b00036" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b00036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b00036%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDavis%2525E2%252580%252593Beirut%252BReaction%25253A%252BAlkoxide%252Bversus%252BHydroxide%252BAddition%252Bto%252Bthe%252BKey%252Bo-Nitrosoimine%252BIntermediate%26aulast%3DZhu%26aufirst%3DJie%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04012018%26date%3D12022018%26date%3D02032018%26volume%3D20%26issue%3D5%26spage%3D1308%26epage%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing-Jun  Tu</span>, <span class="hlFld-ContribAuthor ">Wen-Juan  Hao</span>, <span class="hlFld-ContribAuthor ">Qin  Ye</span>, <span class="hlFld-ContribAuthor ">Shuang-Shuang  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Jiang</span>, <span class="hlFld-ContribAuthor ">Guigen  Li</span>, and <span class="hlFld-ContribAuthor ">Shu-Jiang  Tu</span>  . </span><span class="cited-content_cbyCitation_article-title">Four-Component Bicyclization Approaches to Skeletally Diverse Pyrazolo[3,4-b]pyridine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (22)
                                     , 11110-11118. <a href="https://doi.org/10.1021/jo502096t" title="DOI URL">https://doi.org/10.1021/jo502096t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo502096t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo502096t%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFour-Component%252BBicyclization%252BApproaches%252Bto%252BSkeletally%252BDiverse%252BPyrazolo%25255B3%25252C4-b%25255Dpyridine%252BDerivatives%26aulast%3DTu%26aufirst%3DXing-Jun%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D10092014%26date%3D04112014%26date%3D21112014%26date%3D22102014%26volume%3D79%26issue%3D22%26spage%3D11110%26epage%3D11118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wayne E.  Conrad</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Huy H.  Nguyen</span>, <span class="hlFld-ContribAuthor ">James C.  Fettinger</span>, <span class="hlFld-ContribAuthor ">Makhluf J.  Haddadin</span>, and <span class="hlFld-ContribAuthor ">Mark J.  Kurth</span>  . </span><span class="cited-content_cbyCitation_article-title">A One-PotâThree-Step Route to Triazolotriazepinoindazolones from Oxazolino-2H-indazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (15)
                                     , 3870-3873. <a href="https://doi.org/10.1021/ol3015804" title="DOI URL">https://doi.org/10.1021/ol3015804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol3015804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol3015804%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BOne-Pot%2525E2%252580%252593Three-Step%252BRoute%252Bto%252BTriazolotriazepinoindazolones%252Bfrom%252BOxazolino-2H-indazoles%26aulast%3DConrad%26aufirst%3DWayne%2BE.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07062012%26date%3D23072012%26date%3D03082012%26volume%3D14%26issue%3D15%26spage%3D3870%26epage%3D3873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shu-Yang  Li</span>, <span class="hlFld-ContribAuthor ">Yoichi  Yoshida</span>, <span class="hlFld-ContribAuthor ">Eiichi  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Masaaki  Kubota</span>, <span class="hlFld-ContribAuthor ">Tomoo  Matsutani</span>, <span class="hlFld-ContribAuthor ">Seiichiro  Mine</span>, <span class="hlFld-ContribAuthor ">Toshio  Machida</span>, <span class="hlFld-ContribAuthor ">Yoshiro  Maezawa</span>, <span class="hlFld-ContribAuthor ">Minoru  Takemoto</span>, <span class="hlFld-ContribAuthor ">Koutaro  Yokote</span>, <span class="hlFld-ContribAuthor ">Yoshio  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Hirotaka  Takizawa</span>, <span class="hlFld-ContribAuthor ">Mizuki  Sata</span>, <span class="hlFld-ContribAuthor ">Kazumasa  Yamagishi</span>, <span class="hlFld-ContribAuthor ">Hiroyasu  Iso</span>, <span class="hlFld-ContribAuthor ">Norie  Sawada</span>, <span class="hlFld-ContribAuthor ">Shoichiro  Tsugane</span>, <span class="hlFld-ContribAuthor ">Sohei  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Kazuyuki  Matsushita</span>, <span class="hlFld-ContribAuthor ">Fumio  Nomura</span>, <span class="hlFld-ContribAuthor ">Hisahiro  Matsubara</span>, <span class="hlFld-ContribAuthor ">Makoto  Sumazaki</span>, <span class="hlFld-ContribAuthor ">Masaaki  Ito</span>, <span class="hlFld-ContribAuthor ">Satoshi  Yajima</span>, <span class="hlFld-ContribAuthor ">Hideaki  Shimada</span>, <span class="hlFld-ContribAuthor ">Katsuro  Iwase</span>, <span class="hlFld-ContribAuthor ">Hiromi  Ashino</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Kenichiro  Goto</span>, <span class="hlFld-ContribAuthor ">Go  Tomiyoshi</span>, <span class="hlFld-ContribAuthor ">Natsuko  Shinmen</span>, <span class="hlFld-ContribAuthor ">Rika  Nakamura</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Kuroda</span>, <span class="hlFld-ContribAuthor ">Yasuo  Iwadate</span>, <span class="hlFld-ContribAuthor ">Takaki  Hiwasa</span>. </span><span class="cited-content_cbyCitation_article-title">Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-92786-9" title="DOI URL">https://doi.org/10.1038/s41598-021-92786-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-92786-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-92786-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSerum%252Banti-AP3D1%252Bantibodies%252Bare%252Brisk%252Bfactors%252Bfor%252Bacute%252Bischemic%252Bstroke%252Brelated%252Bwith%252Batherosclerosis%26aulast%3DLi%26aufirst%3DShu-Yang%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Nikpassand</span>, <span class="hlFld-ContribAuthor ">Leila  Zare Fekri</span>, <span class="hlFld-ContribAuthor ">Parissa  Naddaf Rahro</span>. </span><span class="cited-content_cbyCitation_article-title">Solvent-free Synthesis and DFT Studies on Mechanistic Pathway of 4-Aryl-4,10-Dihydroindeno[1,2-
              b
              ]Pyrazolo[4,3-
              e
              ]Pyridin-5(
              1H
              )-ones. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2020,</strong> <em> </em>, 1-11. <a href="https://doi.org/10.1080/10406638.2020.1855217" title="DOI URL">https://doi.org/10.1080/10406638.2020.1855217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2020.1855217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2020.1855217%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DSolvent-free%252BSynthesis%252Band%252BDFT%252BStudies%252Bon%252BMechanistic%252BPathway%252Bof%252B4-Aryl-4%25252C10-Dihydroindeno%25255B1%25252C2-%252Bb%252B%25255DPyrazolo%25255B4%25252C3-%252Be%252B%25255DPyridin-5%252528%252B1H%252B%252529-ones%26aulast%3DNikpassand%26aufirst%3DMohammad%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia A.  Elkina</span>, <span class="hlFld-ContribAuthor ">Yanina V.  Burgart</span>, <span class="hlFld-ContribAuthor ">Evgeny V.  Shchegolkov</span>, <span class="hlFld-ContribAuthor ">Olga P.  Krasnykh</span>, <span class="hlFld-ContribAuthor ">Vera V.  Maslova</span>, <span class="hlFld-ContribAuthor ">Galina A.  Triandafilova</span>, <span class="hlFld-ContribAuthor ">Sergey S.  Solodnikov</span>, <span class="hlFld-ContribAuthor ">Anna A.  Muryleva</span>, <span class="hlFld-ContribAuthor ">Maria A.  Misiurina</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Slita</span>, <span class="hlFld-ContribAuthor ">Vladimir V.  Zarubaev</span>, <span class="hlFld-ContribAuthor ">Victor I.  Saloutin</span>. </span><span class="cited-content_cbyCitation_article-title">Competitive routes to cyclizations of polyfluoroalkyl-containing 2-tolylhydrazinylidene-1,3-diketones with 3-aminopyrazoles into bioactive pyrazoloazines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2020,</strong> <em>240 </em>, 109648. <a href="https://doi.org/10.1016/j.jfluchem.2020.109648" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2020.109648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2020.109648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2020.109648%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DCompetitive%252Broutes%252Bto%252Bcyclizations%252Bof%252Bpolyfluoroalkyl-containing%252B2-tolylhydrazinylidene-1%25252C3-diketones%252Bwith%252B3-aminopyrazoles%252Binto%252Bbioactive%252Bpyrazoloazines%26aulast%3DElkina%26aufirst%3DNatalia%2BA.%26date%3D2020%26volume%3D240%26spage%3D109648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linda  Supe</span>, <span class="hlFld-ContribAuthor ">Martin  Hein</span>, <span class="hlFld-ContribAuthor ">Viktor O.  Iaroshenko</span>, <span class="hlFld-ContribAuthor ">Alexander  Villinger</span>, <span class="hlFld-ContribAuthor ">Peter  Langer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of glycosides of 1H-Pyrazolo[3,4-b]pyridin-3(2H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (44)
                                     , 131522. <a href="https://doi.org/10.1016/j.tet.2020.131522" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131522%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bglycosides%252Bof%252B1H-Pyrazolo%25255B3%25252C4-b%25255Dpyridin-3%2525282H%252529-ones%26aulast%3DSupe%26aufirst%3DLinda%26date%3D2020%26volume%3D76%26issue%3D44%26spage%3D131522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sampath  Ravula</span>, <span class="hlFld-ContribAuthor ">Ramana Reddy  Bobbala</span>, <span class="hlFld-ContribAuthor ">Balakrishna  Kolli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel isoxazole functionalized pyrazolo[3,4â
              b
              ]pyridine derivatives; their anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (6)
                                     , 2535-2538. <a href="https://doi.org/10.1002/jhet.3968" title="DOI URL">https://doi.org/10.1002/jhet.3968</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3968%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnovel%252Bisoxazole%252Bfunctionalized%252Bpyrazolo%25255B3%25252C4%2525E2%252580%252590%252Bb%252B%25255Dpyridine%252Bderivatives%25253B%252Btheir%252Banticancer%252Bactivity%26aulast%3DRavula%26aufirst%3DSampath%26date%3D2020%26date%3D2020%26volume%3D57%26issue%3D6%26spage%3D2535%26epage%3D2538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khadija  Gambouz</span>, <span class="hlFld-ContribAuthor ">Abdelmoula  El Abbouchi</span>, <span class="hlFld-ContribAuthor ">Sarah  Nassiri</span>, <span class="hlFld-ContribAuthor ">Franck  Suzenet</span>, <span class="hlFld-ContribAuthor ">Mostapha  Bousmina</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">GÃ©rald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">SaÃ¯d  El Kazzouli</span>. </span><span class="cited-content_cbyCitation_article-title">âOn Waterâ Palladium Catalyzed Direct Arylation of 1H-Indazole and 1H-7-Azaindazole. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (12)
                                     , 2820. <a href="https://doi.org/10.3390/molecules25122820" title="DOI URL">https://doi.org/10.3390/molecules25122820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25122820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25122820%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D%2525E2%252580%25259COn%252BWater%2525E2%252580%25259D%252BPalladium%252BCatalyzed%252BDirect%252BArylation%252Bof%252B1H-Indazole%252Band%252B1H-7-Azaindazole%26aulast%3DGambouz%26aufirst%3DKhadija%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D12%26spage%3D2820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janos  Sapi</span>, <span class="hlFld-ContribAuthor ">StÃ©phane  GÃ©rard</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems: Three Heteroatoms 2:1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00021-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00021-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00021-4%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%25253A%252BThree%252BHeteroatoms%252B2%25253A1%26aulast%3DSapi%26aufirst%3DJanos%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Hou</span>, <span class="hlFld-ContribAuthor ">Huan  Xiong</span>, <span class="hlFld-ContribAuthor ">Ruisong  Bai</span>, <span class="hlFld-ContribAuthor ">Zaozao  Xiao</span>, <span class="hlFld-ContribAuthor ">Lin  Su</span>, <span class="hlFld-ContribAuthor ">Bengfang Helen  Ruan</span>, <span class="hlFld-ContribAuthor ">Hongtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Indazolo[2,1-a]Cinnolines via Rhodium (III)-Catalyzed CâH activation/annulation under mild conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (30)
                                     , 4005-4009. <a href="https://doi.org/10.1016/j.tet.2019.06.021" title="DOI URL">https://doi.org/10.1016/j.tet.2019.06.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.06.021%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252BIndazolo%25255B2%25252C1-a%25255DCinnolines%252Bvia%252BRhodium%252B%252528III%252529-Catalyzed%252BC%2525E2%252580%252593H%252Bactivation%25252Fannulation%252Bunder%252Bmild%252Bconditions%26aulast%3DHou%26aufirst%3DWei%26date%3D2019%26volume%3D75%26issue%3D30%26spage%3D4005%26epage%3D4009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianbao  Yang</span>, <span class="hlFld-ContribAuthor ">Huiai  Lu</span>, <span class="hlFld-ContribAuthor ">Renhua  Qiu</span>, <span class="hlFld-ContribAuthor ">Ling  Hong</span>, <span class="hlFld-ContribAuthor ">ShuangâFeng  Yin</span>, <span class="hlFld-ContribAuthor ">Nobuaki  Kambe</span>. </span><span class="cited-content_cbyCitation_article-title">Photocatalystâfree Synthesis of Indazolones under CO
              2
              Atmosphere. </span><span class="cited-content_cbyCitation_journal-name">Chemistry â An Asian Journal</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , 1436-1442. <a href="https://doi.org/10.1002/asia.201900306" title="DOI URL">https://doi.org/10.1002/asia.201900306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201900306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201900306%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DPhotocatalyst%2525E2%252580%252590free%252BSynthesis%252Bof%252BIndazolones%252Bunder%252BCO%252B2%252BAtmosphere%26aulast%3DYang%26aufirst%3DTianbao%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3D1436%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Jun  Nie</span>, <span class="hlFld-ContribAuthor ">An-Di  Guo</span>, <span class="hlFld-ContribAuthor ">Hai-Xia  Lin</span>, <span class="hlFld-ContribAuthor ">Xiao-Hua  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid and halide compatible synthesis of 2-
              N
              -substituted indazolone derivatives
              via
              photochemical cyclization in aqueous media. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (23)
                                     , 13249-13253. <a href="https://doi.org/10.1039/C9RA02466B" title="DOI URL">https://doi.org/10.1039/C9RA02466B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA02466B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA02466B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRapid%252Band%252Bhalide%252Bcompatible%252Bsynthesis%252Bof%252B2-%252BN%252B-substituted%252Bindazolone%252Bderivatives%252Bvia%252Bphotochemical%252Bcyclization%252Bin%252Baqueous%252Bmedia%26aulast%3DNie%26aufirst%3DHui-Jun%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D23%26spage%3D13249%26epage%3D13253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Nikpassand</span>, <span class="hlFld-ContribAuthor ">Leila Zare  Fekri</span>, <span class="hlFld-ContribAuthor ">Parissa Naddaf  Rahro</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-free grinding method: a new avenue for synthesis of 6-amino-3-methyl-4-aryl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile and DFT studies on the mechanistic pathway of this category of compounds. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2019,</strong> <em>45 </em>
                                    (4)
                                     , 1707-1719. <a href="https://doi.org/10.1007/s11164-018-3701-9" title="DOI URL">https://doi.org/10.1007/s11164-018-3701-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-018-3701-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-018-3701-9%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DCatalyst-free%252Bgrinding%252Bmethod%25253A%252Ba%252Bnew%252Bavenue%252Bfor%252Bsynthesis%252Bof%252B6-amino-3-methyl-4-aryl-1H-pyrazolo%25255B3%25252C4-b%25255Dpyridine-5-carbonitrile%252Band%252BDFT%252Bstudies%252Bon%252Bthe%252Bmechanistic%252Bpathway%252Bof%252Bthis%252Bcategory%252Bof%252Bcompounds%26aulast%3DNikpassand%26aufirst%3DMohammad%26date%3D2019%26date%3D2019%26volume%3D45%26issue%3D4%26spage%3D1707%26epage%3D1719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linda  Supe</span>, <span class="hlFld-ContribAuthor ">Saira  Afzal</span>, <span class="hlFld-ContribAuthor ">Abid  Mahmood</span>, <span class="hlFld-ContribAuthor ">Syeda Abida  Ejaz</span>, <span class="hlFld-ContribAuthor ">Martin  Hein</span>, <span class="hlFld-ContribAuthor ">Viktor O.  Iaroshenko</span>, <span class="hlFld-ContribAuthor ">Alexander  Villinger</span>, <span class="hlFld-ContribAuthor ">Joanna  Lecka</span>, <span class="hlFld-ContribAuthor ">Jean  SÃ©vigny</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>, <span class="hlFld-ContribAuthor ">Peter  Langer</span>. </span><span class="cited-content_cbyCitation_article-title">Deazapurine Analogues Bearing a 1
              H
              -Pyrazolo[3,4-
              b
              ]pyridin-3(2
              H
              )-one Core: Synthesis and Biological Activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (20-21)
                                     , 2629-2644. <a href="https://doi.org/10.1002/ejoc.201800163" title="DOI URL">https://doi.org/10.1002/ejoc.201800163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800163%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDeazapurine%252BAnalogues%252BBearing%252Ba%252B1%252BH%252B-Pyrazolo%25255B3%25252C4-%252Bb%252B%25255Dpyridin-3%2525282%252BH%252B%252529-one%252BCore%25253A%252BSynthesis%252Band%252BBiological%252BActivity%26aulast%3DSupe%26aufirst%3DLinda%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D20-21%26spage%3D2629%26epage%3D2644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Xu</span>, <span class="hlFld-ContribAuthor ">Lei  Li</span>, <span class="hlFld-ContribAuthor ">Zhansheng  Wang</span>, <span class="hlFld-ContribAuthor ">Junhua  Xi</span>, <span class="hlFld-ContribAuthor ">Liangce  Rong</span>. </span><span class="cited-content_cbyCitation_article-title">A green synthesis of 1,7-dihydrodipyrazolo[3,4-b:4â²,3â²-e]pyridin-3(2H)-one derivatives from deamination cyclization reactions in aqueous medium. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2018,</strong> <em>44 </em>
                                    (5)
                                     , 3211-3226. <a href="https://doi.org/10.1007/s11164-018-3302-7" title="DOI URL">https://doi.org/10.1007/s11164-018-3302-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-018-3302-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-018-3302-7%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DA%252Bgreen%252Bsynthesis%252Bof%252B1%25252C7-dihydrodipyrazolo%25255B3%25252C4-b%25253A4%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2-e%25255Dpyridin-3%2525282H%252529-one%252Bderivatives%252Bfrom%252Bdeamination%252Bcyclization%252Breactions%252Bin%252Baqueous%252Bmedium%26aulast%3DXu%26aufirst%3DHui%26date%3D2018%26date%3D2018%26volume%3D44%26issue%3D5%26spage%3D3211%26epage%3D3226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serdar  Durdagi</span>, <span class="hlFld-ContribAuthor ">Busecan  Aksoydan</span>, <span class="hlFld-ContribAuthor ">Ismail  Erol</span>, <span class="hlFld-ContribAuthor ">Isik  Kantarcioglu</span>, <span class="hlFld-ContribAuthor ">Yavuz  Ergun</span>, <span class="hlFld-ContribAuthor ">Gulay  Bulut</span>, <span class="hlFld-ContribAuthor ">Melih  Acar</span>, <span class="hlFld-ContribAuthor ">Timucin  Avsar</span>, <span class="hlFld-ContribAuthor ">George  Liapakis</span>, <span class="hlFld-ContribAuthor ">Vlasios  Karageorgos</span>, <span class="hlFld-ContribAuthor ">Ramin E.  Salmas</span>, <span class="hlFld-ContribAuthor ">BarÄ±Å  Sergi</span>, <span class="hlFld-ContribAuthor ">Sara  Alkhatib</span>, <span class="hlFld-ContribAuthor ">Gizem  Turan</span>, <span class="hlFld-ContribAuthor ">Berfu Nur  Yigit</span>, <span class="hlFld-ContribAuthor ">Kutay  Cantasir</span>, <span class="hlFld-ContribAuthor ">Bahar  Kurt</span>, <span class="hlFld-ContribAuthor ">Turker  Kilic</span>. </span><span class="cited-content_cbyCitation_article-title">Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and imidazolone derivatives and analysis of their potential restrictive effects on cell proliferation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>145 </em>, 273-290. <a href="https://doi.org/10.1016/j.ejmech.2017.12.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntegration%252Bof%252Bmulti-scale%252Bmolecular%252Bmodeling%252Bapproaches%252Bwith%252Bexperiments%252Bfor%252Bthe%252Bin%252Bsilico%252Bguided%252Bdesign%252Band%252Bdiscovery%252Bof%252Bnovel%252BhERG-Neutral%252Bantihypertensive%252Boxazalone%252Band%252Bimidazolone%252Bderivatives%252Band%252Banalysis%252Bof%252Btheir%252Bpotential%252Brestrictive%252Beffects%252Bon%252Bcell%252Bproliferation%26aulast%3DDurdagi%26aufirst%3DSerdar%26date%3D2018%26volume%3D145%26spage%3D273%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Busecan  Aksoydan</span>, <span class="hlFld-ContribAuthor ">Isik  Kantarcioglu</span>, <span class="hlFld-ContribAuthor ">Ismail  Erol</span>, <span class="hlFld-ContribAuthor ">Ramin Ekhteiari  Salmas</span>, <span class="hlFld-ContribAuthor ">Serdar  Durdagi</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2018,</strong> <em>79 </em>, 103-117. <a href="https://doi.org/10.1016/j.jmgm.2017.10.011" title="DOI URL">https://doi.org/10.1016/j.jmgm.2017.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2017.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2017.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DStructure-based%252Bdesign%252Bof%252BhERG-neutral%252Bantihypertensive%252Boxazalone%252Band%252Bimidazolone%252Bderivatives%26aulast%3DAksoydan%26aufirst%3DBusecan%26date%3D2018%26volume%3D79%26spage%3D103%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atsushi  Ohtaka</span>, <span class="hlFld-ContribAuthor ">Akira  Sakon</span>, <span class="hlFld-ContribAuthor ">Asuka  Yasui</span>, <span class="hlFld-ContribAuthor ">Taira  Kawaguchi</span>, <span class="hlFld-ContribAuthor ">Go  Hamasaka</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Uozumi</span>, <span class="hlFld-ContribAuthor ">Tsutomu  Shinagawa</span>, <span class="hlFld-ContribAuthor ">Osamu  Shimomura</span>, <span class="hlFld-ContribAuthor ">RyÃ´ki  Nomura</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic specificity of linear polystyrene-stabilized Pd nanoparticles during Ullmann coupling reaction in water and the associated mechanism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Organometallic Chemistry</span><span> <strong>2018,</strong> <em>854 </em>, 87-93. <a href="https://doi.org/10.1016/j.jorganchem.2017.11.016" title="DOI URL">https://doi.org/10.1016/j.jorganchem.2017.11.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jorganchem.2017.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jorganchem.2017.11.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Organometallic%2520Chemistry%26atitle%3DCatalytic%252Bspecificity%252Bof%252Blinear%252Bpolystyrene-stabilized%252BPd%252Bnanoparticles%252Bduring%252BUllmann%252Bcoupling%252Breaction%252Bin%252Bwater%252Band%252Bthe%252Bassociated%252Bmechanism%26aulast%3DOhtaka%26aufirst%3DAtsushi%26date%3D2018%26volume%3D854%26spage%3D87%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahnaz  Ezzati</span>, <span class="hlFld-ContribAuthor ">Jabbar  Khalafy</span>, <span class="hlFld-ContribAuthor ">Ahmad Poursattar  Marjani</span>, <span class="hlFld-ContribAuthor ">Rolf H.  Prager</span>. </span><span class="cited-content_cbyCitation_article-title">The catalyst-free syntheses of pyrazolo[3,4-b]quinolin-5-one and pyrazolo[4â²,3â²:5,6]pyrido[2,3-d]pyrimidin-5,7-dione derivatives by one-pot, three-component reactions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (47)
                                     , 6587-6596. <a href="https://doi.org/10.1016/j.tet.2017.10.004" title="DOI URL">https://doi.org/10.1016/j.tet.2017.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DThe%252Bcatalyst-free%252Bsyntheses%252Bof%252Bpyrazolo%25255B3%25252C4-b%25255Dquinolin-5-one%252Band%252Bpyrazolo%25255B4%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%25253A5%25252C6%25255Dpyrido%25255B2%25252C3-d%25255Dpyrimidin-5%25252C7-dione%252Bderivatives%252Bby%252Bone-pot%25252C%252Bthree-component%252Breactions%26aulast%3DEzzati%26aufirst%3DMahnaz%26date%3D2017%26volume%3D73%26issue%3D47%26spage%3D6587%26epage%3D6596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Publisher's note. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2017,</strong>,, 240. <a href="https://doi.org/10.1016/j.jmgm.2017.08.004" title="DOI URL">https://doi.org/10.1016/j.jmgm.2017.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2017.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DPublisher%252527s%252Bnote%26date%3D2017%26volume%3D77%26spage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ran  Su</span>, <span class="hlFld-ContribAuthor ">Zhun  Hou</span>, <span class="hlFld-ContribAuthor ">Lihong  Sang</span>, <span class="hlFld-ContribAuthor ">Zhi-ming  Zhou</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioseparation of angiotensin II receptor type 1 blockers: evaluation of 6-substituted carbamoyl benzimidazoles on immobilized polysaccharide-based chiral stationary phases. Unusual temperature behavior. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography A</span><span> <strong>2017,</strong> <em>1515 </em>, 118-128. <a href="https://doi.org/10.1016/j.chroma.2017.07.081" title="DOI URL">https://doi.org/10.1016/j.chroma.2017.07.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chroma.2017.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chroma.2017.07.081%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520A%26atitle%3DEnantioseparation%252Bof%252Bangiotensin%252BII%252Breceptor%252Btype%252B1%252Bblockers%25253A%252Bevaluation%252Bof%252B6-substituted%252Bcarbamoyl%252Bbenzimidazoles%252Bon%252Bimmobilized%252Bpolysaccharide-based%252Bchiral%252Bstationary%252Bphases.%252BUnusual%252Btemperature%252Bbehavior%26aulast%3DSu%26aufirst%3DRan%26date%3D2017%26volume%3D1515%26spage%3D118%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Wan</span>, <span class="hlFld-ContribAuthor ">Shu-Ying  Huang</span>, <span class="hlFld-ContribAuthor ">Gui-Xiang  Liu</span>, <span class="hlFld-ContribAuthor ">Liang-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Shu-Ning  Yue</span>, <span class="hlFld-ContribAuthor ">Wen-Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Huan  Zou</span>, <span class="hlFld-ContribAuthor ">Li-Zhuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Cui</span>, <span class="hlFld-ContribAuthor ">Sheng-Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Hui  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">A Catalyst-free Synthesis of Pyrazolopyridines Derived from Alicyclic Mono-ketones. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2016,</strong> <em>53 </em>
                                    (6)
                                     , 1715-1720. <a href="https://doi.org/10.1002/jhet.2171" title="DOI URL">https://doi.org/10.1002/jhet.2171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2171%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DA%252BCatalyst-free%252BSynthesis%252Bof%252BPyrazolopyridines%252BDerived%252Bfrom%252BAlicyclic%252BMono-ketones%26aulast%3DWan%26aufirst%3DYu%26date%3D2016%26date%3D2016%26volume%3D53%26issue%3D6%26spage%3D1715%26epage%3D1720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolu  Bao</span>, <span class="hlFld-ContribAuthor ">Weibo  Zhu</span>, <span class="hlFld-ContribAuthor ">Weidong  Yuan</span>, <span class="hlFld-ContribAuthor ">Xingbo  Zhu</span>, <span class="hlFld-ContribAuthor ">Yijia  Yan</span>, <span class="hlFld-ContribAuthor ">Hesheng  Tang</span>, <span class="hlFld-ContribAuthor ">Zhilong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of novel potent angiotensin II receptor 1 antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>123 </em>, 115-127. <a href="https://doi.org/10.1016/j.ejmech.2016.07.023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.07.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.07.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252Bpotent%252Bangiotensin%252BII%252Breceptor%252B1%252Bantagonists%26aulast%3DBao%26aufirst%3DXiaolu%26date%3D2016%26volume%3D123%26spage%3D115%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Paolino</span>, <span class="hlFld-ContribAuthor ">Giorgio  Grisci</span>, <span class="hlFld-ContribAuthor ">Germano  Giuliani</span>, <span class="hlFld-ContribAuthor ">Iacopo  Zanardi</span>, <span class="hlFld-ContribAuthor ">Marco  Andreassi</span>, <span class="hlFld-ContribAuthor ">Valter  Travagli</span>, <span class="hlFld-ContribAuthor ">Mariano  Licciardi</span>, <span class="hlFld-ContribAuthor ">Cinzia  Scialabba</span>, <span class="hlFld-ContribAuthor ">Gaetano  Giammona</span>, <span class="hlFld-ContribAuthor ">Andrea  Cappelli</span>, <span class="hlFld-ContribAuthor ">Salvatore  Vomero</span>. </span><span class="cited-content_cbyCitation_article-title">Ï-Stacked polymers in drug delivery applications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Delivery Science and Technology</span><span> <strong>2016,</strong> <em>32 </em>, 142-166. <a href="https://doi.org/10.1016/j.jddst.2015.04.001" title="DOI URL">https://doi.org/10.1016/j.jddst.2015.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jddst.2015.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jddst.2015.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Delivery%2520Science%2520and%2520Technology%26atitle%3D%2525CF%252580-Stacked%252Bpolymers%252Bin%252Bdrug%252Bdelivery%252Bapplications%26aulast%3DPaolino%26aufirst%3DMarco%26date%3D2016%26volume%3D32%26spage%3D142%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbora  Orlikova</span>, <span class="hlFld-ContribAuthor ">Wafaa  Chaouni</span>, <span class="hlFld-ContribAuthor ">Marc  Schumacher</span>, <span class="hlFld-ContribAuthor ">Mina  Aadil</span>, <span class="hlFld-ContribAuthor ">Marc  Diederich</span>, <span class="hlFld-ContribAuthor ">Gilbert  Kirsch</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and bioactivity of novel amino-pyrazolopyridines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 450-457. <a href="https://doi.org/10.1016/j.ejmech.2014.08.008" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.08.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.08.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbioactivity%252Bof%252Bnovel%252Bamino-pyrazolopyridines%26aulast%3DOrlikova%26aufirst%3DBarbora%26date%3D2014%26volume%3D85%26spage%3D450%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Cappelli</span>, <span class="hlFld-ContribAuthor ">Marco  Paolino</span>, <span class="hlFld-ContribAuthor ">Giorgio  Grisci</span>, <span class="hlFld-ContribAuthor ">Germano  Giuliani</span>, <span class="hlFld-ContribAuthor ">Alessandro  Donati</span>, <span class="hlFld-ContribAuthor ">Antonella Caterina  Boccia</span>, <span class="hlFld-ContribAuthor ">Filippo  Samperi</span>, <span class="hlFld-ContribAuthor ">Raniero  Mendichi</span>, <span class="hlFld-ContribAuthor ">Salvatore  Vomero</span>. </span><span class="cited-content_cbyCitation_article-title">Reversible Polymerization Techniques Leading to Ï-Stacked Polymers. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 51-149. <a href="https://doi.org/10.1007/978-4-431-54129-5_2" title="DOI URL">https://doi.org/10.1007/978-4-431-54129-5_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-4-431-54129-5_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-4-431-54129-5_2%26sid%3Dliteratum%253Aachs%26atitle%3DReversible%252BPolymerization%252BTechniques%252BLeading%252Bto%252B%2525CF%252580-Stacked%252BPolymers%26aulast%3DCappelli%26aufirst%3DAndrea%26date%3D2014%26date%3D2013%26spage%3D51%26epage%3D149%26pub%3DSpringer%2520Japan%26atitle%3D%2525CF%252580-Stacked%252BPolymers%252Band%252BMolecules%26aulast%3DNakano%26aufirst%3DTamaki%26date%3D2014%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jin-Liang  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Fa  Yu</span>, <span class="hlFld-ContribAuthor ">Zhi-Ming  Zhou</span>, <span class="hlFld-ContribAuthor ">Wen-Chang  Tao</span>, <span class="hlFld-ContribAuthor ">Yi-Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Zhe  Xue</span>, <span class="hlFld-ContribAuthor ">Di  Xu</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Hao</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Han</span>, <span class="hlFld-ContribAuthor ">Fan  Fei</span>, <span class="hlFld-ContribAuthor ">Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Ai-Hua  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Nonpeptidic angiotensin II AT1 receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>69 </em>, 44-54. <a href="https://doi.org/10.1016/j.ejmech.2013.08.014" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.08.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.08.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNonpeptidic%252Bangiotensin%252BII%252BAT1%252Breceptor%252Bantagonists%252Bderived%252Bfrom%252B6-substituted%252Baminocarbonyl%252Band%252Bacylamino%252Bbenzimidazoles%26aulast%3DZhang%26aufirst%3DJun%26date%3D2013%26volume%3D69%26spage%3D44%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George  Agelis</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Kelaidonis</span>, <span class="hlFld-ContribAuthor ">Amalia  Resvani</span>, <span class="hlFld-ContribAuthor ">Dimitra  Kalavrizioti</span>, <span class="hlFld-ContribAuthor ">Maria-Eleni  Androutsou</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Plotas</span>, <span class="hlFld-ContribAuthor ">Demetrios  Vlahakos</span>, <span class="hlFld-ContribAuthor ">Catherine  Koukoulitsa</span>, <span class="hlFld-ContribAuthor ">Theodore  Tselios</span>, <span class="hlFld-ContribAuthor ">Thomas  Mavromoustakos</span>, <span class="hlFld-ContribAuthor ">John  Matsoukas</span>. </span><span class="cited-content_cbyCitation_article-title">Facile and Efficient Syntheses of a Series of N-Benzyl and  N-Biphenylmethyl Substituted Imidazole Derivatives Based on (E)-Urocanic acid, as Angiotensin II AT1 Receptor Blockers. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2013,</strong> <em>18 </em>
                                    (7)
                                     , 7510-7532. <a href="https://doi.org/10.3390/molecules18077510" title="DOI URL">https://doi.org/10.3390/molecules18077510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules18077510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules18077510%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DFacile%252Band%252BEfficient%252BSyntheses%252Bof%252Ba%252BSeries%252Bof%252BN-Benzyl%252Band%252BN-Biphenylmethyl%252BSubstituted%252BImidazole%252BDerivatives%252BBased%252Bon%252B%252528E%252529-Urocanic%252Bacid%25252C%252Bas%252BAngiotensin%252BII%252BAT1%252BReceptor%252BBlockers%26aulast%3DAgelis%26aufirst%3DGeorge%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D7%26spage%3D7510%26epage%3D7532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George  Agelis</span>, <span class="hlFld-ContribAuthor ">Amalia  Resvani</span>, <span class="hlFld-ContribAuthor ">Catherine  Koukoulitsa</span>, <span class="hlFld-ContribAuthor ">Tereza  TÅ¯movÃ¡</span>, <span class="hlFld-ContribAuthor ">JiÅina  SlaninovÃ¡</span>, <span class="hlFld-ContribAuthor ">Dimitra  Kalavrizioti</span>, <span class="hlFld-ContribAuthor ">Katerina  Spyridaki</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>, <span class="hlFld-ContribAuthor ">Georgia  Melagraki</span>, <span class="hlFld-ContribAuthor ">Athanasia  Siafaka</span>, <span class="hlFld-ContribAuthor ">Eleni  Gkini</span>, <span class="hlFld-ContribAuthor ">Grigorios  Megariotis</span>, <span class="hlFld-ContribAuthor ">Simona Golic  Grdadolnik</span>, <span class="hlFld-ContribAuthor ">Manthos G.  Papadopoulos</span>, <span class="hlFld-ContribAuthor ">Demetrios  Vlahakos</span>, <span class="hlFld-ContribAuthor ">Michael  Maragoudakis</span>, <span class="hlFld-ContribAuthor ">George  Liapakis</span>, <span class="hlFld-ContribAuthor ">Thomas  Mavromoustakos</span>, <span class="hlFld-ContribAuthor ">John  Matsoukas</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design, efficient syntheses and biological evaluation of N , N â²-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>62 </em>, 352-370. <a href="https://doi.org/10.1016/j.ejmech.2012.12.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesign%25252C%252Befficient%252Bsyntheses%252Band%252Bbiological%252Bevaluation%252Bof%252BN%252B%25252C%252BN%252B%2525E2%252580%2525B2-symmetrically%252Bbis-substituted%252Bbutylimidazole%252Banalogs%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Bpotent%252BAngiotensin%252BII%252Breceptor%252Bblockers%26aulast%3DAgelis%26aufirst%3DGeorge%26date%3D2013%26volume%3D62%26spage%3D352%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin C.  Michel</span>, <span class="hlFld-ContribAuthor ">Carolyn  Foster</span>, <span class="hlFld-ContribAuthor ">Hans R.  Brunner</span>, <span class="hlFld-ContribAuthor ">Lisheng  Liu</span>, . </span><span class="cited-content_cbyCitation_article-title">A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2013,</strong> <em>65 </em>
                                    (2)
                                     , 809-848. <a href="https://doi.org/10.1124/pr.112.007278" title="DOI URL">https://doi.org/10.1124/pr.112.007278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.112.007278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.112.007278%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DA%252BSystematic%252BComparison%252Bof%252Bthe%252BProperties%252Bof%252BClinically%252BUsed%252BAngiotensin%252BII%252BType%252B1%252BReceptor%252BAntagonists%26aulast%3DMichel%26aufirst%3DMartin%2BC.%26date%3D2013%26date%3D2013%26volume%3D65%26issue%3D2%26spage%3D809%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pethaiah  Gunasekaran</span>, <span class="hlFld-ContribAuthor ">Sethuraman  Indumathi</span>, <span class="hlFld-ContribAuthor ">Subbu  Perumal</span>. </span><span class="cited-content_cbyCitation_article-title">l-Proline-catalyzed three-component domino reactions in the regioselective synthesis of novel densely functionalized pyrazolo[3,4-b]pyridines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2013,</strong> <em>3 </em>
                                    (22)
                                     , 8318. <a href="https://doi.org/10.1039/c3ra00136a" title="DOI URL">https://doi.org/10.1039/c3ra00136a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra00136a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra00136a%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3Dl-Proline-catalyzed%252Bthree-component%252Bdomino%252Breactions%252Bin%252Bthe%252Bregioselective%252Bsynthesis%252Bof%252Bnovel%252Bdensely%252Bfunctionalized%252Bpyrazolo%25255B3%25252C4-b%25255Dpyridines%26aulast%3DGunasekaran%26aufirst%3DPethaiah%26date%3D2013%26volume%3D3%26issue%3D22%26spage%3D8318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">SÃ©bastien  Degorce</span>, <span class="hlFld-ContribAuthor ">BÃ©nÃ©dicte  DelouvriÃ©</span>, <span class="hlFld-ContribAuthor ">Paul R.J.  Davey</span>, <span class="hlFld-ContribAuthor ">Myriam  Didelot</span>, <span class="hlFld-ContribAuthor ">HervÃ©  Germain</span>, <span class="hlFld-ContribAuthor ">Craig S.  Harris</span>, <span class="hlFld-ContribAuthor ">Christine Lambert-van der  Brempt</span>, <span class="hlFld-ContribAuthor ">Honorine  Lebraud</span>, <span class="hlFld-ContribAuthor ">Gilles  Ouvry</span>. </span><span class="cited-content_cbyCitation_article-title">Facile, diversity-orientated one-pot synthesis of ethyl 1,5-disubstituted-1H-1,2,4-triazole-3-carboxylates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (45)
                                     , 6078-6082. <a href="https://doi.org/10.1016/j.tetlet.2012.08.130" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.08.130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.08.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.08.130%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFacile%25252C%252Bdiversity-orientated%252Bone-pot%252Bsynthesis%252Bof%252Bethyl%252B1%25252C5-disubstituted-1H-1%25252C2%25252C4-triazole-3-carboxylates%26aulast%3DDegorce%26aufirst%3DS%25C3%25A9bastien%26date%3D2012%26volume%3D53%26issue%3D45%26spage%3D6078%26epage%3D6082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George  Agelis</span>, <span class="hlFld-ContribAuthor ">Amalia  Resvani</span>, <span class="hlFld-ContribAuthor ">Serdar  Durdagi</span>, <span class="hlFld-ContribAuthor ">Katerina  Spyridaki</span>, <span class="hlFld-ContribAuthor ">Tereza  TÅ¯movÃ¡</span>, <span class="hlFld-ContribAuthor ">JiÅina  SlaninovÃ¡</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Giannopoulos</span>, <span class="hlFld-ContribAuthor ">Demetrios  Vlahakos</span>, <span class="hlFld-ContribAuthor ">George  Liapakis</span>, <span class="hlFld-ContribAuthor ">Thomas  Mavromoustakos</span>, <span class="hlFld-ContribAuthor ">John  Matsoukas</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: A concise synthesis, molecular docking studies and biological evaluation ofÂ N-substituted 5-butylimidazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>, 358-374. <a href="https://doi.org/10.1016/j.ejmech.2012.07.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.07.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.07.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Bof%252Bnew%252Bpotent%252Bnon-peptide%252BAngiotensin%252BII%252BAT1%252Breceptor%252Bblockers%25253A%252BA%252Bconcise%252Bsynthesis%25252C%252Bmolecular%252Bdocking%252Bstudies%252Band%252Bbiological%252Bevaluation%252Bof%2525C2%2525A0N-substituted%252B5-butylimidazole%252Bderivatives%26aulast%3DAgelis%26aufirst%3DGeorge%26date%3D2012%26volume%3D55%26spage%3D358%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jin-Liang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Ming  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhi-Huai  Li</span>, <span class="hlFld-ContribAuthor ">Wei-Zhe  Xue</span>, <span class="hlFld-ContribAuthor ">Di  Xu</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Hao</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Han</span>, <span class="hlFld-ContribAuthor ">Fan  Fei</span>, <span class="hlFld-ContribAuthor ">Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Ai-Hua  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT1 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (14)
                                     , 4208-4216. <a href="https://doi.org/10.1016/j.bmc.2012.05.056" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.05.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.05.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivity%252Bof%252B6-substituted%252Bcarbamoyl%252Bbenzimidazoles%252Bas%252Bnew%252Bnonpeptidic%252Bangiotensin%252BII%252BAT1%252Breceptor%252Bantagonists%26aulast%3DZhang%26aufirst%3DJun%26date%3D2012%26volume%3D20%26issue%3D14%26spage%3D4208%26epage%3D4216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-yan  Nie</span>, <span class="hlFld-ContribAuthor ">Ya-jing  Da</span>, <span class="hlFld-ContribAuthor ">Hao  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiao-xia  Yang</span>, <span class="hlFld-ContribAuthor ">Lin  Jia</span>, <span class="hlFld-ContribAuthor ">Cai-hong  Wen</span>, <span class="hlFld-ContribAuthor ">Li-sha  Liang</span>, <span class="hlFld-ContribAuthor ">Juan  Tian</span>, <span class="hlFld-ContribAuthor ">Zhi-long  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (8)
                                     , 2747-2761. <a href="https://doi.org/10.1016/j.bmc.2012.02.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpotent%252Bangiotensin%252BII%252Breceptor%252Bantagonists%252Bwith%252Banti-hypertension%252Beffect%26aulast%3DNie%26aufirst%3DYong-yan%26date%3D2012%26volume%3D20%26issue%3D8%26spage%3D2747%26epage%3D2761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Liang  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Ming  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhi-Huai  Li</span>, <span class="hlFld-ContribAuthor ">Wei-Zhe  Xue</span>, <span class="hlFld-ContribAuthor ">Di  Xu</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Hao</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Han</span>, <span class="hlFld-ContribAuthor ">Fan  Fei</span>, <span class="hlFld-ContribAuthor ">Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Ai-Hua  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>49 </em>, 183-190. <a href="https://doi.org/10.1016/j.ejmech.2012.01.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.01.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.01.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B6-substituted%252Baminocarbonyl%252Bbenzimidazole%252Bderivatives%252Bas%252Bnonpeptidic%252Bangiotensin%252BII%252BAT1%252Breceptor%252Bantagonists%26aulast%3DWang%26aufirst%3DJin-Liang%26date%3D2012%26volume%3D49%26spage%3D183%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William J.  Lominac</span>, <span class="hlFld-ContribAuthor ">Megan L.  DâAngelo</span>, <span class="hlFld-ContribAuthor ">Mark D.  Smith</span>, <span class="hlFld-ContribAuthor ">Darius A.  Ollison</span>, <span class="hlFld-ContribAuthor ">James M.  Hanna</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of pyrazolo[3,4-b]pyridines and pyrazolo[4,3-c]pyridines by ring closure of 3-acylpyridine N-oxide tosylhydrazones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (8)
                                     , 906-909. <a href="https://doi.org/10.1016/j.tetlet.2011.12.055" title="DOI URL">https://doi.org/10.1016/j.tetlet.2011.12.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2011.12.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2011.12.055%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DConstruction%252Bof%252Bpyrazolo%25255B3%25252C4-b%25255Dpyridines%252Band%252Bpyrazolo%25255B4%25252C3-c%25255Dpyridines%252Bby%252Bring%252Bclosure%252Bof%252B3-acylpyridine%252BN-oxide%252Btosylhydrazones%26aulast%3DLominac%26aufirst%3DWilliam%2BJ.%26date%3D2012%26volume%3D53%26issue%3D8%26spage%3D906%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rebecca  Deprez-Poulain</span>, <span class="hlFld-ContribAuthor ">Nicolas  Cousaert</span>, <span class="hlFld-ContribAuthor ">Patrick  Toto</span>, <span class="hlFld-ContribAuthor ">Nicolas  Willand</span>, <span class="hlFld-ContribAuthor ">Benoit  Deprez</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Ullmann and UllmannâFinkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (9)
                                     , 3867-3876. <a href="https://doi.org/10.1016/j.ejmech.2011.05.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.05.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.05.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BUllmann%252Band%252BUllmann%2525E2%252580%252593Finkelstein%252Breactions%252Bfor%252Bthe%252Bsynthesis%252Bof%252BN-aryl-N-%2525281H-pyrazol-3-yl%252529%252Bacetamide%252Bor%252BN-%2525281-aryl-1H-pyrazol-3-yl%252529%252Bacetamide%252Bderivatives%252Band%252Bpharmacological%252Bevaluation%26aulast%3DDeprez-Poulain%26aufirst%3DRebecca%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D3867%26epage%3D3876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. S.  Golubev</span>, <span class="hlFld-ContribAuthor ">G. S.  Starostin</span>, <span class="hlFld-ContribAuthor ">K. S.  Chunikhin</span>, <span class="hlFld-ContribAuthor ">A. S.  Peregudov</span>, <span class="hlFld-ContribAuthor ">K. C.  Rodygin</span>, <span class="hlFld-ContribAuthor ">S. A.  Rubtsova</span>, <span class="hlFld-ContribAuthor ">P. A.  Slepukhin</span>, <span class="hlFld-ContribAuthor ">A. V.  Kuchin</span>, <span class="hlFld-ContribAuthor ">N. D.  Chkanikov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new fluorine-containing pyrazolo[3,4-b]pyridinones as promising drug precursors. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2011,</strong> <em>60 </em>
                                    (4)
                                     , 733-745. <a href="https://doi.org/10.1007/s11172-011-0114-y" title="DOI URL">https://doi.org/10.1007/s11172-011-0114-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-011-0114-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-011-0114-y%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DSynthesis%252Bof%252Bnew%252Bfluorine-containing%252Bpyrazolo%25255B3%25252C4-b%25255Dpyridinones%252Bas%252Bpromising%252Bdrug%252Bprecursors%26aulast%3DGolubev%26aufirst%3DA.%2BS.%26date%3D2011%26date%3D2011%26volume%3D60%26issue%3D4%26spage%3D733%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmytro  Tymoshenko</span>, <span class="hlFld-ContribAuthor ">Gyorgy  Jeges</span>, <span class="hlFld-ContribAuthor ">Brian T.  Gregg</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Heterocycles by Palladium-Catalyzed Intramolecular Heteroarylation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 27-74. <a href="https://doi.org/10.1016/B978-0-08-096805-6.00002-4" title="DOI URL">https://doi.org/10.1016/B978-0-08-096805-6.00002-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096805-6.00002-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096805-6.00002-4%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Bof%252BHeterocycles%252Bby%252BPalladium-Catalyzed%252BIntramolecular%252BHeteroarylation%26aulast%3DTymoshenko%26aufirst%3DDmytro%26date%3D2011%26spage%3D27%26epage%3D74%26pub%3DElsevier%26date%3D2011%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George  Agelis</span>, <span class="hlFld-ContribAuthor ">Panagiota  Roumelioti</span>, <span class="hlFld-ContribAuthor ">Amalia  Resvani</span>, <span class="hlFld-ContribAuthor ">Serdar  Durdagi</span>, <span class="hlFld-ContribAuthor ">Maria-Eleni  Androutsou</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Kelaidonis</span>, <span class="hlFld-ContribAuthor ">Demetrios  Vlahakos</span>, <span class="hlFld-ContribAuthor ">Thomas  Mavromoustakos</span>, <span class="hlFld-ContribAuthor ">John  Matsoukas</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT1 Angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2010,</strong> <em>24 </em>
                                    (9)
                                     , 749-758. <a href="https://doi.org/10.1007/s10822-010-9371-3" title="DOI URL">https://doi.org/10.1007/s10822-010-9371-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-010-9371-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-010-9371-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252Ba%252Brationally%252Bdesigned%252B1%25252C5%252Bdisubstituted%252Bimidazole%252BAT1%252BAngiotensin%252BII%252Breceptor%252Bantagonist%25253A%252Breorientation%252Bof%252Bimidazole%252Bpharmacophore%252Bgroups%252Bin%252Blosartan%252Breserves%252Bhigh%252Breceptor%252Baffinity%252Band%252Bconfirms%252Bdocking%252Bstudies%26aulast%3DAgelis%26aufirst%3DGeorge%26date%3D2010%26date%3D2010%26volume%3D24%26issue%3D9%26spage%3D749%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason  Arsenault</span>, <span class="hlFld-ContribAuthor ">Julie  Lehoux</span>, <span class="hlFld-ContribAuthor ">Luc  Lanthier</span>, <span class="hlFld-ContribAuthor ">JÃ©rÃ´me  Cabana</span>, <span class="hlFld-ContribAuthor ">GaÃ«tan  Guillemette</span>, <span class="hlFld-ContribAuthor ">Pierre  Lavigne</span>, <span class="hlFld-ContribAuthor ">Richard  Leduc</span>, <span class="hlFld-ContribAuthor ">Emanuel  Escher</span>. </span><span class="cited-content_cbyCitation_article-title">A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity. </span><span class="cited-content_cbyCitation_journal-name">Pharmacogenetics and Genomics</span><span> <strong>2010,</strong> <em>20 </em>
                                    (6)
                                     , 377-388. <a href="https://doi.org/10.1097/FPC.0b013e32833a6d4a" title="DOI URL">https://doi.org/10.1097/FPC.0b013e32833a6d4a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FPC.0b013e32833a6d4a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFPC.0b013e32833a6d4a%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacogenetics%2520and%2520Genomics%26atitle%3DA%252Bsingle-nucleotide%252Bpolymorphism%252Bof%252Balanine%252Bto%252Bthreonine%252Bat%252Bposition%252B163%252Bof%252Bthe%252Bhuman%252Bangiotensin%252BII%252Btype%252B1%252Breceptor%252Bimpairs%252BLosartan%252Baffinity%26aulast%3DArsenault%26aufirst%3DJason%26date%3D2010%26volume%3D20%26issue%3D6%26spage%3D377%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dengke  Shen</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Xu</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Lili  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a nitric oxide-dependent hypotensive effect of anticoagulation factor II from the venom of Agkistrodon acutus. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2010,</strong> <em>79 </em>
                                    (3)
                                     , 498-506. <a href="https://doi.org/10.1016/j.bcp.2009.08.023" title="DOI URL">https://doi.org/10.1016/j.bcp.2009.08.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2009.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2009.08.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DIdentification%252Bof%252Ba%252Bnitric%252Boxide-dependent%252Bhypotensive%252Beffect%252Bof%252Banticoagulation%252Bfactor%252BII%252Bfrom%252Bthe%252Bvenom%252Bof%252BAgkistrodon%252Bacutus%26aulast%3DShen%26aufirst%3DDengke%26date%3D2010%26volume%3D79%26issue%3D3%26spage%3D498%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Li  Zhong</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Lindale</span>, <span class="hlFld-ContribAuthor ">Nobuyoshi  Yasuda</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient access to 3,6-disubstituted 1H-pyrazolo[3,4-b]pyridines via a one-pot double SNAr reaction and pyrazole formation. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2009,</strong> <em>50 </em>
                                    (20)
                                     , 2293-2297. <a href="https://doi.org/10.1016/j.tetlet.2009.02.142" title="DOI URL">https://doi.org/10.1016/j.tetlet.2009.02.142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2009.02.142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2009.02.142%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Baccess%252Bto%252B3%25252C6-disubstituted%252B1H-pyrazolo%25255B3%25252C4-b%25255Dpyridines%252Bvia%252Ba%252Bone-pot%252Bdouble%252BSNAr%252Breaction%252Band%252Bpyrazole%252Bformation%26aulast%3DZhong%26aufirst%3DYong-Li%26date%3D2009%26volume%3D50%26issue%3D20%26spage%3D2293%26epage%3D2297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0003.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) SOCl<sub>2</sub>, DMF (cat.); (b) R<sub>1</sub>-NHNH<sub>2</sub>Â·C<sub>2</sub>O<sub>4</sub>H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, NaOH, H<sub>2</sub>O; (c) 1-pentanol, Na<sub>2</sub>CO<sub>3</sub>; (d) NaH, DMF; (e) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, DMF; (f) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0004.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) H<sub>2</sub>, Pd/C, Na<sub>2</sub>CO<sub>3</sub>, C<sub>2</sub>H<sub>5</sub>OH; (b) morpholine, C<sub>2</sub>H<sub>5</sub>OH.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0007.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R = H (<b>7j</b>), C(C<sub>6</sub>H<sub>5</sub>)<sub>3</sub> (<b>17j</b>). Reagents: (a) CH<sub>3</sub>ONa, CH<sub>3</sub>OH; (b) CH<sub>3</sub>NH<sub>2</sub>, C<sub>2</sub>H<sub>5</sub>OH.</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structure of pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>16aÂ·H<sub>2</sub>O</b> (left) and <b>16c</b> (right). Ellipsoids enclose 50% probability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of target compound <b>7a</b>. Ellipsoids enclose 50% probability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0008.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>-NHNH<sub>2</sub>Â·C<sub>2</sub>O<sub>4</sub>H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, NaOH, H<sub>2</sub>O; (c) NaOH, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, C<sub>2</sub>H<sub>5</sub>OH; (d) NaH, DMF; (e) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, DMF; (f) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0009.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) NBS, benzoyl peroxide, CCl<sub>4</sub>; (b) CH<sub>3</sub>(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub>, C<sub>2</sub>H<sub>5</sub>OH; (c) CH<sub>3</sub>OCOOCH<sub>3</sub>, NaH, DMF; (d) NaH, THF; (e) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, THF; (f) NaOH, H<sub>2</sub>O, C<sub>2</sub>H<sub>5</sub>OH.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0010.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R<sub>1</sub> = <i>n</i>-C<sub>3</sub>H<sub>7</sub> (<b>35a</b>), <i>n</i>-C<sub>4</sub>H<sub>9</sub> (<b>35b</b>); R<sub>2</sub> = H (<b>8a</b>), CH<sub>3</sub> (<b>8b</b>), Cl (<b>8c</b>). Reagents: (a) R<sub>1</sub>-NH-NH<sub>2</sub>Â·C<sub>2</sub>O<sub>4</sub>H<sub>2</sub>, TEA, C<sub>2</sub>H<sub>5</sub>OH; (b) NaH, DMF; (c) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, DMF; (d) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>; (e) <i>tert</i>-butyldimethylsilyl trifluoromethanesulfonate, <i>N,N</i>-diisopropylethylamine, THF; (f) Br-C<sub>6</sub>H<sub>4</sub>-CH<sub>2</sub>Br, (<i>n</i>-Bu)<sub>4</sub>NF, THF; (g) 5-(2â²-boronophenyl)-2-(triphenylmethyl)-2<i>H</i>-tetrazole, PPh<sub>3</sub>, Pd(OAc)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, diethoxymethane (DEM), H<sub>2</sub>O.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of pyrazolo[3,4-<i>b</i>]pyridine derivatives <b>30</b> (left) and <b>32</b> (right). Ellipsoids enclose 50% probability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0012.jpeg" id="rightTab-gs7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>R<sub>1</sub> = H (<b>8d</b>), C<sub>2</sub>H<sub>5</sub> (<b>8e</b>), <i>n</i>-C<sub>3</sub>H<sub>7</sub> (<b>8f</b>), <i>n</i>-C<sub>4</sub>H<sub>9</sub> (<b>8g</b>). Reagents: (a) NBS, benzoyl peroxide, CCl<sub>4</sub>; (b) 4-bromobenzylamine hydrochloride, TEA, C<sub>2</sub>H<sub>5</sub>OH; (c) 5-(2â²-boronophenyl)-2-(triphenylmethyl)-2<i>H</i>-tetrazole, PPh<sub>3</sub>, Pd(OAc)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, DEM, H<sub>2</sub>O; (d) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>; (e) CH<sub>3</sub>OCOOCH<sub>3</sub>, NaH, DMF; (f) DBU, DMF, R<sub>1</sub>I; (g) NaOH, H<sub>2</sub>O, C<sub>2</sub>H<sub>5</sub>OH.</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0013.jpeg" id="rightTab-gs8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) NH<sub>2</sub>NHC<sub>4</sub>H<sub>9</sub><sup>â¢</sup>C<sub>2</sub>O<sub>4</sub>H<sub>2</sub>, TEA, C<sub>2</sub>H<sub>5</sub>OH; (b) NaH, DMF; (c) 5-[4â²-(bromomethyl)biphenyl-2-yl]-2-(triphenylmethyl)-2<i>H</i>-tetrazole, DMF; (d) HCO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superposition of <b>7a</b> crystallographic structure (white) with a low energy conformer of <b>7q</b> (cyan). This result suggests that <b>7q</b>can populate the solid state conformation of <b>7a</b>. Thus, the difference in the AT<sub>1</sub> receptor affinity between <b>7a</b> and <b>7q</b> is probably connected to the relative orientation of the pendent bicyclic system determined by the linker geometry (a sp<sup>3</sup> carbon in the case of <b>7q</b> and a partially pyramidal nitrogen atom for <b>7a</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0001.jpeg" id="rightTab-gc1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Compounds <b>1</b>â<b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0002.jpeg" id="rightTab-gc2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Structures of Compounds <b>2a</b>, <b>7</b>â<b>9</b>, and Irbesartan<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>The potential hydrogen bonding acceptors are indicated in red.</p></p></figure><figure data-id="fig5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0016.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Concentrationâcontractile response curves for Ang II in isolated rabbit aortic strips, in the presence of different concentrations [10 nM (â¼), 30 nM (â²), or 100 nM (Ã)] of compound <b>8a</b> or of its vehicle (â).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/medium/jm-2007-011563_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0018.jpeg" id="rightTab-gc3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Structures of Compounds <b>7c</b>, <b>8a</b>, <b>9</b>, <b>49</b>, and <b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-7/jm7011563/production/images/large/jm-2007-011563_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011563&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>The potential hydrogen bonding acceptors are indicated in red.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">De Gasparo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catt, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, T.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXIII. The Angiotensin II Receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">â</span> <span class="NLM_lpage">472</span><div class="note"><p class="first last">and references cited therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=10977869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCmsbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2000&pages=415-472&author=M.+De+Gasparoauthor=K.+J.+Cattauthor=T.+Inagamiauthor=J.+W.+Wrightauthor=T.+Unger&title=International+Union+of+Pharmacology.+XXIII.+The+Angiotensin+II+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">International union of pharmacology. XXIII. The angiotensin II receptors</span></div><div class="casAuthors">De Gasparo, M.; Catt, K. J.; Inagami, T.; Wright, J. W.; Unger, Th.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">415-472</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with 741 refs.  The cardiovascular and other actions of angiotensin II (Ang II) are mediated by AT1 and AT2 receptors, which are seven transmembrane glycoproteins with 30% sequence similarity.  Most species express a single autosomal AT1 gene, but two related AT1A and AT1B receptor genes are expressed in rodents.  AT1 receptors are predominantly coupled to Gq/11, and signal through phospholipases A, C, D, inositol phosphates, calcium channels, and a variety of serine/threonine and tyrosine kinases.  Many AT1-induced growth responses are mediated by transactivation of growth factor receptors.  The receptor binding sites for agonist and nonpeptide antagonist ligands have been defined.  The latter compds. are as effective as angiotensin converting enzyme inhibitors in cardiovascular diseases but are better tolerated.  The AT2 receptor is expressed at high d. during fetal development.  It is much less abundant in adult tissues and is up-regulated in pathol. conditions.  Its signaling pathways include serine and tyrosine phosphatases, phospholipase A2, nitric oxide, and cyclic guanosine monophosphate.  The AT2 receptor counteracts several of the growth responses initiated by the AT1 and growth factor receptors.  The AT4 receptor specifically binds Ang IV (Ang 3-8), and is located in brain and kidney.  Its signaling mechanisms are unknown, but it influences local blood flow and is assocd. with cognitive processes and sensory and motor functions.  Although AT1 receptors mediate most of the known actions of Ang II, the AT2 receptor contributes to the regulation of blood pressure and renal function.  The development of specific nonpeptide receptor antagonists has led to major advances in the physiol., pharmacol., and therapy of the renin-angiotensin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSSYESfE8nPrVg90H21EOLACvtfcHk0lh-F1138Rd4pQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCmsbk%253D&md5=6abc5466d51de53202ecf1fd9ba3c186</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGasparo%26aufirst%3DM.%26aulast%3DCatt%26aufirst%3DK.%2BJ.%26aulast%3DInagami%26aufirst%3DT.%26aulast%3DWright%26aufirst%3DJ.%2BW.%26aulast%3DUnger%26aufirst%3DT.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXIII.%2520The%2520Angiotensin%2520II%2520Receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2000%26volume%3D52%26spage%3D415%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Inoue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagami, T.</span><span> </span><span class="NLM_article-title">A Review of Mutagenesis Studies of Angiotensin II Type 1 Receptor, the Three-Dimensional Receptor Model in Search of the Agonist Binding Site and the Hypothesis of a Receptor Activation Mechanism</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">â</span> <span class="NLM_lpage">714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1097%2F00004872-199715070-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=9222937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK2sXkslaktL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=703-714&author=Y.+Inoueauthor=N.+Nakamuraauthor=T.+Inagami&title=A+Review+of+Mutagenesis+Studies+of+Angiotensin+II+Type+1+Receptor%2C+the+Three-Dimensional+Receptor+Model+in+Search+of+the+Agonist+Binding+Site+and+the+Hypothesis+of+a+Receptor+Activation+Mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism</span></div><div class="casAuthors">Inoue, Yoshihisa; Nakamura, Norifumi; Inagami, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">703-714</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">A review with 91 refs.  To seek the mechanism whereby agonists, competitive antagonists and insurmountable antagonists affect the receptor function differently, by reviewing recent mutagenesis studies of angiotensin II type 1 receptor (AT1) in which the binding of the agonist and antagonists and receptor signaling were affected.  The authors built a model of seven transmembrane spanning domains of the AT1 receptors using bacteriorhodopsin as a template.  The C-terminal of angiotensin II binds to Lys199 in transmembrane domain 5, whereas the guanidinium group of Arg2 binds to Asp281 in transmembrane domain 7.  Of studies using mutagenesis supporting proposed ligand-docking models are discussed.  The authors submit a set of hypotheses for a mechanism whereby the ligand binding induces changes in the receptor conformation by the rotation of transmembrane helixes as the initial event for the subsequent activation of a G protein.  In this mechanism antagonists are not capable of rotating the helixes but agonists are able to do so, which results in the formation of a hydrogen bond between Asp74 in transmembrane domain 2 and Tyr292 in transmembrane domain 7.  This mechanism also provides plausible explanation for the activation of monoamine receptors.  Competitive antagonists share the same binding sites with agonists, but insurmountable antagonists do not, and binding of the latter does not preclude agonist binding, for example, to Asp281.  This hypothesis of the intrareceptor signaling mechanism and the receptor model indicate that some amino acid residues essential for the signaling play their roles in the intrareceptor activation mechanism, whereas others participate directly in ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxQyRUXveVbVg90H21EOLACvtfcHk0lh-F1138Rd4pQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslaktL8%253D&md5=48cbe83dca10ab04adf9b6cfa47a7e55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2F00004872-199715070-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-199715070-00001%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DInagami%26aufirst%3DT.%26atitle%3DA%2520Review%2520of%2520Mutagenesis%2520Studies%2520of%2520Angiotensin%2520II%2520Type%25201%2520Receptor%252C%2520the%2520Three-Dimensional%2520Receptor%2520Model%2520in%2520Search%2520of%2520the%2520Agonist%2520Binding%2520Site%2520and%2520the%2520Hypothesis%2520of%2520a%2520Receptor%2520Activation%2520Mechanism%26jtitle%3DJ.%2520Hypertens.%26date%3D1997%26volume%3D15%26spage%3D703%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, P. B. M. W. M.</span><span> </span><span class="NLM_article-title">Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive Therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">â</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9504722" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK28Xjt1Oltw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=625-656&author=R.+R.+Wexlerauthor=W.+J.+Greenleeauthor=J.+D.+Irvinauthor=M.+R.+Goldbergauthor=K.+Prendergastauthor=R.+D.+Smithauthor=P.+B.+M.+W.+M.+Timmermans&title=Nonpeptide+Angiotensin+II+Receptor+Antagonists%3A+The+Next+Generation+in+Antihypertensive+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive Therapy</span></div><div class="casAuthors">Wexler, Ruth R.; Greenlee, William J.; Irvin, John D.; Goldberg, Michael R.; Prendergast, Kristine; Smith, Ronald D.; Timmermans, Pieter B. M. W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-56</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 326 refs. which includes AT1-selective antagonists, AT2-selective antagonists, mol. modeling, and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox8R0LMBNKD7Vg90H21EOLACvtfcHk0lh-F1138Rd4pQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjt1Oltw%253D%253D&md5=218425943d7b9f3bcf37c205eca08c6f</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fjm9504722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9504722%26sid%3Dliteratum%253Aachs%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DIrvin%26aufirst%3DJ.%2BD.%26aulast%3DGoldberg%26aufirst%3DM.%2BR.%26aulast%3DPrendergast%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26aulast%3DTimmermans%26aufirst%3DP.%2BB.%2BM.%2BW.%2BM.%26atitle%3DNonpeptide%2520Angiotensin%2520II%2520Receptor%2520Antagonists%253A%2520The%2520Next%2520Generation%2520in%2520Antihypertensive%2520Therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D625%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieffer, B.</span><span> </span><span class="NLM_article-title">Angiotensin II AT<sub>1</sub> Receptor Antagonist. Clinical Implications of Active Metabolites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">â</span> <span class="NLM_lpage">2270</span><div class="note"><p class="first last">and references cited therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm0204237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2261-2270&author=B.+Schmidtauthor=B.+Schieffer&title=Angiotensin+II+AT1+Receptor+Antagonist.+Clinical+Implications+of+Active+Metabolites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1021%2Fjm0204237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204237%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DSchieffer%26aufirst%3DB.%26atitle%3DAngiotensin%2520II%2520AT1%2520Receptor%2520Antagonist.%2520Clinical%2520Implications%2520of%2520Active%2520Metabolites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2261%26epage%3D2270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mantlo, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondeyka, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegl, P. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotti, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schorn, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmert, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patchett, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Potent, Orally Active Imidazo[4,5-b]pyridine-Based Angiotensin II Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2919</span><span class="NLM_x">â</span> <span class="NLM_lpage">2922</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00113a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2919-2922&author=N.+B.+Mantloauthor=P.+K.+Chakravartyauthor=D.+L.+Ondeykaauthor=P.+K.+S.+Sieglauthor=R.+S.+Changauthor=V.+J.+Lottiauthor=K.+A.+Faustauthor=T.-B.+Chenauthor=T.+W.+Schornauthor=C.+S.+Sweetauthor=S.+E.+Emmertauthor=A.+A.+Patchettauthor=W.+J.+Greenlee&title=Potent%2C+Orally+Active+Imidazo%5B4%2C5-b%5Dpyridine-Based+Angiotensin+II+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm00113a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00113a035%26sid%3Dliteratum%253Aachs%26aulast%3DMantlo%26aufirst%3DN.%2BB.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DOndeyka%26aufirst%3DD.%2BL.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DChang%26aufirst%3DR.%2BS.%26aulast%3DLotti%26aufirst%3DV.%2BJ.%26aulast%3DFaust%26aufirst%3DK.%2BA.%26aulast%3DChen%26aufirst%3DT.-B.%26aulast%3DSchorn%26aufirst%3DT.%2BW.%26aulast%3DSweet%26aufirst%3DC.%2BS.%26aulast%3DEmmert%26aufirst%3DS.%2BE.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DPotent%252C%2520Orally%2520Active%2520Imidazo%255B4%252C5-b%255Dpyridine-Based%2520Angiotensin%2520II%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2919%26epage%3D2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantlo, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivlighn, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Evaluation of Heterocyclic Acid Equivalents as Tetrazole Replacements in Imidazopyridine-Based Nonpeptide Angiotensin II Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">â</span> <span class="NLM_lpage">44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=41-44&author=D.+Kimauthor=N.+B.+Mantloauthor=R.+S.+Changauthor=S.+D.+Kivlighnauthor=W.+J.+Greenlee&title=Evaluation+of+Heterocyclic+Acid+Equivalents+as+Tetrazole+Replacements+in+Imidazopyridine-Based+Nonpeptide+Angiotensin+II+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DMantlo%26aufirst%3DN.%2BB.%26aulast%3DChang%26aufirst%3DR.%2BS.%26aulast%3DKivlighn%26aufirst%3DS.%2BD.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DEvaluation%2520of%2520Heterocyclic%2520Acid%2520Equivalents%2520as%2520Tetrazole%2520Replacements%2520in%2520Imidazopyridine-Based%2520Nonpeptide%2520Angiotensin%2520II%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D41%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Adams, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudeau, L.</span><span> </span><span class="NLM_article-title">Irbesartan: Review of Pharmacology and Comparative Properties</span> <span class="citation_source-journal">Can. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">â</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=10822210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A280%3ADC%252BD3c3osVWjsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=22-31&author=M.+A.+Adamsauthor=L.+Trudeau&title=Irbesartan%3A+Review+of+Pharmacology+and+Comparative+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Irbesartan: review of pharmacology and comparative properties</span></div><div class="casAuthors">Adams M A; Trudeau L</div><div class="citationInfo"><span class="NLM_cas:title">The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-31</span>
        ISSN:<span class="NLM_cas:issn">1198-581X</span>.
    </div><div class="casAbstract">The recently developed and marketed angiotensin II type 1 (AT1) receptor blockers (ARBs) have demonstrated efficacy equivalent to that of other leading classes of antihypertensive agents, with superior tolerability profiles.  The specific targeting of the AT1 receptor afforded by these agents has demonstrated more complete blockade of the renin-angiotensin system than that offered by angiotensin-converting enzyme inhibitors.  These data notwithstanding, differentiation within the class of ARBs has been limited.  With the accumulation of additional data with ARBs, it has recently become possible to make within-class distinctions, based in large part on the individual pharmacological profiles of the ARBs.  To this end, absorption, distribution, half-life, dose response and level of angiotensin II antagonism are of special note.  When these properties are viewed as a group, the ARB irbesartan appears to offer advantages beyond those attained with other ARBs.  Irbesartan is well absorbed, does not require biotransformation to an active metabolite to exert its antihypertensive activity, offers a large volume of distribution, has a half-life that is sufficient to allow once-daily dosing, is associated with a strong and consistent dose-response and has been demonstrated to provide a level of angiotensin II antagonism that is statistically superior to that offered by some other ARBs.  These pharmacological differences may explain the clinical superiority of irbesartan compared with losartan, the first member of the ARB class.  As even more data on the ARBs become available, the ability to determine the advantages of specific members of this class will be enhanced, distinctions that already have begun to come to light.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjRUmdpq1iC3y-c-E1v-fmfW6udTcc2eZY9Z-VTYPirLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3osVWjsg%253D%253D&md5=9b02dbb76e7f666999255a94fdcdb11f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DM.%2BA.%26aulast%3DTrudeau%26aufirst%3DL.%26atitle%3DIrbesartan%253A%2520Review%2520of%2520Pharmacology%2520and%2520Comparative%2520Properties%26jtitle%3DCan.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D7%26spage%3D22%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chakravarty, P. K.</span><span> </span><span class="NLM_article-title">Antihypertensive Agents</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">â</span> <span class="NLM_lpage">458</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1517%2F13543776.5.5.431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK2MXotVWhtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=431-458&author=P.+K.+Chakravarty&title=Antihypertensive+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antihypertensive agents</span></div><div class="casAuthors">Chakravarty, Prasun K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">431-58</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications</span>)
        </div><div class="casAbstract">A review with 383 refs.  The primary agent and patent literature (July 1993 to Feb. 1995) describing angiotensin II antagonists, renin inhibitors, angiotensin converting enzyme(ACE) inhibitors, endothelin antagonists, potassium channel agonist/openers, calcium channel blockers, Î±-adrenergic receptor antagonists and nitro vasodilators are assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYlfxpMESlMLVg90H21EOLACvtfcHk0ljFQ8ONp_jddA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotVWhtbc%253D&md5=06a90374c3b2c7b5ab2fb3484884af31</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543776.5.5.431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.5.5.431%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26atitle%3DAntihypertensive%2520Agents%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D1995%26volume%3D5%26spage%3D431%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pericot Mohr, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennuni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menziani, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Benedetti, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, G.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Structural Studies, Biological Evaluation, and Computational Simulations of Novel Potent AT<sub>1</sub> Angiotensin II Receptor Antagonists Based on the 4-Phenylquinoline Structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2574</span><span class="NLM_x">â</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031100t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2574-2586&author=A.+Cappelliauthor=G.+Pericot+Mohrauthor=A.+Gallelliauthor=M.+Rizzoauthor=M.+Anziniauthor=S.+Vomeroauthor=L.+Mennuniauthor=F.+Ferrariauthor=F.+Makovecauthor=M.+C.+Menzianiauthor=P.+G.+De+Benedettiauthor=G.+Giorgi&title=Design%2C+Synthesis%2C+Structural+Studies%2C+Biological+Evaluation%2C+and+Computational+Simulations+of+Novel+Potent+AT1+Angiotensin+II+Receptor+Antagonists+Based+on+the+4-Phenylquinoline+Structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm031100t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031100t%26sid%3Dliteratum%253Aachs%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DPericot%2BMohr%26aufirst%3DG.%26aulast%3DGallelli%26aufirst%3DA.%26aulast%3DRizzo%26aufirst%3DM.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DVomero%26aufirst%3DS.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DMenziani%26aufirst%3DM.%2BC.%26aulast%3DDe%2BBenedetti%26aufirst%3DP.%2BG.%26aulast%3DGiorgi%26aufirst%3DG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Structural%2520Studies%252C%2520Biological%2520Evaluation%252C%2520and%2520Computational%2520Simulations%2520of%2520Novel%2520Potent%2520AT1%2520Angiotensin%2520II%2520Receptor%2520Antagonists%2520Based%2520on%2520the%25204-Phenylquinoline%2520Structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2574%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rizzo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventrice, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Sarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procopio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span> </span><span class="NLM_article-title">Determination of a Novel Angiotensin-AT<sub>1</sub> Antagonist CR3210 in Biological Samples by HPLC</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">â</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1016%2FS0014-827X%2803%2900141-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=13679177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Gqsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=837-844&author=M.+Rizzoauthor=M.+Anziniauthor=A.+Cappelliauthor=S.+Vomeroauthor=D.+Ventriceauthor=G.+De+Sarroauthor=S.+Procopioauthor=N.+Costaauthor=F.+Makovec&title=Determination+of+a+Novel+Angiotensin-AT1+Antagonist+CR3210+in+Biological+Samples+by+HPLC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of a novel angiotensin-AT1 antagonist CR 3210 in biological samples by HPLC</span></div><div class="casAuthors">Rizzo, M.; Anzini, M.; Cappelli, A.; Vomero, S.; Ventrice, D.; De Sarro, G.; Procopio, S.; Costa, N.; Makovec, F.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">837-844</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A simple and sensitive method for the detn. of a new angiotensin-AT1 antagonist i.e. CR 3210, 4-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-3-(2H-tetrazol-5-yl)quinoline, is described.  The assay was used to describe the pharmacokinetic profile of the title compd. after i.v. and i.p. administration to Sprague Dawley rats.  CR 3210 and the internal std. CR 1505 (loxiglumide, 4-[(3,4-dichlorobenzoyl)amino]-5-[(3-methoxypropyl)pentylamino]-5-oxopentanoic acid) were isolated from rat plasma by solid-phase extn.  The sorbent extn. material along with the pH in the conditioning soln. and the washing vol. were considered pivotal parameters for the optimization of the procedure.  The sepns. were performed by reversed-phase HPLC with UV detection.  The samples were injected onto the anal. column (Tracer Extrasil ODS1) and detected at 238 nm, giving a retention time of 6.19 min for CR 3210 and 4.39 min for the internal std., resp.  The selectivity of the method showed to be satisfactory.  The mean recovery of CR 3210 from spiked rat plasma was 80.3 at 1 Î¼g/mL and 79.9 at 2 Î¼g/mL.  The lower limit of detection (LOD) was taken as 0.014 Î¼g/mL in plasma samples.  The lower limit of quantification (LOQ) was taken as 0.02 Î¼g/mL, the lowest calibration std. using 500 Î¼g rat plasma.  The procedures were validated according to international stds. with a good reproducibility and linear response from 0.02 to 2 Î¼g/mL.  The sensitivity of the method allowed for its application to pharmacokinetic studies.  The maximal concn. was detected 5' after the IV administration, whereas no significant absorption was evident after IP administration of CR 3210 to Sprague-Dawley rats.  The authors' study suggests the absence of extensive bio-transformation of the drug in vivo, supported by the evidence that no metabolites were detected in plasma samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtXU4w4Rh4_rVg90H21EOLACvtfcHk0lirGSENnJ2hDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Gqsbw%253D&md5=f7cdf0fe5e47495513b5001419610852</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2803%2900141-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252803%252900141-1%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DM.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DVomero%26aufirst%3DS.%26aulast%3DVentrice%26aufirst%3DD.%26aulast%3DDe%2BSarro%26aufirst%3DG.%26aulast%3DProcopio%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DN.%26aulast%3DMakovec%26aufirst%3DF.%26atitle%3DDetermination%2520of%2520a%2520Novel%2520Angiotensin-AT1%2520Antagonist%2520CR3210%2520in%2520Biological%2520Samples%2520by%2520HPLC%26jtitle%3DFarmaco%26date%3D2003%26volume%3D58%26spage%3D837%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rizzo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventrice, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procopio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Sarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span> </span><span class="NLM_article-title">Sensitive SPE-HPLC Method to Determine a Novel Angiotensin-AT<sub>1</sub> Antagonist in Biological Samples</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">â</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1016%2Fj.jpba.2003.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=15063465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVWrt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2004&pages=321-329&author=M.+Rizzoauthor=D.+Ventriceauthor=F.+Monforteauthor=S.+Procopioauthor=G.+De+Sarroauthor=M.+Anziniauthor=A.+Cappelliauthor=F.+Makovec&title=Sensitive+SPE-HPLC+Method+to+Determine+a+Novel+Angiotensin-AT1+Antagonist+in+Biological+Samples"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitive SPE-HPLC method to determine a novel angiotensin-AT1 antagonist in biological samples</span></div><div class="casAuthors">Rizzo, M.; Ventrice, D.; Monforte, F.; Procopio, S.; De Sarro, G.; Anzini, M.; Cappelli, A.; Makovec, F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-329</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A high-performance liq. chromatog. (HPLC)-method after solid-phase extn. (SPE) was developed to det. a new angiotensin-AT1 antagonist, i.e.  CR 3210 (C27H24N8; MW=460.54), 4-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-3-(2H-tetrazol-5-yl)quinoline in rat plasma and urine after oral administration to Sprague-Dawley rats.  CR 3210 and the internal std. (IS) CR 1505 (loxiglumide), i.e. 4-[(3,4-dichlorobenzoyl)amino]-5-[(3-methoxypropyl)pentylamino]-5-oxopentanoic acid, were isolated from rat urine and plasma by solid-phase extn.  The procedure was optimized regarding the sorbent extn. material, the pH in the conditioning soln., the washing step, the dry time and the type of elution solvent.  The sepn. was performed by reversed-phase high-performance liq. chromatog. with UV detection.  The samples were injected onto the anal. column (Tracer Extrasil ODS1) and detected at 238 nm, giving a capacity factor of 1.87 for CR 3210 and 1.10 for the internal std.  The selectivity of the method was satisfactory.  The mean recovery of CR 3210 from spiked rat plasma was 68.5 at 75 ng/mL and 80.9 at 3000 ng/mL; the mean recovery of CR 3210 from spiked rat urine was 69.9 at 75 ng/mL and 78.6 at 3000 ng/mL.  The lower limit of detection (LOD) was 14 ng/mL in plasma and 22 ng/mL in urine samples.  The lower limit of quantification (LOQ) was taken as 30 ng/mL, the lowest calibration std. using 500 Î¼l rat plasma and urine.  The procedures were validated according to international stds. with a good reproducibility and linear response from 30 to 3000 ng/mL, for either plasma or urine.  The sensitivity of the method allowed for its application to pharmacokinetic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXIDoCq_-GrVg90H21EOLACvtfcHk0lirGSENnJ2hDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVWrt7k%253D&md5=1b393f2832d4f68c2b7ecb93e0fc6e52</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2003.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2003.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DM.%26aulast%3DVentrice%26aufirst%3DD.%26aulast%3DMonforte%26aufirst%3DF.%26aulast%3DProcopio%26aufirst%3DS.%26aulast%3DDe%2BSarro%26aufirst%3DG.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DMakovec%26aufirst%3DF.%26atitle%3DSensitive%2520SPE-HPLC%2520Method%2520to%2520Determine%2520a%2520Novel%2520Angiotensin-AT1%2520Antagonist%2520in%2520Biological%2520Samples%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2004%26volume%3D35%26spage%3D321%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pericot Mohr, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeazzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennuni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinrath, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valoti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span> </span><span class="NLM_article-title">Further Studies on Imidazo[4,5-<i>b</i>]pyridine AT<sub>1</sub> Angiotensin II Receptor Antagonists. Effects of the Transformation of the 4-Phenylquinoline Backbone into 4-Phenylisoquinolinone or 1-Phenylindene Scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6451</span><span class="NLM_x">â</span> <span class="NLM_lpage">6464</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmurvJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6451-6464&author=A.+Cappelliauthor=G.+Pericot+Mohrauthor=G.+Giulianiauthor=S.+Galeazziauthor=M.+Anziniauthor=L.+Mennuniauthor=F.+Ferrariauthor=F.+Makovecauthor=E.+M.+Kleinrathauthor=T.+Langerauthor=M.+Valotiauthor=G.+Giorgiauthor=S.+Vomero&title=Further+Studies+on+Imidazo%5B4%2C5-b%5Dpyridine+AT1+Angiotensin+II+Receptor+Antagonists.+Effects+of+the+Transformation+of+the+4-Phenylquinoline+Backbone+into+4-Phenylisoquinolinone+or+1-Phenylindene+Scaffolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Further Studies on Imidazo[4,5-b]pyridine AT1 Angiotensin II Receptor Antagonists. Effects of the Transformation of the 4-Phenylquinoline Backbone into 4-Phenylisoquinolinone or 1-Phenylindene Scaffolds</span></div><div class="casAuthors">Cappelli, Andrea; Mohr, Galla Pericot; Giuliani, Germano; Galeazzi, Simone; Anzini, Maurizio; Mennuni, Laura; Ferrari, Flora; Makovec, Francesco; Kleinrath, Eva M.; Langer, Thierry; Valoti, Massimo; Giorgi, Gianluca; Vomero, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6451-6464</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 4-phenylquinoline fragment of novel AT1 receptor antagonists 4 based on imidazo[4,5-b]pyridine moiety was replaced by 4-phenylisoquinolinone (compds. 5) or 1-phenylindene (compds. 6) scaffolds to investigate the structure-activity relationships.  Binding studies showed that most of the synthesized compds. display high affinity for the AT1 receptor.  Because of the in vitro high potency of carboxylic acids 5b,f, they were evaluated in permeability (in Caco-2 cells) and in pharmacokinetic studies in comparison with quinoline derivs. 4b,i,j,k.  The studies showed that these compds. are characterized by rapid excretion, low membrane permeability, and low oral bioavailability.  The structure optimization of the indene derivs. led to compds. 6e,f possessing interesting AT1 receptor affinities.  Optimization produced polymg. AT1 receptor ligand 6c, which forms a thermoreversible polymer (poly-6c) and is released from the latter by a temp.-dependent kinetics.  The results suggest the possibility of developing novel polymeric prodrugs based on a new release mechanism.  Finally, a set of 34 AT1 receptor antagonists was used as a new test for the evaluation of the predictive capability of the previously published qual. and quant. pharmacophore models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRYwdCWa7Tw7Vg90H21EOLACvtfcHk0lirGSENnJ2hDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmurvJ&md5=9a5ed2a095d5b881e3f39f47cc33613a</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1021%2Fjm0603163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603163%26sid%3Dliteratum%253Aachs%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DPericot%2BMohr%26aufirst%3DG.%26aulast%3DGiuliani%26aufirst%3DG.%26aulast%3DGaleazzi%26aufirst%3DS.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DKleinrath%26aufirst%3DE.%2BM.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DValoti%26aufirst%3DM.%26aulast%3DGiorgi%26aufirst%3DG.%26aulast%3DVomero%26aufirst%3DS.%26atitle%3DFurther%2520Studies%2520on%2520Imidazo%255B4%252C5-b%255Dpyridine%2520AT1%2520Angiotensin%2520II%2520Receptor%2520Antagonists.%2520Effects%2520of%2520the%2520Transformation%2520of%2520the%25204-Phenylquinoline%2520Backbone%2520into%25204-Phenylisoquinolinone%2520or%25201-Phenylindene%2520Scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6451%26epage%3D6464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">While this work was in progress, a series of potent AT<sub>1</sub> receptor antagonists based on the pyrazolidine-3,5-dione structure was reported.</p></div><span class="NLM_contrib-group">Le Bourdonnec, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houssin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ©nichart, J.-P.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacological Evaluation of New Pyrazolidine-3,5-diones as AT<sub>1</sub> Angiotensin II Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2685</span><span class="NLM_x">â</span> <span class="NLM_lpage">2697</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9904147" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2685-2697&author=B.+Le+Bourdonnecauthor=E.+Meulonauthor=S.+Yousauthor=J.-F.+Goossensauthor=R.+Houssinauthor=J.-P.+H%C3%A9nichart&title=Synthesis+and+Pharmacological+Evaluation+of+New+Pyrazolidine-3%2C5-diones+as+AT1+Angiotensin+II+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm9904147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904147%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBourdonnec%26aufirst%3DB.%26aulast%3DMeulon%26aufirst%3DE.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DJ.-F.%26aulast%3DHoussin%26aufirst%3DR.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.-P.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520New%2520Pyrazolidine-3%252C5-diones%2520as%2520AT1%2520Angiotensin%2520II%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2685%26epage%3D2697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Le Bourdonnec, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauvin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durant, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houssin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">HÃ©nichart, J.-P.</span><span> </span><span class="NLM_article-title">Comparison of 3D Structures and AT<sub>1</sub> Binding Properties of Pyrazolidine-3,5-diones and Tetrahydropyridazine-3,6-diones with Parent Antihypertensive Drug Irbesartan</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">â</span> <span class="NLM_lpage">4798</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010457z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4794-4798&author=B.+Le+Bourdonnecauthor=C.+Cauvinauthor=E.+Meulonauthor=S.+Yousauthor=J.-F.+Goossensauthor=F.+Durantauthor=R.+Houssinauthor=J.-P.+H%C3%A9nichart&title=Comparison+of+3D+Structures+and+AT1+Binding+Properties+of+Pyrazolidine-3%2C5-diones+and+Tetrahydropyridazine-3%2C6-diones+with+Parent+Antihypertensive+Drug+Irbesartan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm010457z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010457z%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBourdonnec%26aufirst%3DB.%26aulast%3DCauvin%26aufirst%3DC.%26aulast%3DMeulon%26aufirst%3DE.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DJ.-F.%26aulast%3DDurant%26aufirst%3DF.%26aulast%3DHoussin%26aufirst%3DR.%26aulast%3DH%25C3%25A9nichart%26aufirst%3DJ.-P.%26atitle%3DComparison%2520of%25203D%2520Structures%2520and%2520AT1%2520Binding%2520Properties%2520of%2520Pyrazolidine-3%252C5-diones%2520and%2520Tetrahydropyridazine-3%252C6-diones%2520with%2520Parent%2520Antihypertensive%2520Drug%2520Irbesartan%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4794%26epage%3D4798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Carini, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncia, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldrich, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santella, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, P. B. M. W. M.</span><span> </span><span class="NLM_article-title">Nonpeptide Angiotensin II Receptor Antagonists: The Discovery of a Series of <i>N</i>-(Biphenylmethyl)imidazoles as Potent, Orally Active Antihypertensives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2525</span><span class="NLM_x">â</span> <span class="NLM_lpage">2547</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00112a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2525-2547&author=D.+J.+Cariniauthor=J.+V.+Dunciaauthor=P.+E.+Aldrichauthor=A.+T.+Chiuauthor=A.+L.+Johnsonauthor=M.+E.+Pierceauthor=W.+A.+Priceauthor=J.+B.+Santellaauthor=G.+J.+Wellsauthor=R.+R.+Wexlerauthor=P.+C.+Wongauthor=S.-E.+Yooauthor=P.+B.+M.+W.+M.+Timmermans&title=Nonpeptide+Angiotensin+II+Receptor+Antagonists%3A+The+Discovery+of+a+Series+of+N-%28Biphenylmethyl%29imidazoles+as+Potent%2C+Orally+Active+Antihypertensives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm00112a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00112a031%26sid%3Dliteratum%253Aachs%26aulast%3DCarini%26aufirst%3DD.%2BJ.%26aulast%3DDuncia%26aufirst%3DJ.%2BV.%26aulast%3DAldrich%26aufirst%3DP.%2BE.%26aulast%3DChiu%26aufirst%3DA.%2BT.%26aulast%3DJohnson%26aufirst%3DA.%2BL.%26aulast%3DPierce%26aufirst%3DM.%2BE.%26aulast%3DPrice%26aufirst%3DW.%2BA.%26aulast%3DSantella%26aufirst%3DJ.%2BB.%26aulast%3DWells%26aufirst%3DG.%2BJ.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DYoo%26aufirst%3DS.-E.%26aulast%3DTimmermans%26aufirst%3DP.%2BB.%2BM.%2BW.%2BM.%26atitle%3DNonpeptide%2520Angiotensin%2520II%2520Receptor%2520Antagonists%253A%2520The%2520Discovery%2520of%2520a%2520Series%2520of%2520N-%2528Biphenylmethyl%2529imidazoles%2520as%2520Potent%252C%2520Orally%2520Active%2520Antihypertensives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2525%26epage%3D2547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basile, A. S.</span><span> </span><span class="NLM_article-title">Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">4275</span><span class="NLM_x">â</span> <span class="NLM_lpage">4284</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960325j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK28XlslWrtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=4275-4284&author=M.+Anziniauthor=A.+Cappelliauthor=S.+Vomeroauthor=G.+Giorgiauthor=T.+Langerauthor=G.+Bruniauthor=M.+R.+Romeoauthor=A.+S.+Basile&title=Molecular+Basis+of+Peripheral+vs+Central+Benzodiazepine+Receptor+Selectivity+in+a+New+Class+of+Peripheral+Benzodiazepine+Receptor+Ligands+Related+to+Alpidem"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of Peripheral vs. Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem</span></div><div class="casAuthors">Anzini, Maurizio; Cappelli, Andrea; Vomero, Salvatore; Giorgi, Gianluca; Langer, Thierry; Bruni, Giancarlo; Romeo, Raffaella; Basile, Anthony S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4275-4284</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alpidem (1), the anxiolytic imidazopyridine, has nanomolar binding affinity for both the central benzodiazepine receptor (CBR) and the peripheral benzodiazepine receptor (PBR).  A novel class of PBR ligands related to alpidem has been designed by comparing the interaction models of alpidem with PBR and CBR.  Several compds. in this class have shown high selectivity for PBR vs. CBR, and the selectivity has been discussed in terms of interaction models.  The binding behavior of the three selected compds. was extensively studied by competition and satn. assays, and the results suggest that they are capable of recognizing two sites labeled by [3H]PK11195.  The mol. structure of one of the most active compds. has been detd. by x-ray diffraction and compared with that of alpidem.  Mol. modeling studies suggest that the bioactive conformation of the most active compd. is likely to be very similar to the conformation found in the crystal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwjLUHIM9CbrVg90H21EOLACvtfcHk0lg42Gj3TogmfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlslWrtLg%253D&md5=6ca98ac59c013d9a70925ca33ebfaf70</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm960325j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960325j%26sid%3Dliteratum%253Aachs%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DVomero%26aufirst%3DS.%26aulast%3DGiorgi%26aufirst%3DG.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DBruni%26aufirst%3DG.%26aulast%3DRomeo%26aufirst%3DM.%2BR.%26aulast%3DBasile%26aufirst%3DA.%2BS.%26atitle%3DMolecular%2520Basis%2520of%2520Peripheral%2520vs%2520Central%2520Benzodiazepine%2520Receptor%2520Selectivity%2520in%2520a%2520New%2520Class%2520of%2520Peripheral%2520Benzodiazepine%2520Receptor%2520Ligands%2520Related%2520to%2520Alpidem%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D4275%26epage%3D4284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Larsen, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corley, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reamer, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschaen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossano, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bookes, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnett, J. F.</span><span> </span><span class="NLM_article-title">Efficient Synthesis of Losartan, A Nonpeptide Angiotensin II Receptor Antagonist</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6391</span><span class="NLM_x">â</span> <span class="NLM_lpage">6394</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00100a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK2cXmsFGksbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=6391-6394&author=R.+D.+Larsenauthor=A.+O.+Kingauthor=C.+Y.+Chenauthor=E.+G.+Corleyauthor=B.+S.+Fosterauthor=F.+E.+Robertsauthor=C.+Yangauthor=D.+R.+Liebermanauthor=R.+A.+Reamerauthor=D.+M.+Tschaenauthor=T.+R.+Verhoevenauthor=P.+J.+Reiderauthor=Y.+S.+Loauthor=L.+T.+Rossanoauthor=A.+S.+Bookesauthor=D.+Meloniauthor=J.+R.+Mooreauthor=J.+F.+Arnett&title=Efficient+Synthesis+of+Losartan%2C+A+Nonpeptide+Angiotensin+II+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Synthesis of Losartan, A Nonpeptide Angiotensin II Receptor Antagonist</span></div><div class="casAuthors">Larsen, Robert D.; King, Anthony O.; Chen, Cheng Y.; Corley, Edward G.; Foster, Bruce S.; Roberts, F. Edward; Yang, Chunhua; Lieberman, David R.; Reamer, Robert A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6391-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A highly efficient, convergent approach to the synthesis of the angiotensin II receptor antagonist losartan is described.  Directed ortho-metalation of 2-trityl-5-phenyltetrazole provides the key boronic acid intermediate.  This methodol. overcomes many of the drawbacks assocd. with previously reported syntheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwOeIqOlm7mrVg90H21EOLACvtfcHk0lgd7rqGeneT9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsFGksbw%253D&md5=79224d9dee9b79b2f5494cc2f4215f59</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjo00100a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00100a048%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DR.%2BD.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DCorley%26aufirst%3DE.%2BG.%26aulast%3DFoster%26aufirst%3DB.%2BS.%26aulast%3DRoberts%26aufirst%3DF.%2BE.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLieberman%26aufirst%3DD.%2BR.%26aulast%3DReamer%26aufirst%3DR.%2BA.%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26aulast%3DLo%26aufirst%3DY.%2BS.%26aulast%3DRossano%26aufirst%3DL.%2BT.%26aulast%3DBookes%26aufirst%3DA.%2BS.%26aulast%3DMeloni%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%2BR.%26aulast%3DArnett%26aufirst%3DJ.%2BF.%26atitle%3DEfficient%2520Synthesis%2520of%2520Losartan%252C%2520A%2520Nonpeptide%2520Angiotensin%2520II%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D6391%26epage%3D6394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezeny, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, T. R.</span><span> </span><span class="NLM_article-title">Mechanistic Studies of the Suzuki Cross-Coupling Reaction</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8151</span><span class="NLM_x">â</span> <span class="NLM_lpage">8156</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00105a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK2MXit12lt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=8151-8156&author=G.+B.+Smithauthor=G.+C.+Dezenyauthor=D.+L.+Hughesauthor=A.+O.+Kingauthor=T.+R.+Verhoeven&title=Mechanistic+Studies+of+the+Suzuki+Cross-Coupling+Reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Studies of the Suzuki Cross-Coupling Reaction</span></div><div class="casAuthors">Smith, George B.; Dezeny, George C.; Hughes, David L.; King, Anthony O.; Verhoeven, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">8151-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The key step in the synthesis of the drug losartan is a palladium-catalyzed cross-coupling reaction of an aryl bromide and a boronic acid.  The reaction scheme was defined in kinetic studies using HPLC, and computer simulation served to depict the time dependence of the concns. of palladium species, which were not obsd. exptl.  Two catalyst poisons were identified and characterized.  One was an isomeric impurity of the aryl bromide; the other was formed in the reaction mixt. upon hydrolysis of the boronic acid and two of its impurities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJiOg6dctaybVg90H21EOLACvtfcHk0lgd7rqGeneT9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXit12lt7c%253D&md5=db8e7f75415a8032063380eb78e43c90</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fjo00105a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00105a036%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BB.%26aulast%3DDezeny%26aufirst%3DG.%2BC.%26aulast%3DHughes%26aufirst%3DD.%2BL.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DVerhoeven%26aufirst%3DT.%2BR.%26atitle%3DMechanistic%2520Studies%2520of%2520the%2520Suzuki%2520Cross-Coupling%2520Reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D8151%26epage%3D8156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chang, R. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegl, P. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantlo, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patchett, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotti, V. J.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> Pharmacology of L-158,809, a New Highly Potent and Selective Angiotensin II Receptor Antagonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=1625192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK38XlsVejtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1992&pages=133-138&author=R.+S.+L.+Changauthor=P.+K.+S.+Sieglauthor=B.+W.+Clineschmidtauthor=N.+B.+Mantloauthor=P.+K.+Chakravartyauthor=W.+J.+Greenleeauthor=A.+A.+Patchettauthor=V.+J.+Lotti&title=In+vitro+Pharmacology+of+L-158%2C809%2C+a+New+Highly+Potent+and+Selective+Angiotensin+II+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist</span></div><div class="casAuthors">Chang, R. S. L.; Siegl, P. K. S.; Clineschmidt, B. V.; Mantlo, N. B.; Chakravarty, P. K.; Greenlee, W. J.; Patchett, A. A.; Lotti, V. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-8</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">L-158,809 (I), interacted in a competitive manner with rabbit aortic angiotensin II (AII) receptors as detd. by Scatchard anal. of the specific binding of [125I]Sar1Ile8-AII.  The affinity of I (IC50 = 0.3 nM) for AII receptors in this tissue was appreciably greater than that of other reported nonpeptide AII antagonists such as DuP-753 (IC50 = 54 nM) and EXP3174 (IC50 = 6 nM) and similar to the natural ligand, AII.  I also exhibited a high potency at AII receptors in several other tissues from different animal species (IC50 = 0.2-0.8 nM).  In vitro functional assays utilizing AII-induced aldosterone release in rat adrenal cortical cells demonstrated further that I acts as a competitive, high affinity antagonist of AII (pA2 = 10.5) and lacks agonist activity.  I also potently inhibited AII-induced inositol phosphate accumulation in vascular smooth muscle cells and contractile responses to AII in isolated blood vessels.  The specificity of I for AII receptors was demonstrated by its lack of activity (IC50 > 1 Î¼M) in several other receptor binding assays and its inability to affect in vitro functional responses produced by other agonists.  I demonstrated a very high selectivity for the AT1 compared to the AT2 receptor subtype (AT2 IC50 â¥ 10 Î¼M).  The high affinity and selectivity makes I a valuable new tool for investigating the physiol. and pharmacol. actions of AII.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvYXfKq9_TcLVg90H21EOLACvtfcHk0lgd7rqGeneT9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlsVejtb8%253D&md5=c841de436207fc3fa4aa882bfb72170d</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DR.%2BS.%2BL.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DClineschmidt%26aufirst%3DB.%2BW.%26aulast%3DMantlo%26aufirst%3DN.%2BB.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DLotti%26aufirst%3DV.%2BJ.%26atitle%3DIn%2520vitro%2520Pharmacology%2520of%2520L-158%252C809%252C%2520a%2520New%2520Highly%2520Potent%2520and%2520Selective%2520Angiotensin%2520II%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1992%26volume%3D262%26spage%3D133%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Robertoson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunoosamy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. L.</span><span> </span><span class="NLM_article-title">Effects of Peptidase Inhibition on Angiotensin Receptor Agonist and Antagonist Potency in Rabbit Isolated Thoracic Aorta</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">â</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=1354540" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1992&pages=166-172&author=M.+J.+Robertosonauthor=M.+P.+Cunoosamyauthor=K.+L.+Clark&title=Effects+of+Peptidase+Inhibition+on+Angiotensin+Receptor+Agonist+and+Antagonist+Potency+in+Rabbit+Isolated+Thoracic+Aorta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobertoson%26aufirst%3DM.%2BJ.%26aulast%3DCunoosamy%26aufirst%3DM.%2BP.%26aulast%3DClark%26aufirst%3DK.%2BL.%26atitle%3DEffects%2520of%2520Peptidase%2520Inhibition%2520on%2520Angiotensin%2520Receptor%2520Agonist%2520and%2520Antagonist%2520Potency%2520in%2520Rabbit%2520Isolated%2520Thoracic%2520Aorta%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D106%26spage%3D166%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Epithelial Transport of Drugs in Cell Culture. I: A Model for Studying the Passive Diffusion of Drugs over Intestinal Absorbtive (Caco-2) Cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">476</span><span class="NLM_x">â</span> <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1002%2Fjps.2600790604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=1975619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFSru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1990&pages=476-482&author=P.+Artursson&title=Epithelial+Transport+of+Drugs+in+Cell+Culture.+I%3A+A+Model+for+Studying+the+Passive+Diffusion+of+Drugs+over+Intestinal+Absorbtive+%28Caco-2%29+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial transport of drugs in cell culture.  I:  a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells</span></div><div class="casAuthors">Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">476-82</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A human intestinal cell line, Caco-2, was used as a model to study the passive diffusion of drugs across intestinal epithelium.  The cells formed continuous monolayers when grown on permeable filters of polycarbonate.  After 10 days in culture, the monolayers had a transmembrane resistance of â¼260 Î©.cm2 and a cell d. of 0.9 Ã 106 cells/cm2.  At this time the cells were impermeable to [14C]polyethyleneglycol (MW 4000).  These characteristics remained const. for 20 days (i.e., from day 10 to day 30).  Six Î²-blocking agents with a 2000-fold range of lipophilicity were studied for their transepithelial transport properties.  The transport parameters were independent of drug concn. and transport direction.  The apparent permeability coeffs. ranged from 41.91 Ã 10-6 cm/s for the most lipophilic drug, propranolol, to 0.203 Ã 10-6 cm/s for the most hydrophilic drug, atenolol.  The transport parameters were compared with those published for rat ileum.  The transport rates were similar for four out of five drugs.  Atenolol was transported at a slower rate in the Caco-2 model, which may be explained by the fact that the Caco-2 cells form a tighter epithelium than the rat ileal enterocytes.  Thus, Caco-2 cells may be used to model the intestinal absorption of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9RIMzEBiAqrVg90H21EOLACvtfcHk0li9zWZxViDGRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFSru74%253D&md5=68642fc4f08aaaa5a343822bea9ee95f</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600790604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600790604%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DEpithelial%2520Transport%2520of%2520Drugs%2520in%2520Cell%2520Culture.%2520I%253A%2520A%2520Model%2520for%2520Studying%2520the%2520Passive%2520Diffusion%2520of%2520Drugs%2520over%2520Intestinal%2520Absorbtive%2520%2528Caco-2%2529%2520Cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1990%26volume%3D79%26spage%3D476%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Artursson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J.</span><span> </span><span class="NLM_article-title">Correlation between Oral Drug Absorption in Humans and Apparent Drug Permeability Coefficients in Human Intestinal Epithelial (Caco-2) Cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun..</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">â</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1016%2F0006-291X%2891%2991647-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=1673839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1991&pages=880-885&author=P.+Arturssonauthor=J.+Karlsson&title=Correlation+between+Oral+Drug+Absorption+in+Humans+and+Apparent+Drug+Permeability+Coefficients+in+Human+Intestinal+Epithelial+%28Caco-2%29+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells</span></div><div class="casAuthors">Artursson, P.; Karlsson, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">880-5</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Monolayers of a well differentiated human intestinal epithelial cell line, Caco-2, were used as a model to study passive drug absorption across the intestinal epithelium.  Absorption rate consts. (expressed as apparent permeability coeffs.) were detd. for 20 drugs and peptides with different structural properties.  The permeability coeffs. ranged from approx. 5 Ã 10-8 to 5 Ã 10-5 cm/s.  A good correlation was obtained between data on oral absorption in humans and the results in the Caco-2 model.  Drugs that are completely absorbed in humans had permeability coeffs. >1 Ã 10-6 cm/s.  Drugs that are absorbed to >1% but <100% had permeability coeffs. of 0.1-1.0 Ã 10-6 cm/s while drugs and peptides that are absorbed to <1% had permeability coeffs. of â¤1 Ã 10-7 cm/s.  The results indicate that Caco-2 monolayers can be used as a model for studies on intestinal drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdvsEluSXCILVg90H21EOLACvtfcHk0li9zWZxViDGRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D&md5=3b1e14cae3beb0345014284e3aa6a7c0</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991647-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991647-U%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DKarlsson%26aufirst%3DJ.%26atitle%3DCorrelation%2520between%2520Oral%2520Drug%2520Absorption%2520in%2520Humans%2520and%2520Apparent%2520Drug%2520Permeability%2520Coefficients%2520in%2520Human%2520Intestinal%2520Epithelial%2520%2528Caco-2%2529%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun..%26date%3D1991%26volume%3D175%26spage%3D880%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ribadeneira, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aungst, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyermann, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-M.</span><span> </span><span class="NLM_article-title">Effects of Structural Modifications on the Intestinal Permeability of Angiotensin II Receptor Antagonists and the Correlation of In Vitro, In Situ, and In Vivo Absorption</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">â</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=227-233&author=M.+D.+Ribadeneiraauthor=B.+J.+Aungstauthor=C.+J.+Eyermannauthor=S.-M.+Huang&title=Effects+of+Structural+Modifications+on+the+Intestinal+Permeability+of+Angiotensin+II+Receptor+Antagonists+and+the+Correlation+of+In+Vitro%2C+In+Situ%2C+and+In+Vivo+Absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRibadeneira%26aufirst%3DM.%2BD.%26aulast%3DAungst%26aufirst%3DB.%2BJ.%26aulast%3DEyermann%26aufirst%3DC.%2BJ.%26aulast%3DHuang%26aufirst%3DS.-M.%26atitle%3DEffects%2520of%2520Structural%2520Modifications%2520on%2520the%2520Intestinal%2520Permeability%2520of%2520Angiotensin%2520II%2520Receptor%2520Antagonists%2520and%2520the%2520Correlation%2520of%2520In%2520Vitro%252C%2520In%2520Situ%252C%2520and%2520In%2520Vivo%2520Absorption%26jtitle%3DPharm.%2520Res.%26date%3D1996%26volume%3D13%26spage%3D227%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Takezako, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogonea, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnik, S. S.</span><span> </span><span class="NLM_article-title">âNetwork Leaningâ as a Mechanism of Insurmountable Antagonism of the Angiotensin II Type 1 Receptor by Non-peptide Antagonists</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15248</span><span class="NLM_x">â</span> <span class="NLM_lpage">15257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15248-15257&author=T.+Takezakoauthor=C.+Gogoneaauthor=Y.+Saadauthor=K.+Nodaauthor=S.+S.+Karnik&title=%E2%80%9CNetwork+Leaning%E2%80%9D+as+a+Mechanism+of+Insurmountable+Antagonism+of+the+Angiotensin+II+Type+1+Receptor+by+Non-peptide+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakezako%26aufirst%3DT.%26aulast%3DGogonea%26aufirst%3DC.%26aulast%3DSaad%26aufirst%3DY.%26aulast%3DNoda%26aufirst%3DK.%26aulast%3DKarnik%26aufirst%3DS.%2BS.%26atitle%3D%25E2%2580%259CNetwork%2520Leaning%25E2%2580%259D%2520as%2520a%2520Mechanism%2520of%2520Insurmountable%2520Antagonism%2520of%2520the%2520Angiotensin%2520II%2520Type%25201%2520Receptor%2520by%2520Non-peptide%2520Antagonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15248%26epage%3D15257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">The marketed AT<sub>1</sub> receptor antagonists show limited oral bioavailability (e. g. eprosartan 13%, valsartan 25%, losartan 33%, candesartan 42%, telmisartan 50%, irbesartan 60â80%.</p></div><span class="NLM_contrib-group">Israili, Z. H.</span><span> </span><span class="NLM_article-title">Clinical Pharmacokinetics of Angiotensin II (AT1) Receptor Blockers in Hypertension</span> <span class="citation_source-journal">J. Hum. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S73</span><span class="NLM_x">â</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=S73-86&issue=1&author=Z.+H.+Israili&title=Clinical+Pharmacokinetics+of+Angiotensin+II+%28AT1%29+Receptor+Blockers+in+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsraili%26aufirst%3DZ.%2BH.%26atitle%3DClinical%2520Pharmacokinetics%2520of%2520Angiotensin%2520II%2520%2528AT1%2529%2520Receptor%2520Blockers%2520in%2520Hypertension%26jtitle%3DJ.%2520Hum.%2520Hypertens.%26date%3D2000%26volume%3D14%26issue%3D1%26spage%3DS73%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brunner, H. R.</span><span> </span><span class="NLM_article-title">The New Angiotensin II Receptor Antagonist, Irbesartan</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">311S</span><span class="NLM_x">â</span> <span class="NLM_lpage">317S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1997&pages=311S-317S&author=H.+R.+Brunner&title=The+New+Angiotensin+II+Receptor+Antagonist%2C+Irbesartan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunner%26aufirst%3DH.%2BR.%26atitle%3DThe%2520New%2520Angiotensin%2520II%2520Receptor%2520Antagonist%252C%2520Irbesartan%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D1997%26volume%3D10%26spage%3D311S%26epage%3D317S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">Moreover, losartan exhibiting highly variable oral bioavailability is transported by P-glycoprotein, while its carboxylic acid metabolite is not a P-glycoprotein substrate; see:</p></div><span class="NLM_contrib-group">Soldner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutschler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christians, U.</span><span> </span><span class="NLM_article-title">Active Transport of the Angiotensin-II Antagonist Losartan and its Main Metabolite EXP 3174 Across MDCK-MDR1 and Caco-2 Cell Monolayers</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">â</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1038%2Fsj.bjp.0703150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=10725273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1egsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=1235-1243&author=A.+Soldnerauthor=L.+Z.+Benetauthor=E.+Mutschlerauthor=U.+Christians&title=Active+Transport+of+the+Angiotensin-II+Antagonist+Losartan+and+its+Main+Metabolite+EXP+3174+Across+MDCK-MDR1+and+Caco-2+Cell+Monolayers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers</span></div><div class="casAuthors">Soldner, Andrea; Benet, Leslie Z.; Mutschler, Ernst; Christians, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1235-1243</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors studied the functional interaction between transport and metab. by comparing the transport of losartan and its active metabolite EXP 3174 (EXP) across cell monolayers.  Epithelial layers of Caco-2 cells as well as MDR1, MRP-1 and MRP-2 overexpressing cells, in comparison to the resp. wild-types, were used to characterize the transcellular transport of losartan and EXP.  Losartan transport in MDCK-MDR1 and Caco-2 cells was saturable and energy-dependent with a significantly greater basolateral-to-apical (B/A) than apical-to-basolateral (A/B) flux (ratio = 31Â±1 in MDCK-MDR1 and ratio 4Â±1 in Caco-2 cells).  The B/A flux of losartan was inhibited by cyclosporine and vinblastine, inhibitors of P-glycoprotein and MRP.  In contrast, no active losartan transport was obsd. in MRP-1 or MRP-2 overexpressing cells.  The metabolite was only transported in Caco-2 cells with a B/A-to-A/B ratio of 5Â±1, while lacking active transport in the MDR1, MRP-1 or MRP-2 overexpressing cells.  The B/A flux of EXP was significantly inhibited by cyclosporine and vinblastine.  In conclusion, losartan is transported by P-glycoprotein and other intestinal transporters, that do not include MRP-1 and MRP-2.  In contrast, the carboxylic acid metabolite is not a P-glycoprotein substrate, but displays considerably higher affinity for other transporters than losartan, that again most probably do not include MRP-1 and MRP-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1aTLfRPhJ9rVg90H21EOLACvtfcHk0lhJ1XV9hDw-Pw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1egsL4%253D&md5=fdc0bf483ec38ec5ba573b295b6a4b7f</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703150%26sid%3Dliteratum%253Aachs%26aulast%3DSoldner%26aufirst%3DA.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DMutschler%26aufirst%3DE.%26aulast%3DChristians%26aufirst%3DU.%26atitle%3DActive%2520Transport%2520of%2520the%2520Angiotensin-II%2520Antagonist%2520Losartan%2520and%2520its%2520Main%2520Metabolite%2520EXP%25203174%2520Across%2520MDCK-MDR1%2520and%2520Caco-2%2520Cell%2520Monolayers%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D129%26spage%3D1235%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><a href="http://www.fda.gov/cder/foi/label/2002/20386s28lbl.pdf" class="extLink">http://www.fda.gov/cder/foi/label/2002/20386s28lbl.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.fda.gov%2Fcder%2Ffoi%2Flabel%2F2002%2F20386s28lbl.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Comparative studies on the UDP-glucuronosyltransferase-dependent metabolism showed that intrinsic clearance (CL<sub>intrinsic</sub> = <i>V</i><sub>max</sub>/<i>K</i><sub>m</sub>) of compound <b>4b</b> is 7-fold higher than that shown by <b>2a</b> (Valoti, M. Personal communication). Interestingly, other authors reported that the absence of <b>2a</b> glucuronide in the hepatocyte and its presence in the bile suggest that its rate of formation is much slower than that of transport out of the cell [see:</p></div><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieter, P. A.</span><span> </span><span class="NLM_article-title">Disposition of Angiotensin II Receptor Antagonist L-158,809 in Rats and Rhesus Monkeys</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">â</span> <span class="NLM_lpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=183-188&author=A.+E.+Collettiauthor=P.+A.+Krieter&title=Disposition+of+Angiotensin+II+Receptor+Antagonist+L-158%2C809+in+Rats+and+Rhesus+Monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DKrieter%26aufirst%3DP.%2BA.%26atitle%3DDisposition%2520of%2520Angiotensin%2520II%2520Receptor%2520Antagonist%2520L-158%252C809%2520in%2520Rats%2520and%2520Rhesus%2520Monkeys%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1994%26volume%3D22%26spage%3D183%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huskey, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.-H. L.</span><span> </span><span class="NLM_article-title">N-Glucuronidation Reactions. I. Tetrazole N-Glucuronidation of Selected Angiotensin II Receptor Antagonists in Hepatic Microsome from Rats, Dogs, Monkeys, and Humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">â</span> <span class="NLM_lpage">799</span><div class="note"><p class="first last">and references cited therein]</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1993&pages=792-799&author=S.+W.+Huskeyauthor=R.+R.+Millerauthor=S.-H.+L.+Chiu&title=N-Glucuronidation+Reactions.+I.+Tetrazole+N-Glucuronidation+of+Selected+Angiotensin+II+Receptor+Antagonists+in+Hepatic+Microsome+from+Rats%2C+Dogs%2C+Monkeys%2C+and+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuskey%26aufirst%3DS.%2BW.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26atitle%3DN-Glucuronidation%2520Reactions.%2520I.%2520Tetrazole%2520N-Glucuronidation%2520of%2520Selected%2520Angiotensin%2520II%2520Receptor%2520Antagonists%2520in%2520Hepatic%2520Microsome%2520from%2520Rats%252C%2520Dogs%252C%2520Monkeys%252C%2520and%2520Humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1993%26volume%3D21%26spage%3D792%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Vauquelin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Liefde, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birzbier, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderheyden, P. M. L.</span><span> </span><span class="NLM_article-title">New Insights in Insurmountable Antagonism</span> <span class="citation_source-journal">Fund. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">â</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm7011563&amp;key=10.1046%2Fj.1472-8206.2002.00095.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm7011563&amp;key=12570014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm7011563&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFGqsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=263-272&author=G.+Vauquelinauthor=I.+Van+Liefdeauthor=B.+B.+Birzbierauthor=P.+M.+L.+Vanderheyden&title=New+Insights+in+Insurmountable+Antagonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">New insights in insurmountable antagonism</span></div><div class="casAuthors">Vauquelin, G.; Van Liefde, I.; Birzbier, B. B.; Vanderheyden, P. M. L.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Antagonists that produce parallel rightward shifts of agonist dose-response curves with no alteration of the maximal response are traditionally classified as surmountable, while insurmountable antagonists also depress the maximal response.  Although the longevity of the antagonist-receptor complex is quoted in many studies to explain insurmountable antagonism, slowly interconverting receptor conformations, allosteric binding sites, and receptor internalization have been evoked as alternative explanations.  To complicate matters even further, insurmountable antagonism is not only drug-related; it may also depend on the tissue, species, and exptl. design.  For the sake of drug development, it is important to elucidate the mol. mechanisms of insurmountable antagonism.  New exptl. approaches, such as intact cell studies and the use of computer-assisted simulations based on dynamic receptor models, herald the advent of better insight in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdd2pIzF7eurVg90H21EOLACvtfcHk0lhJ1XV9hDw-Pw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFGqsbw%253D&md5=3a0a020f6fba65ac16bce0d8b87f4b70</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1046%2Fj.1472-8206.2002.00095.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1472-8206.2002.00095.x%26sid%3Dliteratum%253Aachs%26aulast%3DVauquelin%26aufirst%3DG.%26aulast%3DVan%2BLiefde%26aufirst%3DI.%26aulast%3DBirzbier%26aufirst%3DB.%2BB.%26aulast%3DVanderheyden%26aufirst%3DP.%2BM.%2BL.%26atitle%3DNew%2520Insights%2520in%2520Insurmountable%2520Antagonism%26jtitle%3DFund.%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D16%26spage%3D263%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span>SHELXS-97, Rel. 97-2, A Program for Automatic Solution of Crystal Structures, <span class="NLM_publisher-name">Gottingen University</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=G.+M.+Sheldrick&title=SHELXS-97%2C+Rel.+97-2%2C+A+Program+for+Automatic+Solution+of+Crystal+Structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26jtitle%3DSHELXS-97%252C%2520Rel.%252097-2%252C%2520A%2520Program%2520for%2520Automatic%2520Solution%2520of%2520Crystal%2520Structures%26pub%3DGottingen%2520University%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span>SHELXL-97, Rel. 97-2, A Program for Crystal Structure Refinement, <span class="NLM_publisher-name">Gottingen University</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=G.+M.+Sheldrick&title=SHELXL-97%2C+Rel.+97-2%2C+A+Program+for+Crystal+Structure+Refinement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26jtitle%3DSHELXL-97%252C%2520Rel.%252097-2%252C%2520A%2520Program%2520for%2520Crystal%2520Structure%2520Refinement%26pub%3DGottingen%2520University%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">De Lean, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodbard, D.</span><span> </span><span class="NLM_article-title">Simultaneous Analysis of Families of Sigmoidal Curves: Application to Bioassay, Radioligand Assay and Physiological Dose-Response Curves</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">E97</span><span class="NLM_x">â</span> <span class="NLM_lpage">E102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1978&pages=E97-E102&author=K.+W.+De+Leanauthor=P.+J.+Munsonauthor=D.+Rodbard&title=Simultaneous+Analysis+of+Families+of+Sigmoidal+Curves%3A+Application+to+Bioassay%2C+Radioligand+Assay+and+Physiological+Dose-Response+Curves"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLean%26aufirst%3DK.%2BW.%26aulast%3DMunson%26aufirst%3DP.%2BJ.%26aulast%3DRodbard%26aufirst%3DD.%26atitle%3DSimultaneous%2520Analysis%2520of%2520Families%2520of%2520Sigmoidal%2520Curves%253A%2520Application%2520to%2520Bioassay%252C%2520Radioligand%2520Assay%2520and%2520Physiological%2520Dose-Response%2520Curves%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1978%26volume%3D235%26spage%3DE97%26epage%3DE102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a href="/doi/suppl/10.1021/jm7011563">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14206"></div></div></div></div></div><hr /></hr><p class="last">Full experimental details for the synthesis and the characterization of <b>7</b> and <b>8</b> and related compounds (chemistry, NMR, MS, crystallography). This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7011563/suppl_file/jm7011563-file002.pdf">jm7011563-file002.pdf (1.09 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm7011563&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-7%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm7011563%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm7011563" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                786KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999c3b7c65d1b7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
